data_1df6_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1df6 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 51.8 m . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 121.545 0.688 . . . . 0.0 112.266 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.8 m -104.85 36.11 2.55 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 113.422 -1.717 . . . . 0.0 110.268 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 18.9 t -24.77 -55.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.667 0 N-CA-C 114.968 1.469 . . . . 0.0 114.968 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -126.54 -55.19 1.43 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 103.491 -2.781 . . . . 0.0 103.491 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.5 pt -71.02 158.18 88.73 Favored Pre-proline 0 C--N 1.307 -1.269 0 CA-C-N 112.667 -2.061 . . . . 0.0 108.35 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -55.19 -174.88 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 123.115 2.543 . . . . 0.0 112.216 162.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.44 ' SG ' ' OG1' ' A' ' 10' ' ' THR . 48.4 t -77.68 -52.15 9.43 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.211 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 59.5 p 45.83 33.36 1.52 Allowed 'General case' 0 N--CA 1.507 2.385 0 O-C-N 125.046 1.466 . . . . 0.0 114.085 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 56.0 t -141.29 -40.34 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 113.438 -1.71 . . . . 0.0 110.291 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.448 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 72.4 p -124.19 -17.92 6.02 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 124.031 0.832 . . . . 0.0 110.723 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.75 -23.65 2.86 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 123.782 0.676 . . . . 0.0 111.918 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.2 mp -51.93 -42.67 63.0 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 114.561 -1.2 . . . . 0.0 112.593 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -89.4 -6.61 56.42 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 118.51 20.54 4.24 Favored Glycine 0 N--CA 1.499 2.891 0 O-C-N 123.998 0.811 . . . . 0.0 113.221 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.448 ' SG ' ' HB ' ' A' ' 10' ' ' THR . 83.1 m -81.29 75.56 8.25 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 122.745 1.26 . . . . 0.0 110.972 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.5 m -57.19 124.04 17.41 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 112.217 -2.265 . . . . 0.0 111.481 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.4 ' SG ' ' HB2' ' A' ' 7' ' ' CYS . 48.3 m -62.47 85.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 124.544 1.152 . . . . 0.0 113.562 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.5 m -94.04 125.56 38.74 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.8 p30 46.75 43.4 12.96 Favored 'General case' 0 N--CA 1.503 2.221 0 CA-C-O 122.566 1.174 . . . . 0.0 110.708 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.7 mtm-85 56.81 36.18 27.33 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-N 112.409 -2.178 . . . . 0.0 111.843 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 63.7 t -136.11 122.1 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.447 ' SG ' ' HB3' ' A' ' 30' ' ' GLU . 3.5 m -57.48 122.08 11.8 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.52 124.09 23.61 Favored 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 116.384 1.994 . . . . 0.0 116.384 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.447 ' C ' ' H ' ' A' ' 26' ' ' ILE . 42.5 t-20 -127.9 59.51 1.47 Allowed 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 104.776 -2.305 . . . . 0.0 104.776 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.51 -39.91 3.1 Favored Glycine 0 N--CA 1.482 1.752 0 N-CA-C 106.716 -2.554 . . . . 0.0 106.716 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.447 ' H ' ' C ' ' A' ' 24' ' ' ASN . 2.0 tt -139.37 146.28 47.85 Favored Pre-proline 0 N--CA 1.489 1.521 0 N-CA-C 102.749 -3.056 . . . . 0.0 102.749 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -64.5 172.87 6.05 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 121.898 1.732 . . . . 0.0 111.128 -168.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.5 m -141.68 23.21 2.12 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 113.773 -1.558 . . . . 0.0 108.057 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 63.68 -176.16 0.16 Allowed 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.017 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.447 ' HB3' ' SG ' ' A' ' 22' ' ' CYS . 12.0 tp10 . . . . . 0 N--CA 1.503 2.21 0 O-C-N 124.095 0.872 . . . . 0.0 110.144 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.496 1.851 0 CA-C-O 121.862 0.839 . . . . 0.0 112.133 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -104.72 39.54 1.67 Allowed 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 113.093 -1.867 . . . . 0.0 110.523 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 19.8 t -26.59 -54.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.687 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -125.51 -58.05 1.44 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 103.297 -2.853 . . . . 0.0 103.297 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.5 pt -69.02 156.52 91.37 Favored Pre-proline 0 C--N 1.305 -1.354 0 CA-C-N 112.403 -2.18 . . . . 0.0 108.369 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -58.81 -177.09 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 123.014 2.476 . . . . 0.0 111.262 161.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.5 ' SG ' ' OG1' ' A' ' 10' ' ' THR . 12.7 t -79.03 -43.39 24.36 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.13 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.4 p 39.13 42.15 0.69 Allowed 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.1 t -149.41 -66.26 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 CA-C-N 112.654 -2.066 . . . . 0.0 107.002 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.5 ' OG1' ' SG ' ' A' ' 7' ' ' CYS . 71.9 p -77.67 -5.2 49.63 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.379 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.31 -19.84 6.11 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.604 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 36.1 mt -53.34 -42.59 66.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 124.274 0.984 . . . . 0.0 111.442 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.49 -9.57 49.53 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 124.286 0.991 . . . . 0.0 111.436 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.97 35.41 5.58 Favored Glycine 0 N--CA 1.492 2.371 0 O-C-N 124.317 1.011 . . . . 0.0 110.781 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.521 ' SG ' ' C ' ' A' ' 22' ' ' CYS . 0.9 OUTLIER -75.78 90.1 2.88 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 122.992 1.377 . . . . 0.0 112.02 179.932 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.9 m -62.45 119.6 9.46 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 112.324 -2.217 . . . . 0.0 111.293 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.444 ' SG ' ' HB2' ' A' ' 7' ' ' CYS . 36.9 m -63.7 85.21 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 114.634 -1.166 . . . . 0.0 113.974 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.8 m -90.96 126.35 36.05 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.1 p30 46.42 44.62 13.09 Favored 'General case' 0 N--CA 1.505 2.305 0 CA-C-O 122.732 1.253 . . . . 0.0 110.72 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.1 mtm180 56.7 36.7 28.05 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 112.33 -2.214 . . . . 0.0 112.291 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.5 t -136.03 121.81 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.521 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 3.2 m -57.2 118.92 5.55 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.67 137.36 41.72 Favored 'General case' 0 N--CA 1.506 2.36 0 N-CA-C 118.023 2.601 . . . . 0.0 118.023 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.452 ' HB2' ' HA ' ' A' ' 15' ' ' CYS . 43.6 t-20 -150.21 61.95 0.97 Allowed 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.41 -50.97 3.62 Favored Glycine 0 N--CA 1.481 1.637 0 N-CA-C 104.966 -3.254 . . . . 0.0 104.966 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.3 pt -125.09 146.4 53.61 Favored Pre-proline 0 C--N 1.308 -1.228 0 N-CA-C 103.853 -2.647 . . . . 0.0 103.853 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -67.25 177.74 3.57 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 122.372 2.048 . . . . 0.0 110.646 -177.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.9 m -144.78 25.53 1.45 Allowed 'General case' 0 N--CA 1.501 2.082 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.226 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 65.97 171.78 0.23 Allowed 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.93 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.5 2.067 0 O-C-N 124.426 1.079 . . . . 0.0 110.937 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 77.4 p . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 121.235 0.541 . . . . 0.0 110.829 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.473 ' SG ' ' C ' ' A' ' 20' ' ' ARG . 0.5 OUTLIER -104.8 36.37 2.46 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 114.138 -1.392 . . . . 0.0 111.355 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.452 ' CA ' ' HG2' ' A' ' 20' ' ' ARG . 54.2 t -22.55 -61.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.567 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -120.63 -25.94 5.41 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 113.41 -1.723 . . . . 0.0 107.654 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.417 ' CG1' ' HA ' ' A' ' 2' ' ' CYS . 2.2 pt -80.83 -175.86 0.68 Allowed Pre-proline 0 CA--C 1.562 1.442 0 CA-C-N 113.144 -1.844 . . . . 0.0 110.542 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -87.24 -53.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.322 0 C-N-CA 124.985 3.79 . . . . 0.0 110.981 173.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.52 ' SG ' ' OG1' ' A' ' 10' ' ' THR . 45.5 t 179.34 -49.59 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 124.535 1.147 . . . . 0.0 109.689 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.5 t 36.27 26.68 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 119.621 3.193 . . . . 0.0 119.621 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.0 t -145.38 -55.15 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.635 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.52 ' OG1' ' SG ' ' A' ' 7' ' ' CYS . 41.7 p -95.82 -1.04 50.4 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 124.045 0.84 . . . . 0.0 110.241 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.25 -14.96 43.94 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.482 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.9 mt -54.8 -42.95 72.44 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 114.908 -1.042 . . . . 0.0 112.092 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.38 -2.86 58.57 Favored 'General case' 0 C--N 1.31 -1.13 0 O-C-N 124.108 0.88 . . . . 0.0 111.381 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.3 36.8 6.12 Favored Glycine 0 N--CA 1.494 2.534 0 O-C-N 124.332 1.02 . . . . 0.0 110.808 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.3 t -83.3 90.69 7.17 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.847 1.308 . . . . 0.0 111.843 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.44 ' N ' ' O ' ' A' ' 23' ' ' TYR . 67.7 m -62.39 119.22 8.69 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 112.112 -2.313 . . . . 0.0 112.91 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.512 ' SG ' ' HA ' ' A' ' 20' ' ' ARG . 54.0 t -66.05 132.65 49.03 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 114.888 -1.051 . . . . 0.0 112.629 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.6 m -138.6 130.56 28.15 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 103.524 -2.769 . . . . 0.0 103.524 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.3 p30 46.49 43.12 11.81 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-O 122.816 1.293 . . . . 0.0 110.197 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.512 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 7.7 mtp180 55.87 37.66 29.11 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 112.223 -2.262 . . . . 0.0 112.645 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 63.0 t -135.97 111.76 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 CA-C-N 113.512 -1.676 . . . . 0.0 106.879 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.608 ' HB2' ' SG ' ' A' ' 28' ' ' CYS . 58.0 m -52.64 129.69 30.1 Favored 'General case' 0 N--CA 1.506 2.351 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.44 ' O ' ' N ' ' A' ' 16' ' ' SER . 0.2 OUTLIER -136.08 140.36 43.7 Favored 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 116.106 1.891 . . . . 0.0 116.106 -179.087 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.418 ' C ' ' H ' ' A' ' 26' ' ' ILE . 11.4 t-20 -145.12 57.13 1.26 Allowed 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.48 -48.82 3.39 Favored Glycine 0 N--CA 1.48 1.608 0 N-CA-C 104.377 -3.489 . . . . 0.0 104.377 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.418 ' H ' ' C ' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -126.3 145.33 52.26 Favored Pre-proline 0 C--N 1.308 -1.221 0 N-CA-C 102.82 -3.03 . . . . 0.0 102.82 179.492 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -64.87 177.45 2.34 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.243 1.962 . . . . 0.0 111.02 -175.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.608 ' SG ' ' HB2' ' A' ' 22' ' ' CYS . 2.2 p -142.1 9.17 1.89 Allowed 'General case' 0 N--CA 1.502 2.141 0 CA-C-N 114.693 -1.14 . . . . 0.0 108.486 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 73.52 -176.04 0.16 Allowed 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 . . . . . 0 N--CA 1.502 2.166 0 O-C-N 124.047 0.842 . . . . 0.0 110.042 -179.869 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 31.6 p . . . . . 0 N--CA 1.495 1.822 0 CA-C-O 121.14 0.495 . . . . 0.0 111.055 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.7 m -104.75 36.34 2.46 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 114.275 -1.329 . . . . 0.0 109.726 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.2 t -23.09 -57.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.616 0 O-C-N 125.106 1.504 . . . . 0.0 114.761 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -125.72 -56.97 1.47 Allowed 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 102.985 -2.969 . . . . 0.0 102.985 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.5 pt -70.02 151.79 96.02 Favored Pre-proline 0 C--N 1.306 -1.324 0 CA-C-N 112.371 -2.195 . . . . 0.0 108.798 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -59.39 -176.8 0.11 Allowed 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 123.066 2.511 . . . . 0.0 111.565 167.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.55 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 34.6 t -78.63 -53.39 7.22 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.0 p 39.05 37.29 0.21 Allowed 'General case' 0 N--CA 1.504 2.236 0 O-C-N 125.006 1.441 . . . . 0.0 114.887 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 51.1 t -141.57 -63.12 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 CA-C-N 112.77 -2.014 . . . . 0.0 106.788 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.473 ' OG1' ' SG ' ' A' ' 7' ' ' CYS . 35.6 p -92.31 -10.02 39.87 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.59 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.8 -19.13 15.54 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.912 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -52.35 -38.8 59.67 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 114.72 -1.127 . . . . 0.0 112.684 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.53 -13.7 36.78 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 123.989 0.806 . . . . 0.0 111.374 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.36 27.75 3.26 Favored Glycine 0 N--CA 1.495 2.567 0 O-C-N 124.449 1.093 . . . . 0.0 111.178 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.459 ' SG ' ' C ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER -80.9 81.72 7.07 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 123.001 1.382 . . . . 0.0 111.819 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 38.7 m -58.02 125.03 21.39 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 112.407 -2.179 . . . . 0.0 113.397 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.55 ' SG ' ' HB2' ' A' ' 7' ' ' CYS . 35.0 m -65.66 82.77 0.06 Allowed 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.3 t -91.11 123.09 34.3 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.3 p30 45.98 47.01 12.66 Favored 'General case' 0 N--CA 1.504 2.269 0 CA-C-O 122.984 1.373 . . . . 0.0 110.409 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 56.53 36.83 28.2 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 111.907 -2.406 . . . . 0.0 112.686 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 69.2 t -136.11 118.79 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.459 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 4.3 m -58.38 123.05 14.82 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.87 133.84 38.17 Favored 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 117.064 2.246 . . . . 0.0 117.064 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.459 ' C ' ' H ' ' A' ' 26' ' ' ILE . 22.1 t-20 -144.17 60.71 1.35 Allowed 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.77 -32.1 4.09 Favored Glycine 0 N--CA 1.483 1.813 0 N-CA-C 107.977 -2.049 . . . . 0.0 107.977 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.459 ' H ' ' C ' ' A' ' 24' ' ' ASN . 4.3 tt -149.92 145.42 18.86 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 103.264 -2.865 . . . . 0.0 103.264 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -67.85 177.73 3.98 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.103 1.869 . . . . 0.0 111.108 -171.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.4 m -142.19 19.15 2.09 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.156 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 69.06 172.94 0.3 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 124.377 1.048 . . . . 0.0 110.335 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.501 2.114 0 O-C-N 124.444 1.09 . . . . 0.0 109.55 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 35.8 p . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.181 0.515 . . . . 0.0 111.299 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.6 m -104.67 36.98 2.24 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 114.162 -1.381 . . . . 0.0 109.727 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 19.6 t -25.48 -56.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.681 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -125.07 -57.31 1.52 Allowed 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 103.54 -2.763 . . . . 0.0 103.54 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.2 pt -69.53 152.96 96.14 Favored Pre-proline 0 C--N 1.306 -1.326 0 CA-C-N 112.311 -2.222 . . . . 0.0 108.675 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -59.74 -177.4 0.14 Allowed 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 123.005 2.47 . . . . 0.0 111.661 164.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.523 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 42.1 t -79.34 -50.94 10.09 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.319 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.9 p 37.21 40.99 0.2 Allowed 'General case' 0 N--CA 1.504 2.259 0 O-C-N 125.121 1.513 . . . . 0.0 115.055 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 43.6 t -145.23 -67.87 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-N 112.633 -2.076 . . . . 0.0 106.698 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.446 ' OG1' ' SG ' ' A' ' 7' ' ' CYS . 29.3 p -85.05 -10.37 57.0 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.453 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.49 -17.8 9.45 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.32 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 33.1 mt -54.38 -38.64 66.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 124.332 1.02 . . . . 0.0 112.391 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.44 -8.01 53.9 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 123.91 0.756 . . . . 0.0 111.283 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.22 30.21 4.24 Favored Glycine 0 N--CA 1.494 2.518 0 O-C-N 124.436 1.085 . . . . 0.0 111.33 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.469 ' SG ' ' C ' ' A' ' 22' ' ' CYS . 0.9 OUTLIER -80.98 82.33 6.99 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 122.842 1.306 . . . . 0.0 112.408 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.1 m -60.54 123.68 18.09 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 112.568 -2.106 . . . . 0.0 111.89 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.523 ' SG ' ' HB2' ' A' ' 7' ' ' CYS . 46.7 m -63.04 85.61 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.4 m -92.31 125.8 37.12 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 105.315 -2.106 . . . . 0.0 105.315 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.5 p30 46.6 45.17 14.14 Favored 'General case' 0 N--CA 1.505 2.318 0 CA-C-O 122.785 1.279 . . . . 0.0 110.743 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.4 mtm180 56.24 37.09 28.5 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 112.244 -2.253 . . . . 0.0 112.18 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 55.7 t -136.32 121.05 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.469 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 7.2 m -56.17 122.65 12.21 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.61 136.09 40.75 Favored 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 117.485 2.402 . . . . 0.0 117.485 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.473 ' C ' ' H ' ' A' ' 26' ' ' ILE . 19.9 t-20 -145.95 61.15 1.25 Allowed 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 105.477 -2.045 . . . . 0.0 105.477 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.88 -32.8 3.66 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 108.052 -2.019 . . . . 0.0 108.052 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.473 ' H ' ' C ' ' A' ' 24' ' ' ASN . 3.6 tt -149.93 144.79 18.01 Favored Pre-proline 0 N--CA 1.488 1.457 0 N-CA-C 103.015 -2.957 . . . . 0.0 103.015 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -66.83 177.03 3.79 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.239 1.959 . . . . 0.0 111.646 -170.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.3 m -143.04 23.21 1.88 Allowed 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 114.715 -1.13 . . . . 0.0 108.863 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 69.75 174.65 0.29 Allowed 'General case' 0 N--CA 1.501 2.1 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.461 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 . . . . . 0 N--CA 1.502 2.141 0 O-C-N 124.726 1.266 . . . . 0.0 111.276 -179.923 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.8 p . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.346 0.593 . . . . 0.0 110.06 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.449 ' SG ' ' C ' ' A' ' 20' ' ' ARG . 19.4 p -104.61 57.07 0.7 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 114.013 -1.448 . . . . 0.0 107.844 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.7 t -42.75 -51.57 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.403 0 N-CA-C 116.952 2.204 . . . . 0.0 116.952 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -122.14 -58.25 1.73 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 102.727 -3.064 . . . . 0.0 102.727 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.527 ' CD1' ' H ' ' A' ' 5' ' ' ILE . 0.2 OUTLIER -71.5 148.21 92.99 Favored Pre-proline 0 C--N 1.302 -1.485 0 CA-C-N 111.49 -2.595 . . . . 0.0 106.897 179.512 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -58.92 -178.81 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.899 2.399 . . . . 0.0 111.001 168.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.497 ' SG ' ' OG1' ' A' ' 10' ' ' THR . 42.7 t -73.25 -54.43 8.42 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 114.605 -1.18 . . . . 0.0 111.704 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 68.0 p 41.78 34.45 0.42 Allowed 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 51.6 t -142.92 -65.22 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 113.468 -1.696 . . . . 0.0 106.974 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.497 ' OG1' ' SG ' ' A' ' 7' ' ' CYS . 22.7 p -86.61 -19.13 29.8 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.44 -21.26 59.76 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.357 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 92.6 mt -57.92 -34.24 69.64 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 124.444 1.09 . . . . 0.0 111.175 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.404 ' CD1' HD21 ' A' ' 24' ' ' ASN . 0.5 OUTLIER -89.51 -6.87 56.01 Favored 'General case' 0 N--CA 1.48 1.066 0 O-C-N 123.964 0.79 . . . . 0.0 111.153 179.809 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.15 12.11 6.53 Favored Glycine 0 N--CA 1.497 2.765 0 O-C-N 124.277 0.985 . . . . 0.0 113.893 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -80.74 85.12 6.14 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 123.254 1.502 . . . . 0.0 113.137 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.1 m -63.03 124.85 22.16 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 112.08 -2.327 . . . . 0.0 110.909 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 29.6 t -64.4 92.48 0.09 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 124.158 0.911 . . . . 0.0 113.142 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.452 ' HG ' HD21 ' A' ' 19' ' ' ASN . 27.8 p -109.66 140.22 43.77 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.452 HD21 ' HG ' ' A' ' 18' ' ' SER . 10.3 p30 48.79 37.85 10.65 Favored 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 122.638 1.209 . . . . 0.0 111.028 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.449 ' C ' ' SG ' ' A' ' 2' ' ' CYS . 31.4 mtt180 56.48 31.92 19.78 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-N 112.8 -2.0 . . . . 0.0 112.894 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.2 t -136.2 138.34 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 CA-C-N 112.775 -2.011 . . . . 0.0 107.725 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 29.3 m -63.88 125.89 25.85 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -135.89 120.55 18.33 Favored 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 117.104 2.261 . . . . 0.0 117.104 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.438 ' C ' ' H ' ' A' ' 26' ' ' ILE . 27.7 t-20 -123.03 53.6 1.29 Allowed 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 104.056 -2.572 . . . . 0.0 104.056 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.56 -44.27 2.59 Favored Glycine 0 N--CA 1.479 1.564 0 N-CA-C 104.0 -3.64 . . . . 0.0 104.0 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.438 ' H ' ' C ' ' A' ' 24' ' ' ASN . 1.1 pp -133.65 148.29 67.98 Favored Pre-proline 0 N--CA 1.482 1.161 0 N-CA-C 103.726 -2.694 . . . . 0.0 103.726 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -64.33 175.19 3.52 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.061 1.841 . . . . 0.0 112.073 -171.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.0 m -146.28 27.9 1.12 Allowed 'General case' 0 N--CA 1.5 2.045 0 CA-C-N 114.327 -1.306 . . . . 0.0 108.277 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 67.08 175.86 0.25 Allowed 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.759 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 . . . . . 0 N--CA 1.501 2.093 0 O-C-N 124.461 1.101 . . . . 0.0 111.389 -179.979 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.494 1.764 0 CA-C-O 121.576 0.703 . . . . 0.0 111.345 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.4 m -104.8 38.54 1.89 Allowed 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 113.442 -1.708 . . . . 0.0 109.674 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.6 t -26.21 -55.2 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.72 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -125.31 -58.14 1.45 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 103.266 -2.865 . . . . 0.0 103.266 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.2 pt -68.63 154.94 93.95 Favored Pre-proline 0 C--N 1.305 -1.331 0 CA-C-N 112.209 -2.269 . . . . 0.0 108.631 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -57.88 -174.92 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 123.075 2.517 . . . . 0.0 111.339 162.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.497 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 33.8 t -78.98 -51.09 10.1 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.47 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 68.8 p 41.24 34.8 0.35 Allowed 'General case' 0 N--CA 1.505 2.313 0 O-C-N 125.18 1.55 . . . . 0.0 114.787 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.3 t -145.58 -37.02 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-N 113.369 -1.741 . . . . 0.0 109.748 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.9 p -120.18 -15.14 8.73 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 124.493 1.121 . . . . 0.0 109.668 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.34 -19.09 7.82 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.079 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.1 pp -56.71 -34.51 67.54 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 124.05 0.844 . . . . 0.0 113.229 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 pp -89.4 -5.66 57.25 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 123.808 0.693 . . . . 0.0 111.085 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.39 28.02 4.78 Favored Glycine 0 N--CA 1.495 2.62 0 O-C-N 124.46 1.1 . . . . 0.0 111.465 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.483 ' SG ' ' C ' ' A' ' 22' ' ' CYS . 0.6 OUTLIER -83.35 81.06 8.88 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.736 1.255 . . . . 0.0 112.279 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.9 m -59.96 123.72 17.96 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 112.582 -2.099 . . . . 0.0 111.419 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.497 ' SG ' ' HB2' ' A' ' 7' ' ' CYS . 31.1 m -66.7 85.1 0.11 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 114.109 1.152 . . . . 0.0 114.109 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 96.1 p -96.15 132.86 41.13 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.6 p30 46.0 42.18 9.09 Favored 'General case' 0 N--CA 1.503 2.218 0 CA-C-O 122.663 1.221 . . . . 0.0 110.716 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.0 mtm-85 56.0 38.0 29.47 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-N 112.461 -2.154 . . . . 0.0 112.372 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.3 t -136.29 124.77 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.483 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 4.0 m -60.05 122.19 13.73 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.62 133.48 38.29 Favored 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 117.358 2.355 . . . . 0.0 117.358 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.468 ' C ' ' H ' ' A' ' 26' ' ' ILE . 32.3 t-20 -142.47 60.35 1.44 Allowed 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.73 -33.62 3.69 Favored Glycine 0 N--CA 1.484 1.844 0 N-CA-C 107.891 -2.084 . . . . 0.0 107.891 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.468 ' H ' ' C ' ' A' ' 24' ' ' ASN . 3.3 tt -149.6 144.56 17.94 Favored Pre-proline 0 N--CA 1.488 1.439 0 N-CA-C 103.168 -2.901 . . . . 0.0 103.168 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -65.99 177.45 3.0 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.266 1.978 . . . . 0.0 112.137 -169.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.7 m -141.82 25.81 1.94 Allowed 'General case' 0 N--CA 1.501 2.108 0 CA-C-N 114.821 -1.082 . . . . 0.0 109.03 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 68.96 166.97 0.27 Allowed 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 114.611 -1.177 . . . . 0.0 111.088 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 N--CA 1.501 2.111 0 O-C-N 124.464 1.102 . . . . 0.0 111.606 -179.956 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 62.1 p . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.635 0.731 . . . . 0.0 109.093 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.474 ' SG ' ' C ' ' A' ' 20' ' ' ARG . 14.6 p -104.37 60.4 0.71 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 113.559 -1.655 . . . . 0.0 107.425 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.6 t -48.91 -49.0 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 CA-C-N 113.015 -1.902 . . . . 0.0 115.508 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -116.29 -51.11 2.63 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 104.841 -2.281 . . . . 0.0 104.841 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.9 pt -64.9 164.45 21.46 Favored Pre-proline 0 C--N 1.303 -1.433 0 CA-C-N 112.297 -2.229 . . . . 0.0 108.954 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -68.22 -179.96 2.55 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 123.309 2.672 . . . . 0.0 109.716 153.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.422 ' SG ' ' OG1' ' A' ' 10' ' ' THR . 43.0 t -71.89 -63.67 1.09 Allowed 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.76 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.8 p 43.2 42.85 3.67 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 115.281 1.586 . . . . 0.0 115.281 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 79.0 t -144.99 -70.43 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 105.08 -2.193 . . . . 0.0 105.08 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.422 ' OG1' ' SG ' ' A' ' 7' ' ' CYS . 40.5 p -88.76 -7.84 55.51 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.32 -19.18 32.89 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.498 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 39.2 mt -53.82 -39.02 65.16 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 114.758 -1.11 . . . . 0.0 112.411 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.422 ' CD1' HD21 ' A' ' 24' ' ' ASN . 0.6 OUTLIER -89.4 -11.42 43.25 Favored 'General case' 0 N--CA 1.483 1.202 0 O-C-N 123.974 0.796 . . . . 0.0 110.944 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 124.82 15.57 3.18 Favored Glycine 0 N--CA 1.497 2.708 0 O-C-N 124.294 0.997 . . . . 0.0 113.167 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.88 90.52 5.31 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 123.276 1.513 . . . . 0.0 112.726 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 65.9 m -71.95 126.5 29.9 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 111.8 -2.454 . . . . 0.0 110.057 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.6 t -62.76 90.24 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 124.049 0.843 . . . . 0.0 112.728 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 12.2 m -104.51 137.79 41.84 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 11.1 p30 48.23 39.62 12.42 Favored 'General case' 0 N--CA 1.502 2.138 0 CA-C-O 122.696 1.236 . . . . 0.0 110.7 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.474 ' C ' ' SG ' ' A' ' 2' ' ' CYS . 30.4 mtt180 56.19 31.93 19.27 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-N 112.63 -2.077 . . . . 0.0 113.306 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 50.1 t -136.38 138.71 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-N 112.944 -1.934 . . . . 0.0 107.855 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 71.8 m -61.52 125.0 22.22 Favored 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -135.87 113.81 11.22 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 117.789 2.514 . . . . 0.0 117.789 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.476 ' C ' ' H ' ' A' ' 26' ' ' ILE . 38.3 t-20 -116.67 54.77 0.84 Allowed 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 104.497 -2.409 . . . . 0.0 104.497 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.62 -37.28 3.31 Favored Glycine 0 N--CA 1.482 1.711 0 N-CA-C 106.706 -2.558 . . . . 0.0 106.706 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.476 ' H ' ' C ' ' A' ' 24' ' ' ASN . 4.0 tt -144.08 143.13 21.53 Favored Pre-proline 0 N--CA 1.488 1.451 0 N-CA-C 102.412 -3.181 . . . . 0.0 102.412 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -65.11 175.63 3.76 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 122.071 1.848 . . . . 0.0 112.661 -166.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.1 m -144.77 30.16 1.2 Allowed 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 114.149 -1.387 . . . . 0.0 108.117 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 64.32 -177.4 0.17 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.461 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 N--CA 1.5 2.04 0 O-C-N 124.372 1.045 . . . . 0.0 110.427 179.974 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.2 p . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.271 0.557 . . . . 0.0 111.255 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.4 m -104.79 37.98 2.02 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 114.057 -1.429 . . . . 0.0 109.504 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 18.1 t -25.4 -56.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.623 0 N-CA-C 115.027 1.492 . . . . 0.0 115.027 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -125.04 -56.74 1.54 Allowed 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 103.526 -2.768 . . . . 0.0 103.526 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.6 pt -70.14 153.57 95.2 Favored Pre-proline 0 C--N 1.305 -1.349 0 CA-C-N 112.284 -2.234 . . . . 0.0 108.819 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -59.41 -175.78 0.1 OUTLIER 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.892 2.395 . . . . 0.0 111.211 163.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.508 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 13.8 t -79.47 -52.19 8.37 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.125 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.0 p 40.89 36.37 0.41 Allowed 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 37.2 t -144.46 -41.01 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-N 112.845 -1.98 . . . . 0.0 107.983 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.467 ' OG1' ' SG ' ' A' ' 7' ' ' CYS . 16.0 p -116.38 -0.15 12.63 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 124.415 1.072 . . . . 0.0 108.784 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.11 -25.86 68.29 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -56.59 -31.75 64.56 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.55 -9.95 47.94 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 123.451 0.469 . . . . 0.0 110.569 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.89 25.32 5.7 Favored Glycine 0 N--CA 1.494 2.537 0 O-C-N 124.266 0.979 . . . . 0.0 112.236 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.448 ' SG ' ' C ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER -80.34 86.53 5.69 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.721 1.248 . . . . 0.0 111.348 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 24.0 m -64.69 122.6 17.24 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 112.679 -2.055 . . . . 0.0 111.249 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.508 ' SG ' ' HB2' ' A' ' 7' ' ' CYS . 32.8 m -63.65 84.84 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 124.506 1.129 . . . . 0.0 113.992 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.6 t -92.58 128.33 38.4 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.7 p30 46.64 44.21 13.4 Favored 'General case' 0 N--CA 1.504 2.226 0 CA-C-O 122.678 1.227 . . . . 0.0 110.811 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.5 mtm-85 56.04 37.39 28.79 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 112.308 -2.224 . . . . 0.0 112.173 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.1 t -136.21 121.08 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.448 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 4.0 m -56.94 123.25 14.45 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.48 111.6 9.63 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 116.682 2.105 . . . . 0.0 116.682 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.471 ' C ' ' H ' ' A' ' 26' ' ' ILE . 45.5 t30 -110.2 53.28 0.7 Allowed 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.5 -38.67 3.19 Favored Glycine 0 N--CA 1.483 1.769 0 N-CA-C 106.282 -2.727 . . . . 0.0 106.282 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.471 ' H ' ' C ' ' A' ' 24' ' ' ASN . 3.5 tt -138.53 144.64 43.23 Favored Pre-proline 0 N--CA 1.489 1.479 0 N-CA-C 102.225 -3.25 . . . . 0.0 102.225 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -65.56 176.37 3.52 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 122.157 1.905 . . . . 0.0 111.888 -167.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.2 m -145.76 25.36 1.31 Allowed 'General case' 0 N--CA 1.501 2.122 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.116 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 66.46 173.38 0.24 Allowed 'General case' 0 N--CA 1.5 2.04 0 CA-C-N 114.746 -1.115 . . . . 0.0 110.962 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 . . . . . 0 N--CA 1.501 2.092 0 O-C-N 124.421 1.076 . . . . 0.0 111.664 -179.897 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 12.3 t . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 122.366 1.079 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.535 ' SG ' ' N ' ' A' ' 21' ' ' VAL . 0.7 OUTLIER -106.07 41.3 1.43 Allowed 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 111.975 -2.375 . . . . 0.0 110.607 -179.9 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.9 t -30.92 -53.71 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.571 0 CA-C-N 113.525 -1.671 . . . . 0.0 113.196 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -124.43 -55.44 1.65 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 104.488 -2.412 . . . . 0.0 104.488 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -61.92 131.06 93.03 Favored Pre-proline 0 C--N 1.307 -1.246 0 CA-C-N 112.968 -1.924 . . . . 0.0 109.368 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -37.55 -48.01 1.88 Allowed 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 123.987 3.125 . . . . 0.0 112.752 172.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.496 ' SG ' ' OG1' ' A' ' 10' ' ' THR . 45.5 t 179.08 -45.04 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 O-C-N 124.145 0.903 . . . . 0.0 110.023 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.9 t 36.97 24.68 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 118.56 2.8 . . . . 0.0 118.56 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.7 t -146.89 -54.1 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.589 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.496 ' OG1' ' SG ' ' A' ' 7' ' ' CYS . 16.4 p -101.72 -5.24 25.21 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 124.002 0.814 . . . . 0.0 110.956 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.59 -14.2 28.35 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.574 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -55.77 -41.79 74.55 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 114.946 -1.024 . . . . 0.0 111.816 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.44 4.18 49.92 Favored 'General case' 0 N--CA 1.482 1.169 0 O-C-N 124.097 0.873 . . . . 0.0 111.118 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.41 34.5 7.44 Favored Glycine 0 N--CA 1.492 2.426 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.987 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.2 t -81.33 89.22 6.07 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 122.801 1.286 . . . . 0.0 111.8 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 23' ' ' TYR . 57.8 m -66.8 120.05 12.88 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 112.308 -2.224 . . . . 0.0 111.246 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.544 ' SG ' ' HA ' ' A' ' 20' ' ' ARG . 21.4 t -58.96 146.45 37.92 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.4 m -150.09 124.45 9.57 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 103.6 -2.741 . . . . 0.0 103.6 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.8 p30 45.64 45.25 10.88 Favored 'General case' 0 N--CA 1.505 2.305 0 CA-C-O 122.99 1.376 . . . . 0.0 110.134 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.544 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 4.4 mtm-85 55.34 38.86 30.94 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 112.052 -2.34 . . . . 0.0 112.94 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.535 ' N ' ' SG ' ' A' ' 2' ' ' CYS . 42.5 t -136.18 116.98 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 34.1 m -53.35 131.52 37.84 Favored 'General case' 0 N--CA 1.511 2.583 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.439 ' O ' ' N ' ' A' ' 16' ' ' SER . 0.2 OUTLIER -135.84 140.45 44.2 Favored 'General case' 0 N--CA 1.504 2.274 0 N-CA-C 116.423 2.009 . . . . 0.0 116.423 -179.336 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -148.8 59.97 1.06 Allowed 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.52 -50.36 3.53 Favored Glycine 0 N--CA 1.482 1.752 0 N-CA-C 104.733 -3.347 . . . . 0.0 104.733 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.2 pt -127.59 148.72 67.86 Favored Pre-proline 0 C--N 1.306 -1.311 0 N-CA-C 102.48 -3.156 . . . . 0.0 102.48 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -65.08 175.76 3.64 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 121.978 1.785 . . . . 0.0 110.34 -176.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.0 m -140.69 20.67 2.34 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-N 114.854 -1.067 . . . . 0.0 108.887 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 69.31 179.1 0.25 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 124.328 1.017 . . . . 0.0 109.278 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 . . . . . 0 N--CA 1.5 2.026 0 O-C-N 124.353 1.033 . . . . 0.0 111.165 -179.941 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 17.0 m . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.564 0.697 . . . . 0.0 111.689 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.498 ' SG ' ' HB2' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -104.67 34.53 3.1 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 113.769 -1.559 . . . . 0.0 110.143 -179.936 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.407 ' CA ' ' HG2' ' A' ' 20' ' ' ARG . 42.1 t -27.54 -53.69 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.754 0 O-C-N 125.023 1.452 . . . . 0.0 113.089 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -125.7 -55.57 1.51 Allowed 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 104.387 -2.449 . . . . 0.0 104.387 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.5 pt -67.68 165.68 28.72 Favored Pre-proline 0 C--N 1.306 -1.302 0 CA-C-N 113.247 -1.797 . . . . 0.0 108.9 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -58.4 -178.37 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 123.043 2.495 . . . . 0.0 111.42 154.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.498 ' HB2' ' SG ' ' A' ' 2' ' ' CYS . 0.6 OUTLIER -88.96 -52.24 5.19 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 114.371 -1.286 . . . . 0.0 108.469 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 34.05 54.48 0.57 Allowed 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 26.0 t -150.03 -41.26 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-N 112.849 -1.978 . . . . 0.0 107.287 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.558 ' OG1' ' SG ' ' A' ' 22' ' ' CYS . 33.3 p -123.74 -19.4 5.77 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 114.59 -1.186 . . . . 0.0 109.033 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.45 -27.1 5.88 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.8 pp -54.86 -36.63 65.3 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -89.59 -5.07 57.52 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.62 14.76 5.16 Favored Glycine 0 N--CA 1.5 2.923 0 O-C-N 124.066 0.853 . . . . 0.0 112.6 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.495 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 74.1 m -80.59 87.43 5.76 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 123.95 1.833 . . . . 0.0 109.606 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.0 m -67.19 125.51 26.26 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 111.566 -2.561 . . . . 0.0 112.106 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.4 m -66.41 82.4 0.09 Allowed 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 122.187 0.994 . . . . 0.0 111.796 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.3 m -93.6 123.82 37.18 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.3 p30 47.06 42.37 12.65 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 124.548 1.155 . . . . 0.0 110.402 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.407 ' HG2' ' CA ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER 58.3 36.81 25.86 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 112.475 -2.148 . . . . 0.0 111.815 -179.852 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 74.3 t -136.61 119.99 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 179.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.558 ' SG ' ' OG1' ' A' ' 10' ' ' THR . 0.1 OUTLIER -61.4 124.41 20.53 Favored 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 179.843 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -135.5 125.73 26.34 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -179.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 -130.63 61.36 1.61 Allowed 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.3 -50.93 3.65 Favored Glycine 0 N--CA 1.48 1.569 0 N-CA-C 104.373 -3.491 . . . . 0.0 104.373 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.68 150.15 60.93 Favored Pre-proline 0 C--N 1.308 -1.217 0 N-CA-C 103.769 -2.678 . . . . 0.0 103.769 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -64.49 175.29 3.56 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.215 1.943 . . . . 0.0 110.503 -173.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.8 m -149.35 19.9 0.95 Allowed 'General case' 0 N--CA 1.497 1.875 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.914 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 62.68 -172.49 0.16 Allowed 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.061 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 . . . . . 0 N--CA 1.498 1.959 0 O-C-N 124.325 1.015 . . . . 0.0 110.561 179.999 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 73.7 p . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.493 0.663 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.482 ' SG ' ' C ' ' A' ' 20' ' ' ARG . 6.2 p -104.77 51.96 0.75 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 113.747 -1.569 . . . . 0.0 109.577 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.7 t -40.67 -51.41 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.451 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -120.56 -60.18 1.69 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 103.638 -2.727 . . . . 0.0 103.638 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.2 pt -66.74 147.64 98.98 Favored Pre-proline 0 C--N 1.305 -1.345 0 CA-C-N 112.414 -2.175 . . . . 0.0 106.807 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -60.21 -179.75 0.26 Allowed 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.858 2.372 . . . . 0.0 111.104 169.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 40.8 t -65.38 -61.62 2.01 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.933 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.1 p 37.73 38.51 0.17 Allowed 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.5 t -139.71 -67.44 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-N 112.945 -1.934 . . . . 0.0 106.513 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.6 p -94.36 -5.1 47.27 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 124.222 0.951 . . . . 0.0 109.087 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.34 -18.8 30.2 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.812 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.0 pp -54.91 -36.4 65.16 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -89.44 -11.79 42.08 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 123.831 0.707 . . . . 0.0 110.934 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.85 21.46 3.21 Favored Glycine 0 N--CA 1.496 2.641 0 O-C-N 124.417 1.073 . . . . 0.0 112.443 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -83.36 84.92 7.33 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 123.194 1.474 . . . . 0.0 112.348 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.8 m -65.46 127.37 31.53 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 111.777 -2.465 . . . . 0.0 111.339 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 39.6 t -63.32 87.37 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 124.113 0.883 . . . . 0.0 113.162 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.9 m -99.59 131.02 45.86 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.3 p30 47.22 43.55 14.82 Favored 'General case' 0 N--CA 1.504 2.248 0 CA-C-O 122.861 1.315 . . . . 0.0 110.624 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.482 ' C ' ' SG ' ' A' ' 2' ' ' CYS . 5.7 mtm-85 55.29 33.23 20.26 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 112.248 -2.251 . . . . 0.0 113.155 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.1 t -136.35 130.4 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 CA-C-N 113.059 -1.882 . . . . 0.0 107.244 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 74.2 m -59.5 125.15 22.47 Favored 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -135.88 125.39 25.12 Favored 'General case' 0 N--CA 1.503 2.205 0 N-CA-C 117.632 2.456 . . . . 0.0 117.632 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.416 ' C ' ' H ' ' A' ' 26' ' ' ILE . 37.8 t-20 -132.9 55.96 1.87 Allowed 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.13 -48.38 3.19 Favored Glycine 0 N--CA 1.482 1.75 0 N-CA-C 104.522 -3.431 . . . . 0.0 104.522 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.416 ' H ' ' C ' ' A' ' 24' ' ' ASN . 1.5 pt -127.41 144.42 50.76 Favored Pre-proline 0 C--N 1.308 -1.233 0 N-CA-C 103.365 -2.828 . . . . 0.0 103.365 179.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -65.28 176.3 3.38 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.196 1.931 . . . . 0.0 111.732 -174.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.9 m -146.13 27.04 1.18 Allowed 'General case' 0 N--CA 1.5 2.052 0 CA-C-N 114.671 -1.15 . . . . 0.0 108.185 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 63.35 -176.36 0.15 Allowed 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.539 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 . . . . . 0 N--CA 1.5 2.036 0 O-C-N 124.081 0.863 . . . . 0.0 110.106 -179.992 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 21.0 m . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.952 0.882 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.49 ' SG ' ' N ' ' A' ' 21' ' ' VAL . 0.2 OUTLIER -104.55 42.9 1.15 Allowed 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 112.986 -1.916 . . . . 0.0 110.388 179.983 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.4 t -33.46 -50.41 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.429 0 CA-C-N 113.256 -1.793 . . . . 0.0 113.555 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -123.41 -58.19 1.62 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 104.756 -2.313 . . . . 0.0 104.756 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -61.2 133.41 92.81 Favored Pre-proline 0 C--N 1.306 -1.311 0 CA-C-N 112.587 -2.097 . . . . 0.0 109.009 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -41.48 -46.24 5.99 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 123.472 2.781 . . . . 0.0 112.427 173.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.444 ' SG ' ' OG1' ' A' ' 10' ' ' THR . 52.9 t 179.11 -57.08 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 O-C-N 124.409 1.068 . . . . 0.0 108.542 179.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 71.4 p 38.16 34.63 0.07 Allowed 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 115.961 1.837 . . . . 0.0 115.961 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 50.3 t -144.56 -62.52 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-N 113.621 -1.627 . . . . 0.0 108.707 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.444 ' OG1' ' SG ' ' A' ' 7' ' ' CYS . 15.8 p -98.29 0.56 45.84 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 124.22 0.95 . . . . 0.0 110.514 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.13 -17.37 39.79 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.928 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 48.1 mt -54.92 -44.24 74.05 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 114.448 -1.251 . . . . 0.0 111.52 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.45 2.55 54.36 Favored 'General case' 0 C--N 1.31 -1.139 0 O-C-N 124.174 0.922 . . . . 0.0 111.886 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.34 33.76 7.45 Favored Glycine 0 N--CA 1.494 2.558 0 CA-C-N 115.023 -0.989 . . . . 0.0 112.736 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 2.1 t -80.65 93.31 6.12 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 122.392 1.092 . . . . 0.0 111.449 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 23' ' ' TYR . 67.7 m -73.24 118.07 15.75 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 113.128 -1.851 . . . . 0.0 109.261 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.435 ' SG ' ' HA ' ' A' ' 20' ' ' ARG . 49.3 t -66.45 148.41 51.92 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 60.9 p -150.2 136.62 18.91 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 104.123 -2.547 . . . . 0.0 104.123 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.9 p30 46.53 39.76 7.26 Favored 'General case' 0 N--CA 1.504 2.266 0 CA-C-O 122.652 1.215 . . . . 0.0 110.933 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.435 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 5.0 mtm-85 55.46 39.04 31.05 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 112.624 -2.08 . . . . 0.0 112.501 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.49 ' N ' ' SG ' ' A' ' 2' ' ' CYS . 55.0 t -136.2 116.79 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 59.2 m -51.86 133.45 31.97 Favored 'General case' 0 N--CA 1.512 2.63 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.402 ' O ' ' N ' ' A' ' 16' ' ' SER . 0.2 OUTLIER -135.75 131.56 35.7 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 117.038 2.236 . . . . 0.0 117.038 -179.291 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.469 ' C ' ' H ' ' A' ' 26' ' ' ILE . 11.4 t-20 -138.13 62.06 1.58 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 105.553 -2.018 . . . . 0.0 105.553 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.73 -39.45 3.11 Favored Glycine 0 N--CA 1.485 1.907 0 N-CA-C 107.322 -2.311 . . . . 0.0 107.322 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.469 ' H ' ' C ' ' A' ' 24' ' ' ASN . 2.5 tt -147.44 147.44 28.13 Favored Pre-proline 0 N--CA 1.487 1.408 0 N-CA-C 101.942 -3.355 . . . . 0.0 101.942 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -63.84 176.26 2.49 Favored 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 121.792 1.661 . . . . 0.0 111.63 -168.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.4 m -136.54 21.3 3.13 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 114.436 -1.256 . . . . 0.0 109.045 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 69.33 174.08 0.29 Allowed 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.254 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 . . . . . 0 N--CA 1.501 2.078 0 O-C-N 124.405 1.066 . . . . 0.0 110.176 -179.854 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 10.7 m . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.9 p -104.68 57.29 0.7 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 114.242 -1.345 . . . . 0.0 109.853 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 54.4 t -34.45 -66.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.387 0 CA-C-N 113.4 -1.727 . . . . 0.0 115.093 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -116.86 -52.95 2.52 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 103.065 -2.939 . . . . 0.0 103.065 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.2 pt -72.23 133.97 83.06 Favored Pre-proline 0 C--N 1.304 -1.395 0 CA-C-N 112.24 -2.255 . . . . 0.0 106.675 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -56.17 179.91 0.09 OUTLIER 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.884 2.389 . . . . 0.0 111.479 173.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.48 ' SG ' ' OG1' ' A' ' 10' ' ' THR . 42.1 t -68.53 -58.08 4.84 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 114.521 -1.218 . . . . 0.0 111.037 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.4 p 36.19 41.29 0.13 Allowed 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 115.759 1.762 . . . . 0.0 115.759 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.5 t -146.97 -67.0 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-N 113.076 -1.875 . . . . 0.0 106.644 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.48 ' OG1' ' SG ' ' A' ' 7' ' ' CYS . 36.6 p -84.49 -11.19 56.61 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.1 -18.6 36.94 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.231 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 88.2 mt -55.0 -37.7 66.92 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.108 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.419 ' CD1' HD21 ' A' ' 24' ' ' ASN . 0.7 OUTLIER -89.37 -11.48 43.12 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 123.909 0.755 . . . . 0.0 110.931 179.911 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 123.06 17.72 3.29 Favored Glycine 0 N--CA 1.497 2.743 0 O-C-N 124.27 0.981 . . . . 0.0 113.138 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.75 88.99 6.73 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 122.993 1.378 . . . . 0.0 113.071 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.6 m -70.61 126.92 30.97 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 112.409 -2.178 . . . . 0.0 110.301 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.7 t -62.28 89.89 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 124.133 0.895 . . . . 0.0 112.689 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.7 t -105.69 134.57 48.59 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.7 p30 47.78 42.72 16.17 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 124.762 1.289 . . . . 0.0 111.251 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.7 mtp180 56.86 30.91 18.69 Favored 'General case' 0 N--CA 1.502 2.169 0 CA-C-N 112.58 -2.1 . . . . 0.0 112.948 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 53.7 t -136.29 136.31 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 CA-C-N 113.159 -1.837 . . . . 0.0 108.166 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 84.4 m -62.78 126.98 29.15 Favored 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 105.785 -1.932 . . . . 0.0 105.785 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.82 117.25 14.72 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 118.414 2.746 . . . . 0.0 118.414 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.478 ' C ' ' H ' ' A' ' 26' ' ' ILE . 41.5 t-20 -121.96 55.97 1.1 Allowed 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.0 -37.24 3.28 Favored Glycine 0 N--CA 1.484 1.842 0 N-CA-C 107.16 -2.376 . . . . 0.0 107.16 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.478 ' H ' ' C ' ' A' ' 24' ' ' ASN . 4.5 tt -146.06 142.21 17.46 Favored Pre-proline 0 N--CA 1.487 1.408 0 N-CA-C 102.294 -3.225 . . . . 0.0 102.294 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -65.67 174.98 4.79 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.084 1.856 . . . . 0.0 112.749 -166.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.2 m -140.26 28.12 2.08 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 113.899 -1.5 . . . . 0.0 107.723 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 66.26 -178.49 0.2 Allowed 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.319 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 . . . . . 0 N--CA 1.501 2.096 0 O-C-N 124.439 1.087 . . . . 0.0 112.189 -179.988 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 52.2 p . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 121.553 0.692 . . . . 0.0 110.5 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.407 ' CB ' ' O ' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -104.79 38.6 1.87 Allowed 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 113.764 -1.562 . . . . 0.0 111.046 -179.954 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.1 t -23.87 -53.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.527 0 CA-C-N 113.146 -1.843 . . . . 0.0 115.571 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -122.74 -37.48 2.75 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.402 ' CG1' ' HA ' ' A' ' 2' ' ' CYS . 14.9 pt -72.0 178.47 1.31 Allowed Pre-proline 0 CA--C 1.561 1.379 0 CA-C-N 112.789 -2.005 . . . . 0.0 111.188 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.407 ' O ' ' CB ' ' A' ' 2' ' ' CYS . 13.2 Cg_endo -82.03 -52.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 124.106 3.204 . . . . 0.0 110.766 168.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 51.9 t 179.04 -59.4 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 124.188 0.93 . . . . 0.0 109.334 179.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.2 p 40.38 38.12 0.52 Allowed 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 115.008 1.485 . . . . 0.0 115.008 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 42.1 t -144.29 -63.68 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-N 113.27 -1.786 . . . . 0.0 108.362 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.476 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 26.1 p -100.42 -14.25 18.39 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 124.102 0.876 . . . . 0.0 110.797 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.81 -20.08 1.17 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 123.743 0.652 . . . . 0.0 112.37 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 35.2 mt -54.19 -45.07 72.08 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 124.297 0.998 . . . . 0.0 112.271 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -89.58 13.86 12.98 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 124.182 0.926 . . . . 0.0 112.361 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.68 29.44 16.09 Favored Glycine 0 N--CA 1.495 2.6 0 CA-C-N 115.046 -0.979 . . . . 0.0 113.267 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.476 ' SG ' ' HB ' ' A' ' 10' ' ' THR . 78.6 m -81.3 80.11 7.78 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.67 1.224 . . . . 0.0 110.013 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.8 m -66.52 117.48 8.78 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 112.392 -2.185 . . . . 0.0 110.407 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.595 ' SG ' ' HA ' ' A' ' 20' ' ' ARG . 48.6 t -63.23 144.43 56.94 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 114.567 -1.197 . . . . 0.0 113.993 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.5 m -147.3 130.15 16.18 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 103.443 -2.799 . . . . 0.0 103.443 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.2 p30 45.6 41.59 7.22 Favored 'General case' 0 N--CA 1.506 2.335 0 CA-C-O 122.769 1.271 . . . . 0.0 110.154 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.595 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 0.2 OUTLIER 56.3 41.33 29.28 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 112.346 -2.206 . . . . 0.0 112.741 -179.878 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 78.9 t -136.07 111.84 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 105.685 -1.968 . . . . 0.0 105.685 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 59.5 m -52.44 127.46 22.52 Favored 'General case' 0 N--CA 1.507 2.389 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -135.58 113.67 11.29 Favored 'General case' 0 N--CA 1.509 2.487 0 N-CA-C 117.293 2.331 . . . . 0.0 117.293 -179.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.467 ' C ' ' H ' ' A' ' 26' ' ' ILE . 52.8 t30 -106.26 54.47 0.69 Allowed 'General case' 0 N--CA 1.506 2.348 0 N-CA-C 103.948 -2.612 . . . . 0.0 103.948 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.84 -43.07 2.96 Favored Glycine 0 N--CA 1.482 1.741 0 N-CA-C 104.77 -3.332 . . . . 0.0 104.77 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.467 ' H ' ' C ' ' A' ' 24' ' ' ASN . 2.6 pt -125.08 150.53 67.0 Favored Pre-proline 0 C--N 1.308 -1.204 0 N-CA-C 102.917 -2.994 . . . . 0.0 102.917 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -64.12 174.87 3.62 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 121.827 1.685 . . . . 0.0 110.632 -171.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 5.3 m -148.53 20.4 1.05 Allowed 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 114.614 -1.175 . . . . 0.0 108.701 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 62.46 -172.53 0.16 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.052 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 . . . . . 0 N--CA 1.5 2.046 0 O-C-N 124.277 0.986 . . . . 0.0 110.958 -179.919 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 73.3 m . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.74 0.781 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.518 ' SG ' ' C ' ' A' ' 20' ' ' ARG . 1.4 p -103.98 47.17 0.89 Allowed 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 113.266 -1.788 . . . . 0.0 109.382 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.0 t -47.55 -46.3 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 CA-C-N 113.937 -1.483 . . . . 0.0 113.059 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -118.52 -55.66 2.19 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 104.789 -2.3 . . . . 0.0 104.789 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -61.86 150.81 81.57 Favored Pre-proline 0 C--N 1.307 -1.255 0 CA-C-N 113.192 -1.822 . . . . 0.0 108.424 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -58.94 -48.43 14.48 Favored 'Trans proline' 0 N--CA 1.492 1.441 0 C-N-CA 123.343 2.695 . . . . 0.0 112.891 169.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.419 ' SG ' ' N ' ' A' ' 11' ' ' ALA . 42.0 t 179.49 -62.63 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 60.3 p 40.32 32.52 0.13 Allowed 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 55.3 t -148.06 -44.79 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-N 113.766 -1.561 . . . . 0.0 110.614 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.6 p -118.01 -3.1 11.16 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 124.316 1.01 . . . . 0.0 112.83 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.419 ' N ' ' SG ' ' A' ' 7' ' ' CYS . . . -63.22 -20.14 65.16 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.115 0.483 . . . . 0.0 110.259 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.4 mp -55.74 -38.17 69.45 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-N 114.4 -1.273 . . . . 0.0 113.624 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.32 -4.24 58.18 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 123.903 0.752 . . . . 0.0 112.217 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.65 18.46 10.12 Favored Glycine 0 N--CA 1.497 2.706 0 O-C-N 124.221 0.95 . . . . 0.0 112.556 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.666 ' HB3' ' SG ' ' A' ' 22' ' ' CYS . 2.0 t -75.56 119.87 20.2 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 122.063 0.935 . . . . 0.0 110.088 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.5 m -95.38 118.18 31.67 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 112.914 -1.948 . . . . 0.0 112.419 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.585 ' SG ' ' HA ' ' A' ' 20' ' ' ARG . 42.7 t -62.03 106.01 0.66 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 115.273 1.583 . . . . 0.0 115.273 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.9 m -113.58 133.48 55.25 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 103.934 -2.617 . . . . 0.0 103.934 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.0 p30 46.37 42.12 10.13 Favored 'General case' 0 N--CA 1.506 2.372 0 CA-C-O 122.741 1.258 . . . . 0.0 110.73 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.585 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 0.2 OUTLIER 54.75 38.0 29.37 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 112.341 -2.208 . . . . 0.0 113.354 -179.893 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.478 ' N ' ' SG ' ' A' ' 2' ' ' CYS . 54.4 t -136.4 117.7 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.666 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 0.5 OUTLIER -55.79 129.94 41.4 Favored 'General case' 0 N--CA 1.509 2.493 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 179.893 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.74 105.98 6.36 Favored 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 116.938 2.199 . . . . 0.0 116.938 -178.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.454 ' C ' ' H ' ' A' ' 26' ' ' ILE . 25.5 t-20 -96.94 56.11 1.39 Allowed 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.93 -43.44 3.07 Favored Glycine 0 N--CA 1.484 1.867 0 N-CA-C 106.088 -2.805 . . . . 0.0 106.088 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.454 ' H ' ' C ' ' A' ' 24' ' ' ASN . 3.9 tt -131.37 147.07 64.69 Favored Pre-proline 0 N--CA 1.488 1.474 0 N-CA-C 101.442 -3.54 . . . . 0.0 101.442 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -64.84 174.46 4.62 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 C-N-CA 121.936 1.757 . . . . 0.0 111.429 -166.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.9 m -145.66 21.0 1.49 Allowed 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 114.286 -1.325 . . . . 0.0 108.952 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 66.94 -176.95 0.2 Allowed 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.731 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 . . . . . 0 N--CA 1.499 2.015 0 O-C-N 124.423 1.077 . . . . 0.0 110.98 -179.924 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 51.8 m . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 121.545 0.688 . . . . 0.0 112.266 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.8 m -104.85 36.11 2.55 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 113.422 -1.717 . . . . 0.0 110.268 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 18.9 t -24.77 -55.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.667 0 N-CA-C 114.968 1.469 . . . . 0.0 114.968 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -126.54 -55.19 1.43 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 103.491 -2.781 . . . . 0.0 103.491 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.5 pt -71.02 158.18 88.73 Favored Pre-proline 0 C--N 1.307 -1.269 0 CA-C-N 112.667 -2.061 . . . . 0.0 108.35 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -55.19 -174.88 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 123.115 2.543 . . . . 0.0 112.216 162.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.44 ' SG ' ' OG1' ' A' ' 10' ' ' THR . 48.4 t -77.68 -52.15 9.43 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.211 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 59.5 p 45.83 33.36 1.52 Allowed 'General case' 0 N--CA 1.507 2.385 0 O-C-N 125.046 1.466 . . . . 0.0 114.085 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 56.0 t -141.29 -40.34 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 113.438 -1.71 . . . . 0.0 110.291 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.448 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 72.4 p -124.19 -17.92 6.02 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 124.031 0.832 . . . . 0.0 110.723 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.75 -23.65 2.86 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 123.782 0.676 . . . . 0.0 111.918 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.2 mp -51.93 -42.67 63.0 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 114.561 -1.2 . . . . 0.0 112.593 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -89.4 -6.61 56.42 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 118.51 20.54 4.24 Favored Glycine 0 N--CA 1.499 2.891 0 O-C-N 123.998 0.811 . . . . 0.0 113.221 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.448 ' SG ' ' HB ' ' A' ' 10' ' ' THR . 83.1 m -81.29 75.56 8.25 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 122.745 1.26 . . . . 0.0 110.972 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.5 m -57.19 124.04 17.41 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 112.217 -2.265 . . . . 0.0 111.481 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.4 ' SG ' ' HB2' ' A' ' 7' ' ' CYS . 48.3 m -62.47 85.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 124.544 1.152 . . . . 0.0 113.562 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.5 m -94.04 125.56 38.74 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.8 p30 46.75 43.4 12.96 Favored 'General case' 0 N--CA 1.503 2.221 0 CA-C-O 122.566 1.174 . . . . 0.0 110.708 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.7 mtm-85 56.81 36.18 27.33 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-N 112.409 -2.178 . . . . 0.0 111.843 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 63.7 t -136.11 122.1 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.447 ' SG ' ' HB3' ' A' ' 30' ' ' GLU . 3.5 m -57.48 122.08 11.8 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.52 124.09 23.61 Favored 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 116.384 1.994 . . . . 0.0 116.384 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.447 ' C ' ' H ' ' A' ' 26' ' ' ILE . 42.5 t-20 -127.9 59.51 1.47 Allowed 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 104.776 -2.305 . . . . 0.0 104.776 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.51 -39.91 3.1 Favored Glycine 0 N--CA 1.482 1.752 0 N-CA-C 106.716 -2.554 . . . . 0.0 106.716 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.447 ' H ' ' C ' ' A' ' 24' ' ' ASN . 2.0 tt -139.37 146.28 47.85 Favored Pre-proline 0 N--CA 1.489 1.521 0 N-CA-C 102.749 -3.056 . . . . 0.0 102.749 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -64.5 172.87 6.05 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 121.898 1.732 . . . . 0.0 111.128 -168.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.5 m -141.68 23.21 2.12 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 113.773 -1.558 . . . . 0.0 108.057 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 63.68 -176.16 0.16 Allowed 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.017 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.447 ' HB3' ' SG ' ' A' ' 22' ' ' CYS . 12.0 tp10 . . . . . 0 N--CA 1.503 2.21 0 O-C-N 124.095 0.872 . . . . 0.0 110.144 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.496 1.851 0 CA-C-O 121.862 0.839 . . . . 0.0 112.133 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -104.72 39.54 1.67 Allowed 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 113.093 -1.867 . . . . 0.0 110.523 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 19.8 t -26.59 -54.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.687 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -125.51 -58.05 1.44 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 103.297 -2.853 . . . . 0.0 103.297 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.5 pt -69.02 156.52 91.37 Favored Pre-proline 0 C--N 1.305 -1.354 0 CA-C-N 112.403 -2.18 . . . . 0.0 108.369 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -58.81 -177.09 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 123.014 2.476 . . . . 0.0 111.262 161.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.5 ' SG ' ' OG1' ' A' ' 10' ' ' THR . 12.7 t -79.03 -43.39 24.36 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.13 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.4 p 39.13 42.15 0.69 Allowed 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.1 t -149.41 -66.26 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 CA-C-N 112.654 -2.066 . . . . 0.0 107.002 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.5 ' OG1' ' SG ' ' A' ' 7' ' ' CYS . 71.9 p -77.67 -5.2 49.63 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.379 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.31 -19.84 6.11 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.604 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 36.1 mt -53.34 -42.59 66.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 124.274 0.984 . . . . 0.0 111.442 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.49 -9.57 49.53 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 124.286 0.991 . . . . 0.0 111.436 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.97 35.41 5.58 Favored Glycine 0 N--CA 1.492 2.371 0 O-C-N 124.317 1.011 . . . . 0.0 110.781 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.521 ' SG ' ' C ' ' A' ' 22' ' ' CYS . 0.9 OUTLIER -75.78 90.1 2.88 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 122.992 1.377 . . . . 0.0 112.02 179.932 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.9 m -62.45 119.6 9.46 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 112.324 -2.217 . . . . 0.0 111.293 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.444 ' SG ' ' HB2' ' A' ' 7' ' ' CYS . 36.9 m -63.7 85.21 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 114.634 -1.166 . . . . 0.0 113.974 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.8 m -90.96 126.35 36.05 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.1 p30 46.42 44.62 13.09 Favored 'General case' 0 N--CA 1.505 2.305 0 CA-C-O 122.732 1.253 . . . . 0.0 110.72 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.1 mtm180 56.7 36.7 28.05 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 112.33 -2.214 . . . . 0.0 112.291 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.5 t -136.03 121.81 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.521 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 3.2 m -57.2 118.92 5.55 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.67 137.36 41.72 Favored 'General case' 0 N--CA 1.506 2.36 0 N-CA-C 118.023 2.601 . . . . 0.0 118.023 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.452 ' HB2' ' HA ' ' A' ' 15' ' ' CYS . 43.6 t-20 -150.21 61.95 0.97 Allowed 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.41 -50.97 3.62 Favored Glycine 0 N--CA 1.481 1.637 0 N-CA-C 104.966 -3.254 . . . . 0.0 104.966 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.3 pt -125.09 146.4 53.61 Favored Pre-proline 0 C--N 1.308 -1.228 0 N-CA-C 103.853 -2.647 . . . . 0.0 103.853 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -67.25 177.74 3.57 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 122.372 2.048 . . . . 0.0 110.646 -177.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.9 m -144.78 25.53 1.45 Allowed 'General case' 0 N--CA 1.501 2.082 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.226 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 65.97 171.78 0.23 Allowed 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.93 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.5 2.067 0 O-C-N 124.426 1.079 . . . . 0.0 110.937 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 77.4 p . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 121.235 0.541 . . . . 0.0 110.829 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.473 ' SG ' ' C ' ' A' ' 20' ' ' ARG . 0.5 OUTLIER -104.8 36.37 2.46 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 114.138 -1.392 . . . . 0.0 111.355 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.452 ' CA ' ' HG2' ' A' ' 20' ' ' ARG . 54.2 t -22.55 -61.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.567 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -120.63 -25.94 5.41 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 113.41 -1.723 . . . . 0.0 107.654 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.417 ' CG1' ' HA ' ' A' ' 2' ' ' CYS . 2.2 pt -80.83 -175.86 0.68 Allowed Pre-proline 0 CA--C 1.562 1.442 0 CA-C-N 113.144 -1.844 . . . . 0.0 110.542 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -87.24 -53.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.322 0 C-N-CA 124.985 3.79 . . . . 0.0 110.981 173.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.52 ' SG ' ' OG1' ' A' ' 10' ' ' THR . 45.5 t 179.34 -49.59 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 124.535 1.147 . . . . 0.0 109.689 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.5 t 36.27 26.68 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 119.621 3.193 . . . . 0.0 119.621 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.0 t -145.38 -55.15 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.635 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.52 ' OG1' ' SG ' ' A' ' 7' ' ' CYS . 41.7 p -95.82 -1.04 50.4 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 124.045 0.84 . . . . 0.0 110.241 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.25 -14.96 43.94 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.482 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.9 mt -54.8 -42.95 72.44 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 114.908 -1.042 . . . . 0.0 112.092 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.38 -2.86 58.57 Favored 'General case' 0 C--N 1.31 -1.13 0 O-C-N 124.108 0.88 . . . . 0.0 111.381 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.3 36.8 6.12 Favored Glycine 0 N--CA 1.494 2.534 0 O-C-N 124.332 1.02 . . . . 0.0 110.808 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.3 t -83.3 90.69 7.17 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.847 1.308 . . . . 0.0 111.843 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.44 ' N ' ' O ' ' A' ' 23' ' ' TYR . 67.7 m -62.39 119.22 8.69 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 112.112 -2.313 . . . . 0.0 112.91 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.512 ' SG ' ' HA ' ' A' ' 20' ' ' ARG . 54.0 t -66.05 132.65 49.03 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 114.888 -1.051 . . . . 0.0 112.629 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.6 m -138.6 130.56 28.15 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 103.524 -2.769 . . . . 0.0 103.524 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.3 p30 46.49 43.12 11.81 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-O 122.816 1.293 . . . . 0.0 110.197 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.512 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 7.7 mtp180 55.87 37.66 29.11 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 112.223 -2.262 . . . . 0.0 112.645 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 63.0 t -135.97 111.76 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 CA-C-N 113.512 -1.676 . . . . 0.0 106.879 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.608 ' HB2' ' SG ' ' A' ' 28' ' ' CYS . 58.0 m -52.64 129.69 30.1 Favored 'General case' 0 N--CA 1.506 2.351 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.44 ' O ' ' N ' ' A' ' 16' ' ' SER . 0.2 OUTLIER -136.08 140.36 43.7 Favored 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 116.106 1.891 . . . . 0.0 116.106 -179.087 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.418 ' C ' ' H ' ' A' ' 26' ' ' ILE . 11.4 t-20 -145.12 57.13 1.26 Allowed 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.48 -48.82 3.39 Favored Glycine 0 N--CA 1.48 1.608 0 N-CA-C 104.377 -3.489 . . . . 0.0 104.377 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.418 ' H ' ' C ' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -126.3 145.33 52.26 Favored Pre-proline 0 C--N 1.308 -1.221 0 N-CA-C 102.82 -3.03 . . . . 0.0 102.82 179.492 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -64.87 177.45 2.34 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.243 1.962 . . . . 0.0 111.02 -175.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.608 ' SG ' ' HB2' ' A' ' 22' ' ' CYS . 2.2 p -142.1 9.17 1.89 Allowed 'General case' 0 N--CA 1.502 2.141 0 CA-C-N 114.693 -1.14 . . . . 0.0 108.486 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 73.52 -176.04 0.16 Allowed 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 . . . . . 0 N--CA 1.502 2.166 0 O-C-N 124.047 0.842 . . . . 0.0 110.042 -179.869 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 31.6 p . . . . . 0 N--CA 1.495 1.822 0 CA-C-O 121.14 0.495 . . . . 0.0 111.055 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.7 m -104.75 36.34 2.46 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 114.275 -1.329 . . . . 0.0 109.726 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.2 t -23.09 -57.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.616 0 O-C-N 125.106 1.504 . . . . 0.0 114.761 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -125.72 -56.97 1.47 Allowed 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 102.985 -2.969 . . . . 0.0 102.985 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.5 pt -70.02 151.79 96.02 Favored Pre-proline 0 C--N 1.306 -1.324 0 CA-C-N 112.371 -2.195 . . . . 0.0 108.798 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -59.39 -176.8 0.11 Allowed 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 123.066 2.511 . . . . 0.0 111.565 167.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.55 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 34.6 t -78.63 -53.39 7.22 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.0 p 39.05 37.29 0.21 Allowed 'General case' 0 N--CA 1.504 2.236 0 O-C-N 125.006 1.441 . . . . 0.0 114.887 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 51.1 t -141.57 -63.12 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 CA-C-N 112.77 -2.014 . . . . 0.0 106.788 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.473 ' OG1' ' SG ' ' A' ' 7' ' ' CYS . 35.6 p -92.31 -10.02 39.87 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.59 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.8 -19.13 15.54 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.912 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -52.35 -38.8 59.67 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 114.72 -1.127 . . . . 0.0 112.684 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.53 -13.7 36.78 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 123.989 0.806 . . . . 0.0 111.374 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.36 27.75 3.26 Favored Glycine 0 N--CA 1.495 2.567 0 O-C-N 124.449 1.093 . . . . 0.0 111.178 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.459 ' SG ' ' C ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER -80.9 81.72 7.07 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 123.001 1.382 . . . . 0.0 111.819 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 38.7 m -58.02 125.03 21.39 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 112.407 -2.179 . . . . 0.0 113.397 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.55 ' SG ' ' HB2' ' A' ' 7' ' ' CYS . 35.0 m -65.66 82.77 0.06 Allowed 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.3 t -91.11 123.09 34.3 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.3 p30 45.98 47.01 12.66 Favored 'General case' 0 N--CA 1.504 2.269 0 CA-C-O 122.984 1.373 . . . . 0.0 110.409 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 56.53 36.83 28.2 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 111.907 -2.406 . . . . 0.0 112.686 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 69.2 t -136.11 118.79 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.459 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 4.3 m -58.38 123.05 14.82 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.87 133.84 38.17 Favored 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 117.064 2.246 . . . . 0.0 117.064 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.459 ' C ' ' H ' ' A' ' 26' ' ' ILE . 22.1 t-20 -144.17 60.71 1.35 Allowed 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.77 -32.1 4.09 Favored Glycine 0 N--CA 1.483 1.813 0 N-CA-C 107.977 -2.049 . . . . 0.0 107.977 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.459 ' H ' ' C ' ' A' ' 24' ' ' ASN . 4.3 tt -149.92 145.42 18.86 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 103.264 -2.865 . . . . 0.0 103.264 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -67.85 177.73 3.98 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.103 1.869 . . . . 0.0 111.108 -171.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.4 m -142.19 19.15 2.09 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.156 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 69.06 172.94 0.3 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 124.377 1.048 . . . . 0.0 110.335 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.501 2.114 0 O-C-N 124.444 1.09 . . . . 0.0 109.55 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 35.8 p . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.181 0.515 . . . . 0.0 111.299 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.6 m -104.67 36.98 2.24 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 114.162 -1.381 . . . . 0.0 109.727 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 19.6 t -25.48 -56.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.681 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -125.07 -57.31 1.52 Allowed 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 103.54 -2.763 . . . . 0.0 103.54 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.2 pt -69.53 152.96 96.14 Favored Pre-proline 0 C--N 1.306 -1.326 0 CA-C-N 112.311 -2.222 . . . . 0.0 108.675 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -59.74 -177.4 0.14 Allowed 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 123.005 2.47 . . . . 0.0 111.661 164.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.523 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 42.1 t -79.34 -50.94 10.09 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.319 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.9 p 37.21 40.99 0.2 Allowed 'General case' 0 N--CA 1.504 2.259 0 O-C-N 125.121 1.513 . . . . 0.0 115.055 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 43.6 t -145.23 -67.87 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-N 112.633 -2.076 . . . . 0.0 106.698 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.446 ' OG1' ' SG ' ' A' ' 7' ' ' CYS . 29.3 p -85.05 -10.37 57.0 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.453 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.49 -17.8 9.45 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.32 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 33.1 mt -54.38 -38.64 66.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 124.332 1.02 . . . . 0.0 112.391 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.44 -8.01 53.9 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 123.91 0.756 . . . . 0.0 111.283 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.22 30.21 4.24 Favored Glycine 0 N--CA 1.494 2.518 0 O-C-N 124.436 1.085 . . . . 0.0 111.33 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.469 ' SG ' ' C ' ' A' ' 22' ' ' CYS . 0.9 OUTLIER -80.98 82.33 6.99 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 122.842 1.306 . . . . 0.0 112.408 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.1 m -60.54 123.68 18.09 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 112.568 -2.106 . . . . 0.0 111.89 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.523 ' SG ' ' HB2' ' A' ' 7' ' ' CYS . 46.7 m -63.04 85.61 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.4 m -92.31 125.8 37.12 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 105.315 -2.106 . . . . 0.0 105.315 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.5 p30 46.6 45.17 14.14 Favored 'General case' 0 N--CA 1.505 2.318 0 CA-C-O 122.785 1.279 . . . . 0.0 110.743 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.4 mtm180 56.24 37.09 28.5 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 112.244 -2.253 . . . . 0.0 112.18 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 55.7 t -136.32 121.05 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.469 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 7.2 m -56.17 122.65 12.21 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.61 136.09 40.75 Favored 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 117.485 2.402 . . . . 0.0 117.485 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.473 ' C ' ' H ' ' A' ' 26' ' ' ILE . 19.9 t-20 -145.95 61.15 1.25 Allowed 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 105.477 -2.045 . . . . 0.0 105.477 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.88 -32.8 3.66 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 108.052 -2.019 . . . . 0.0 108.052 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.473 ' H ' ' C ' ' A' ' 24' ' ' ASN . 3.6 tt -149.93 144.79 18.01 Favored Pre-proline 0 N--CA 1.488 1.457 0 N-CA-C 103.015 -2.957 . . . . 0.0 103.015 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -66.83 177.03 3.79 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.239 1.959 . . . . 0.0 111.646 -170.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.3 m -143.04 23.21 1.88 Allowed 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 114.715 -1.13 . . . . 0.0 108.863 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 69.75 174.65 0.29 Allowed 'General case' 0 N--CA 1.501 2.1 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.461 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 . . . . . 0 N--CA 1.502 2.141 0 O-C-N 124.726 1.266 . . . . 0.0 111.276 -179.923 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.8 p . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.346 0.593 . . . . 0.0 110.06 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.449 ' SG ' ' C ' ' A' ' 20' ' ' ARG . 19.4 p -104.61 57.07 0.7 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 114.013 -1.448 . . . . 0.0 107.844 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.7 t -42.75 -51.57 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.403 0 N-CA-C 116.952 2.204 . . . . 0.0 116.952 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -122.14 -58.25 1.73 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 102.727 -3.064 . . . . 0.0 102.727 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.527 ' CD1' ' H ' ' A' ' 5' ' ' ILE . 0.2 OUTLIER -71.5 148.21 92.99 Favored Pre-proline 0 C--N 1.302 -1.485 0 CA-C-N 111.49 -2.595 . . . . 0.0 106.897 179.512 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -58.92 -178.81 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.899 2.399 . . . . 0.0 111.001 168.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.497 ' SG ' ' OG1' ' A' ' 10' ' ' THR . 42.7 t -73.25 -54.43 8.42 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 114.605 -1.18 . . . . 0.0 111.704 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 68.0 p 41.78 34.45 0.42 Allowed 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 51.6 t -142.92 -65.22 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 113.468 -1.696 . . . . 0.0 106.974 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.497 ' OG1' ' SG ' ' A' ' 7' ' ' CYS . 22.7 p -86.61 -19.13 29.8 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.44 -21.26 59.76 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.357 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 92.6 mt -57.92 -34.24 69.64 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 124.444 1.09 . . . . 0.0 111.175 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.404 ' CD1' HD21 ' A' ' 24' ' ' ASN . 0.5 OUTLIER -89.51 -6.87 56.01 Favored 'General case' 0 N--CA 1.48 1.066 0 O-C-N 123.964 0.79 . . . . 0.0 111.153 179.809 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.15 12.11 6.53 Favored Glycine 0 N--CA 1.497 2.765 0 O-C-N 124.277 0.985 . . . . 0.0 113.893 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -80.74 85.12 6.14 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 123.254 1.502 . . . . 0.0 113.137 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.1 m -63.03 124.85 22.16 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 112.08 -2.327 . . . . 0.0 110.909 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 29.6 t -64.4 92.48 0.09 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 124.158 0.911 . . . . 0.0 113.142 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.452 ' HG ' HD21 ' A' ' 19' ' ' ASN . 27.8 p -109.66 140.22 43.77 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.452 HD21 ' HG ' ' A' ' 18' ' ' SER . 10.3 p30 48.79 37.85 10.65 Favored 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 122.638 1.209 . . . . 0.0 111.028 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.449 ' C ' ' SG ' ' A' ' 2' ' ' CYS . 31.4 mtt180 56.48 31.92 19.78 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-N 112.8 -2.0 . . . . 0.0 112.894 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.2 t -136.2 138.34 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 CA-C-N 112.775 -2.011 . . . . 0.0 107.725 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 29.3 m -63.88 125.89 25.85 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -135.89 120.55 18.33 Favored 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 117.104 2.261 . . . . 0.0 117.104 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.438 ' C ' ' H ' ' A' ' 26' ' ' ILE . 27.7 t-20 -123.03 53.6 1.29 Allowed 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 104.056 -2.572 . . . . 0.0 104.056 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.56 -44.27 2.59 Favored Glycine 0 N--CA 1.479 1.564 0 N-CA-C 104.0 -3.64 . . . . 0.0 104.0 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.438 ' H ' ' C ' ' A' ' 24' ' ' ASN . 1.1 pp -133.65 148.29 67.98 Favored Pre-proline 0 N--CA 1.482 1.161 0 N-CA-C 103.726 -2.694 . . . . 0.0 103.726 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -64.33 175.19 3.52 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.061 1.841 . . . . 0.0 112.073 -171.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.0 m -146.28 27.9 1.12 Allowed 'General case' 0 N--CA 1.5 2.045 0 CA-C-N 114.327 -1.306 . . . . 0.0 108.277 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 67.08 175.86 0.25 Allowed 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.759 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 . . . . . 0 N--CA 1.501 2.093 0 O-C-N 124.461 1.101 . . . . 0.0 111.389 -179.979 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.494 1.764 0 CA-C-O 121.576 0.703 . . . . 0.0 111.345 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.4 m -104.8 38.54 1.89 Allowed 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 113.442 -1.708 . . . . 0.0 109.674 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.6 t -26.21 -55.2 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.72 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -125.31 -58.14 1.45 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 103.266 -2.865 . . . . 0.0 103.266 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.2 pt -68.63 154.94 93.95 Favored Pre-proline 0 C--N 1.305 -1.331 0 CA-C-N 112.209 -2.269 . . . . 0.0 108.631 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -57.88 -174.92 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 123.075 2.517 . . . . 0.0 111.339 162.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.497 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 33.8 t -78.98 -51.09 10.1 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.47 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 68.8 p 41.24 34.8 0.35 Allowed 'General case' 0 N--CA 1.505 2.313 0 O-C-N 125.18 1.55 . . . . 0.0 114.787 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.3 t -145.58 -37.02 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-N 113.369 -1.741 . . . . 0.0 109.748 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.9 p -120.18 -15.14 8.73 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 124.493 1.121 . . . . 0.0 109.668 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.34 -19.09 7.82 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.079 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.1 pp -56.71 -34.51 67.54 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 124.05 0.844 . . . . 0.0 113.229 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 pp -89.4 -5.66 57.25 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 123.808 0.693 . . . . 0.0 111.085 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.39 28.02 4.78 Favored Glycine 0 N--CA 1.495 2.62 0 O-C-N 124.46 1.1 . . . . 0.0 111.465 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.483 ' SG ' ' C ' ' A' ' 22' ' ' CYS . 0.6 OUTLIER -83.35 81.06 8.88 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.736 1.255 . . . . 0.0 112.279 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.9 m -59.96 123.72 17.96 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 112.582 -2.099 . . . . 0.0 111.419 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.497 ' SG ' ' HB2' ' A' ' 7' ' ' CYS . 31.1 m -66.7 85.1 0.11 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 114.109 1.152 . . . . 0.0 114.109 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 96.1 p -96.15 132.86 41.13 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.6 p30 46.0 42.18 9.09 Favored 'General case' 0 N--CA 1.503 2.218 0 CA-C-O 122.663 1.221 . . . . 0.0 110.716 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.0 mtm-85 56.0 38.0 29.47 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-N 112.461 -2.154 . . . . 0.0 112.372 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.3 t -136.29 124.77 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.483 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 4.0 m -60.05 122.19 13.73 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.62 133.48 38.29 Favored 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 117.358 2.355 . . . . 0.0 117.358 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.468 ' C ' ' H ' ' A' ' 26' ' ' ILE . 32.3 t-20 -142.47 60.35 1.44 Allowed 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.73 -33.62 3.69 Favored Glycine 0 N--CA 1.484 1.844 0 N-CA-C 107.891 -2.084 . . . . 0.0 107.891 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.468 ' H ' ' C ' ' A' ' 24' ' ' ASN . 3.3 tt -149.6 144.56 17.94 Favored Pre-proline 0 N--CA 1.488 1.439 0 N-CA-C 103.168 -2.901 . . . . 0.0 103.168 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -65.99 177.45 3.0 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.266 1.978 . . . . 0.0 112.137 -169.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.7 m -141.82 25.81 1.94 Allowed 'General case' 0 N--CA 1.501 2.108 0 CA-C-N 114.821 -1.082 . . . . 0.0 109.03 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 68.96 166.97 0.27 Allowed 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 114.611 -1.177 . . . . 0.0 111.088 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 N--CA 1.501 2.111 0 O-C-N 124.464 1.102 . . . . 0.0 111.606 -179.956 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 62.1 p . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.635 0.731 . . . . 0.0 109.093 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.474 ' SG ' ' C ' ' A' ' 20' ' ' ARG . 14.6 p -104.37 60.4 0.71 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 113.559 -1.655 . . . . 0.0 107.425 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.6 t -48.91 -49.0 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 CA-C-N 113.015 -1.902 . . . . 0.0 115.508 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -116.29 -51.11 2.63 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 104.841 -2.281 . . . . 0.0 104.841 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.9 pt -64.9 164.45 21.46 Favored Pre-proline 0 C--N 1.303 -1.433 0 CA-C-N 112.297 -2.229 . . . . 0.0 108.954 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -68.22 -179.96 2.55 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 123.309 2.672 . . . . 0.0 109.716 153.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.422 ' SG ' ' OG1' ' A' ' 10' ' ' THR . 43.0 t -71.89 -63.67 1.09 Allowed 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.76 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.8 p 43.2 42.85 3.67 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 115.281 1.586 . . . . 0.0 115.281 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 79.0 t -144.99 -70.43 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 105.08 -2.193 . . . . 0.0 105.08 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.422 ' OG1' ' SG ' ' A' ' 7' ' ' CYS . 40.5 p -88.76 -7.84 55.51 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.32 -19.18 32.89 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.498 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 39.2 mt -53.82 -39.02 65.16 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 114.758 -1.11 . . . . 0.0 112.411 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.422 ' CD1' HD21 ' A' ' 24' ' ' ASN . 0.6 OUTLIER -89.4 -11.42 43.25 Favored 'General case' 0 N--CA 1.483 1.202 0 O-C-N 123.974 0.796 . . . . 0.0 110.944 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 124.82 15.57 3.18 Favored Glycine 0 N--CA 1.497 2.708 0 O-C-N 124.294 0.997 . . . . 0.0 113.167 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.88 90.52 5.31 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 123.276 1.513 . . . . 0.0 112.726 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 65.9 m -71.95 126.5 29.9 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 111.8 -2.454 . . . . 0.0 110.057 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.6 t -62.76 90.24 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 124.049 0.843 . . . . 0.0 112.728 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 12.2 m -104.51 137.79 41.84 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 11.1 p30 48.23 39.62 12.42 Favored 'General case' 0 N--CA 1.502 2.138 0 CA-C-O 122.696 1.236 . . . . 0.0 110.7 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.474 ' C ' ' SG ' ' A' ' 2' ' ' CYS . 30.4 mtt180 56.19 31.93 19.27 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-N 112.63 -2.077 . . . . 0.0 113.306 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 50.1 t -136.38 138.71 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-N 112.944 -1.934 . . . . 0.0 107.855 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 71.8 m -61.52 125.0 22.22 Favored 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -135.87 113.81 11.22 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 117.789 2.514 . . . . 0.0 117.789 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.476 ' C ' ' H ' ' A' ' 26' ' ' ILE . 38.3 t-20 -116.67 54.77 0.84 Allowed 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 104.497 -2.409 . . . . 0.0 104.497 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.62 -37.28 3.31 Favored Glycine 0 N--CA 1.482 1.711 0 N-CA-C 106.706 -2.558 . . . . 0.0 106.706 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.476 ' H ' ' C ' ' A' ' 24' ' ' ASN . 4.0 tt -144.08 143.13 21.53 Favored Pre-proline 0 N--CA 1.488 1.451 0 N-CA-C 102.412 -3.181 . . . . 0.0 102.412 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -65.11 175.63 3.76 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 122.071 1.848 . . . . 0.0 112.661 -166.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.1 m -144.77 30.16 1.2 Allowed 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 114.149 -1.387 . . . . 0.0 108.117 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 64.32 -177.4 0.17 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.461 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 N--CA 1.5 2.04 0 O-C-N 124.372 1.045 . . . . 0.0 110.427 179.974 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.2 p . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.271 0.557 . . . . 0.0 111.255 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.4 m -104.79 37.98 2.02 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 114.057 -1.429 . . . . 0.0 109.504 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 18.1 t -25.4 -56.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.623 0 N-CA-C 115.027 1.492 . . . . 0.0 115.027 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -125.04 -56.74 1.54 Allowed 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 103.526 -2.768 . . . . 0.0 103.526 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.6 pt -70.14 153.57 95.2 Favored Pre-proline 0 C--N 1.305 -1.349 0 CA-C-N 112.284 -2.234 . . . . 0.0 108.819 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -59.41 -175.78 0.1 OUTLIER 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.892 2.395 . . . . 0.0 111.211 163.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.508 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 13.8 t -79.47 -52.19 8.37 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.125 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.0 p 40.89 36.37 0.41 Allowed 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 37.2 t -144.46 -41.01 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-N 112.845 -1.98 . . . . 0.0 107.983 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.467 ' OG1' ' SG ' ' A' ' 7' ' ' CYS . 16.0 p -116.38 -0.15 12.63 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 124.415 1.072 . . . . 0.0 108.784 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.11 -25.86 68.29 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -56.59 -31.75 64.56 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.55 -9.95 47.94 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 123.451 0.469 . . . . 0.0 110.569 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.89 25.32 5.7 Favored Glycine 0 N--CA 1.494 2.537 0 O-C-N 124.266 0.979 . . . . 0.0 112.236 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.448 ' SG ' ' C ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER -80.34 86.53 5.69 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.721 1.248 . . . . 0.0 111.348 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 24.0 m -64.69 122.6 17.24 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 112.679 -2.055 . . . . 0.0 111.249 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.508 ' SG ' ' HB2' ' A' ' 7' ' ' CYS . 32.8 m -63.65 84.84 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 124.506 1.129 . . . . 0.0 113.992 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.6 t -92.58 128.33 38.4 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.7 p30 46.64 44.21 13.4 Favored 'General case' 0 N--CA 1.504 2.226 0 CA-C-O 122.678 1.227 . . . . 0.0 110.811 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.5 mtm-85 56.04 37.39 28.79 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 112.308 -2.224 . . . . 0.0 112.173 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.1 t -136.21 121.08 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.448 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 4.0 m -56.94 123.25 14.45 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.48 111.6 9.63 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 116.682 2.105 . . . . 0.0 116.682 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.471 ' C ' ' H ' ' A' ' 26' ' ' ILE . 45.5 t30 -110.2 53.28 0.7 Allowed 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.5 -38.67 3.19 Favored Glycine 0 N--CA 1.483 1.769 0 N-CA-C 106.282 -2.727 . . . . 0.0 106.282 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.471 ' H ' ' C ' ' A' ' 24' ' ' ASN . 3.5 tt -138.53 144.64 43.23 Favored Pre-proline 0 N--CA 1.489 1.479 0 N-CA-C 102.225 -3.25 . . . . 0.0 102.225 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -65.56 176.37 3.52 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 122.157 1.905 . . . . 0.0 111.888 -167.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.2 m -145.76 25.36 1.31 Allowed 'General case' 0 N--CA 1.501 2.122 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.116 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 66.46 173.38 0.24 Allowed 'General case' 0 N--CA 1.5 2.04 0 CA-C-N 114.746 -1.115 . . . . 0.0 110.962 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 . . . . . 0 N--CA 1.501 2.092 0 O-C-N 124.421 1.076 . . . . 0.0 111.664 -179.897 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 12.3 t . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 122.366 1.079 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.535 ' SG ' ' N ' ' A' ' 21' ' ' VAL . 0.7 OUTLIER -106.07 41.3 1.43 Allowed 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 111.975 -2.375 . . . . 0.0 110.607 -179.9 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.9 t -30.92 -53.71 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.571 0 CA-C-N 113.525 -1.671 . . . . 0.0 113.196 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -124.43 -55.44 1.65 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 104.488 -2.412 . . . . 0.0 104.488 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -61.92 131.06 93.03 Favored Pre-proline 0 C--N 1.307 -1.246 0 CA-C-N 112.968 -1.924 . . . . 0.0 109.368 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -37.55 -48.01 1.88 Allowed 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 123.987 3.125 . . . . 0.0 112.752 172.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.496 ' SG ' ' OG1' ' A' ' 10' ' ' THR . 45.5 t 179.08 -45.04 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 O-C-N 124.145 0.903 . . . . 0.0 110.023 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.9 t 36.97 24.68 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 118.56 2.8 . . . . 0.0 118.56 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.7 t -146.89 -54.1 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.589 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.496 ' OG1' ' SG ' ' A' ' 7' ' ' CYS . 16.4 p -101.72 -5.24 25.21 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 124.002 0.814 . . . . 0.0 110.956 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.59 -14.2 28.35 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.574 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -55.77 -41.79 74.55 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 114.946 -1.024 . . . . 0.0 111.816 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.44 4.18 49.92 Favored 'General case' 0 N--CA 1.482 1.169 0 O-C-N 124.097 0.873 . . . . 0.0 111.118 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.41 34.5 7.44 Favored Glycine 0 N--CA 1.492 2.426 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.987 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.2 t -81.33 89.22 6.07 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 122.801 1.286 . . . . 0.0 111.8 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 23' ' ' TYR . 57.8 m -66.8 120.05 12.88 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 112.308 -2.224 . . . . 0.0 111.246 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.544 ' SG ' ' HA ' ' A' ' 20' ' ' ARG . 21.4 t -58.96 146.45 37.92 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.4 m -150.09 124.45 9.57 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 103.6 -2.741 . . . . 0.0 103.6 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.8 p30 45.64 45.25 10.88 Favored 'General case' 0 N--CA 1.505 2.305 0 CA-C-O 122.99 1.376 . . . . 0.0 110.134 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.544 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 4.4 mtm-85 55.34 38.86 30.94 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 112.052 -2.34 . . . . 0.0 112.94 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.535 ' N ' ' SG ' ' A' ' 2' ' ' CYS . 42.5 t -136.18 116.98 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 34.1 m -53.35 131.52 37.84 Favored 'General case' 0 N--CA 1.511 2.583 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.439 ' O ' ' N ' ' A' ' 16' ' ' SER . 0.2 OUTLIER -135.84 140.45 44.2 Favored 'General case' 0 N--CA 1.504 2.274 0 N-CA-C 116.423 2.009 . . . . 0.0 116.423 -179.336 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -148.8 59.97 1.06 Allowed 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.52 -50.36 3.53 Favored Glycine 0 N--CA 1.482 1.752 0 N-CA-C 104.733 -3.347 . . . . 0.0 104.733 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.2 pt -127.59 148.72 67.86 Favored Pre-proline 0 C--N 1.306 -1.311 0 N-CA-C 102.48 -3.156 . . . . 0.0 102.48 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -65.08 175.76 3.64 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 121.978 1.785 . . . . 0.0 110.34 -176.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.0 m -140.69 20.67 2.34 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-N 114.854 -1.067 . . . . 0.0 108.887 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 69.31 179.1 0.25 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 124.328 1.017 . . . . 0.0 109.278 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 . . . . . 0 N--CA 1.5 2.026 0 O-C-N 124.353 1.033 . . . . 0.0 111.165 -179.941 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 17.0 m . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.564 0.697 . . . . 0.0 111.689 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.498 ' SG ' ' HB2' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -104.67 34.53 3.1 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 113.769 -1.559 . . . . 0.0 110.143 -179.936 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.407 ' CA ' ' HG2' ' A' ' 20' ' ' ARG . 42.1 t -27.54 -53.69 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.754 0 O-C-N 125.023 1.452 . . . . 0.0 113.089 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -125.7 -55.57 1.51 Allowed 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 104.387 -2.449 . . . . 0.0 104.387 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.5 pt -67.68 165.68 28.72 Favored Pre-proline 0 C--N 1.306 -1.302 0 CA-C-N 113.247 -1.797 . . . . 0.0 108.9 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -58.4 -178.37 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 123.043 2.495 . . . . 0.0 111.42 154.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.498 ' HB2' ' SG ' ' A' ' 2' ' ' CYS . 0.6 OUTLIER -88.96 -52.24 5.19 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 114.371 -1.286 . . . . 0.0 108.469 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 34.05 54.48 0.57 Allowed 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 26.0 t -150.03 -41.26 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-N 112.849 -1.978 . . . . 0.0 107.287 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.558 ' OG1' ' SG ' ' A' ' 22' ' ' CYS . 33.3 p -123.74 -19.4 5.77 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 114.59 -1.186 . . . . 0.0 109.033 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.45 -27.1 5.88 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.8 pp -54.86 -36.63 65.3 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -89.59 -5.07 57.52 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.62 14.76 5.16 Favored Glycine 0 N--CA 1.5 2.923 0 O-C-N 124.066 0.853 . . . . 0.0 112.6 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.495 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 74.1 m -80.59 87.43 5.76 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 123.95 1.833 . . . . 0.0 109.606 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.0 m -67.19 125.51 26.26 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 111.566 -2.561 . . . . 0.0 112.106 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.4 m -66.41 82.4 0.09 Allowed 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 122.187 0.994 . . . . 0.0 111.796 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.3 m -93.6 123.82 37.18 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.3 p30 47.06 42.37 12.65 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 124.548 1.155 . . . . 0.0 110.402 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.407 ' HG2' ' CA ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER 58.3 36.81 25.86 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 112.475 -2.148 . . . . 0.0 111.815 -179.852 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 74.3 t -136.61 119.99 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 179.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.558 ' SG ' ' OG1' ' A' ' 10' ' ' THR . 0.1 OUTLIER -61.4 124.41 20.53 Favored 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 179.843 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -135.5 125.73 26.34 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -179.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 -130.63 61.36 1.61 Allowed 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.3 -50.93 3.65 Favored Glycine 0 N--CA 1.48 1.569 0 N-CA-C 104.373 -3.491 . . . . 0.0 104.373 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.68 150.15 60.93 Favored Pre-proline 0 C--N 1.308 -1.217 0 N-CA-C 103.769 -2.678 . . . . 0.0 103.769 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -64.49 175.29 3.56 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.215 1.943 . . . . 0.0 110.503 -173.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.8 m -149.35 19.9 0.95 Allowed 'General case' 0 N--CA 1.497 1.875 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.914 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 62.68 -172.49 0.16 Allowed 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.061 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 . . . . . 0 N--CA 1.498 1.959 0 O-C-N 124.325 1.015 . . . . 0.0 110.561 179.999 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 73.7 p . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.493 0.663 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.482 ' SG ' ' C ' ' A' ' 20' ' ' ARG . 6.2 p -104.77 51.96 0.75 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 113.747 -1.569 . . . . 0.0 109.577 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.7 t -40.67 -51.41 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.451 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -120.56 -60.18 1.69 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 103.638 -2.727 . . . . 0.0 103.638 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.2 pt -66.74 147.64 98.98 Favored Pre-proline 0 C--N 1.305 -1.345 0 CA-C-N 112.414 -2.175 . . . . 0.0 106.807 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -60.21 -179.75 0.26 Allowed 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.858 2.372 . . . . 0.0 111.104 169.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 40.8 t -65.38 -61.62 2.01 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.933 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.1 p 37.73 38.51 0.17 Allowed 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.5 t -139.71 -67.44 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-N 112.945 -1.934 . . . . 0.0 106.513 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.6 p -94.36 -5.1 47.27 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 124.222 0.951 . . . . 0.0 109.087 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.34 -18.8 30.2 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.812 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.0 pp -54.91 -36.4 65.16 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -89.44 -11.79 42.08 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 123.831 0.707 . . . . 0.0 110.934 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.85 21.46 3.21 Favored Glycine 0 N--CA 1.496 2.641 0 O-C-N 124.417 1.073 . . . . 0.0 112.443 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -83.36 84.92 7.33 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 123.194 1.474 . . . . 0.0 112.348 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.8 m -65.46 127.37 31.53 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 111.777 -2.465 . . . . 0.0 111.339 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 39.6 t -63.32 87.37 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 124.113 0.883 . . . . 0.0 113.162 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.9 m -99.59 131.02 45.86 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.3 p30 47.22 43.55 14.82 Favored 'General case' 0 N--CA 1.504 2.248 0 CA-C-O 122.861 1.315 . . . . 0.0 110.624 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.482 ' C ' ' SG ' ' A' ' 2' ' ' CYS . 5.7 mtm-85 55.29 33.23 20.26 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 112.248 -2.251 . . . . 0.0 113.155 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.1 t -136.35 130.4 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 CA-C-N 113.059 -1.882 . . . . 0.0 107.244 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 74.2 m -59.5 125.15 22.47 Favored 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -135.88 125.39 25.12 Favored 'General case' 0 N--CA 1.503 2.205 0 N-CA-C 117.632 2.456 . . . . 0.0 117.632 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.416 ' C ' ' H ' ' A' ' 26' ' ' ILE . 37.8 t-20 -132.9 55.96 1.87 Allowed 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.13 -48.38 3.19 Favored Glycine 0 N--CA 1.482 1.75 0 N-CA-C 104.522 -3.431 . . . . 0.0 104.522 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.416 ' H ' ' C ' ' A' ' 24' ' ' ASN . 1.5 pt -127.41 144.42 50.76 Favored Pre-proline 0 C--N 1.308 -1.233 0 N-CA-C 103.365 -2.828 . . . . 0.0 103.365 179.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -65.28 176.3 3.38 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.196 1.931 . . . . 0.0 111.732 -174.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.9 m -146.13 27.04 1.18 Allowed 'General case' 0 N--CA 1.5 2.052 0 CA-C-N 114.671 -1.15 . . . . 0.0 108.185 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 63.35 -176.36 0.15 Allowed 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.539 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 . . . . . 0 N--CA 1.5 2.036 0 O-C-N 124.081 0.863 . . . . 0.0 110.106 -179.992 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 21.0 m . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.952 0.882 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.49 ' SG ' ' N ' ' A' ' 21' ' ' VAL . 0.2 OUTLIER -104.55 42.9 1.15 Allowed 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 112.986 -1.916 . . . . 0.0 110.388 179.983 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.4 t -33.46 -50.41 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.429 0 CA-C-N 113.256 -1.793 . . . . 0.0 113.555 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -123.41 -58.19 1.62 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 104.756 -2.313 . . . . 0.0 104.756 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -61.2 133.41 92.81 Favored Pre-proline 0 C--N 1.306 -1.311 0 CA-C-N 112.587 -2.097 . . . . 0.0 109.009 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -41.48 -46.24 5.99 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 123.472 2.781 . . . . 0.0 112.427 173.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.444 ' SG ' ' OG1' ' A' ' 10' ' ' THR . 52.9 t 179.11 -57.08 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 O-C-N 124.409 1.068 . . . . 0.0 108.542 179.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 71.4 p 38.16 34.63 0.07 Allowed 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 115.961 1.837 . . . . 0.0 115.961 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 50.3 t -144.56 -62.52 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-N 113.621 -1.627 . . . . 0.0 108.707 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.444 ' OG1' ' SG ' ' A' ' 7' ' ' CYS . 15.8 p -98.29 0.56 45.84 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 124.22 0.95 . . . . 0.0 110.514 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.13 -17.37 39.79 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.928 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 48.1 mt -54.92 -44.24 74.05 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 114.448 -1.251 . . . . 0.0 111.52 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.45 2.55 54.36 Favored 'General case' 0 C--N 1.31 -1.139 0 O-C-N 124.174 0.922 . . . . 0.0 111.886 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.34 33.76 7.45 Favored Glycine 0 N--CA 1.494 2.558 0 CA-C-N 115.023 -0.989 . . . . 0.0 112.736 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 2.1 t -80.65 93.31 6.12 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 122.392 1.092 . . . . 0.0 111.449 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 23' ' ' TYR . 67.7 m -73.24 118.07 15.75 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 113.128 -1.851 . . . . 0.0 109.261 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.435 ' SG ' ' HA ' ' A' ' 20' ' ' ARG . 49.3 t -66.45 148.41 51.92 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 60.9 p -150.2 136.62 18.91 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 104.123 -2.547 . . . . 0.0 104.123 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.9 p30 46.53 39.76 7.26 Favored 'General case' 0 N--CA 1.504 2.266 0 CA-C-O 122.652 1.215 . . . . 0.0 110.933 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.435 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 5.0 mtm-85 55.46 39.04 31.05 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 112.624 -2.08 . . . . 0.0 112.501 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.49 ' N ' ' SG ' ' A' ' 2' ' ' CYS . 55.0 t -136.2 116.79 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 59.2 m -51.86 133.45 31.97 Favored 'General case' 0 N--CA 1.512 2.63 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.402 ' O ' ' N ' ' A' ' 16' ' ' SER . 0.2 OUTLIER -135.75 131.56 35.7 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 117.038 2.236 . . . . 0.0 117.038 -179.291 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.469 ' C ' ' H ' ' A' ' 26' ' ' ILE . 11.4 t-20 -138.13 62.06 1.58 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 105.553 -2.018 . . . . 0.0 105.553 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.73 -39.45 3.11 Favored Glycine 0 N--CA 1.485 1.907 0 N-CA-C 107.322 -2.311 . . . . 0.0 107.322 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.469 ' H ' ' C ' ' A' ' 24' ' ' ASN . 2.5 tt -147.44 147.44 28.13 Favored Pre-proline 0 N--CA 1.487 1.408 0 N-CA-C 101.942 -3.355 . . . . 0.0 101.942 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -63.84 176.26 2.49 Favored 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 121.792 1.661 . . . . 0.0 111.63 -168.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.4 m -136.54 21.3 3.13 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 114.436 -1.256 . . . . 0.0 109.045 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 69.33 174.08 0.29 Allowed 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.254 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 . . . . . 0 N--CA 1.501 2.078 0 O-C-N 124.405 1.066 . . . . 0.0 110.176 -179.854 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 10.7 m . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.9 p -104.68 57.29 0.7 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 114.242 -1.345 . . . . 0.0 109.853 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 54.4 t -34.45 -66.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.387 0 CA-C-N 113.4 -1.727 . . . . 0.0 115.093 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -116.86 -52.95 2.52 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 103.065 -2.939 . . . . 0.0 103.065 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.2 pt -72.23 133.97 83.06 Favored Pre-proline 0 C--N 1.304 -1.395 0 CA-C-N 112.24 -2.255 . . . . 0.0 106.675 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -56.17 179.91 0.09 OUTLIER 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.884 2.389 . . . . 0.0 111.479 173.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.48 ' SG ' ' OG1' ' A' ' 10' ' ' THR . 42.1 t -68.53 -58.08 4.84 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 114.521 -1.218 . . . . 0.0 111.037 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.4 p 36.19 41.29 0.13 Allowed 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 115.759 1.762 . . . . 0.0 115.759 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.5 t -146.97 -67.0 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-N 113.076 -1.875 . . . . 0.0 106.644 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.48 ' OG1' ' SG ' ' A' ' 7' ' ' CYS . 36.6 p -84.49 -11.19 56.61 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.1 -18.6 36.94 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.231 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 88.2 mt -55.0 -37.7 66.92 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.108 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.419 ' CD1' HD21 ' A' ' 24' ' ' ASN . 0.7 OUTLIER -89.37 -11.48 43.12 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 123.909 0.755 . . . . 0.0 110.931 179.911 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 123.06 17.72 3.29 Favored Glycine 0 N--CA 1.497 2.743 0 O-C-N 124.27 0.981 . . . . 0.0 113.138 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.75 88.99 6.73 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 122.993 1.378 . . . . 0.0 113.071 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.6 m -70.61 126.92 30.97 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 112.409 -2.178 . . . . 0.0 110.301 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.7 t -62.28 89.89 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 124.133 0.895 . . . . 0.0 112.689 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.7 t -105.69 134.57 48.59 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.7 p30 47.78 42.72 16.17 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 124.762 1.289 . . . . 0.0 111.251 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.7 mtp180 56.86 30.91 18.69 Favored 'General case' 0 N--CA 1.502 2.169 0 CA-C-N 112.58 -2.1 . . . . 0.0 112.948 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 53.7 t -136.29 136.31 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 CA-C-N 113.159 -1.837 . . . . 0.0 108.166 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 84.4 m -62.78 126.98 29.15 Favored 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 105.785 -1.932 . . . . 0.0 105.785 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.82 117.25 14.72 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 118.414 2.746 . . . . 0.0 118.414 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.478 ' C ' ' H ' ' A' ' 26' ' ' ILE . 41.5 t-20 -121.96 55.97 1.1 Allowed 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.0 -37.24 3.28 Favored Glycine 0 N--CA 1.484 1.842 0 N-CA-C 107.16 -2.376 . . . . 0.0 107.16 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.478 ' H ' ' C ' ' A' ' 24' ' ' ASN . 4.5 tt -146.06 142.21 17.46 Favored Pre-proline 0 N--CA 1.487 1.408 0 N-CA-C 102.294 -3.225 . . . . 0.0 102.294 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -65.67 174.98 4.79 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.084 1.856 . . . . 0.0 112.749 -166.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.2 m -140.26 28.12 2.08 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 113.899 -1.5 . . . . 0.0 107.723 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 66.26 -178.49 0.2 Allowed 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.319 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 . . . . . 0 N--CA 1.501 2.096 0 O-C-N 124.439 1.087 . . . . 0.0 112.189 -179.988 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 52.2 p . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 121.553 0.692 . . . . 0.0 110.5 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.407 ' CB ' ' O ' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -104.79 38.6 1.87 Allowed 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 113.764 -1.562 . . . . 0.0 111.046 -179.954 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.1 t -23.87 -53.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.527 0 CA-C-N 113.146 -1.843 . . . . 0.0 115.571 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -122.74 -37.48 2.75 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.402 ' CG1' ' HA ' ' A' ' 2' ' ' CYS . 14.9 pt -72.0 178.47 1.31 Allowed Pre-proline 0 CA--C 1.561 1.379 0 CA-C-N 112.789 -2.005 . . . . 0.0 111.188 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.407 ' O ' ' CB ' ' A' ' 2' ' ' CYS . 13.2 Cg_endo -82.03 -52.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 124.106 3.204 . . . . 0.0 110.766 168.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 51.9 t 179.04 -59.4 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 124.188 0.93 . . . . 0.0 109.334 179.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.2 p 40.38 38.12 0.52 Allowed 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 115.008 1.485 . . . . 0.0 115.008 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 42.1 t -144.29 -63.68 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-N 113.27 -1.786 . . . . 0.0 108.362 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.476 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 26.1 p -100.42 -14.25 18.39 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 124.102 0.876 . . . . 0.0 110.797 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.81 -20.08 1.17 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 123.743 0.652 . . . . 0.0 112.37 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 35.2 mt -54.19 -45.07 72.08 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 124.297 0.998 . . . . 0.0 112.271 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -89.58 13.86 12.98 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 124.182 0.926 . . . . 0.0 112.361 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.68 29.44 16.09 Favored Glycine 0 N--CA 1.495 2.6 0 CA-C-N 115.046 -0.979 . . . . 0.0 113.267 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.476 ' SG ' ' HB ' ' A' ' 10' ' ' THR . 78.6 m -81.3 80.11 7.78 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.67 1.224 . . . . 0.0 110.013 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.8 m -66.52 117.48 8.78 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 112.392 -2.185 . . . . 0.0 110.407 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.595 ' SG ' ' HA ' ' A' ' 20' ' ' ARG . 48.6 t -63.23 144.43 56.94 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 114.567 -1.197 . . . . 0.0 113.993 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.5 m -147.3 130.15 16.18 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 103.443 -2.799 . . . . 0.0 103.443 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.2 p30 45.6 41.59 7.22 Favored 'General case' 0 N--CA 1.506 2.335 0 CA-C-O 122.769 1.271 . . . . 0.0 110.154 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.595 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 0.2 OUTLIER 56.3 41.33 29.28 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 112.346 -2.206 . . . . 0.0 112.741 -179.878 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 78.9 t -136.07 111.84 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 105.685 -1.968 . . . . 0.0 105.685 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 59.5 m -52.44 127.46 22.52 Favored 'General case' 0 N--CA 1.507 2.389 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -135.58 113.67 11.29 Favored 'General case' 0 N--CA 1.509 2.487 0 N-CA-C 117.293 2.331 . . . . 0.0 117.293 -179.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.467 ' C ' ' H ' ' A' ' 26' ' ' ILE . 52.8 t30 -106.26 54.47 0.69 Allowed 'General case' 0 N--CA 1.506 2.348 0 N-CA-C 103.948 -2.612 . . . . 0.0 103.948 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.84 -43.07 2.96 Favored Glycine 0 N--CA 1.482 1.741 0 N-CA-C 104.77 -3.332 . . . . 0.0 104.77 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.467 ' H ' ' C ' ' A' ' 24' ' ' ASN . 2.6 pt -125.08 150.53 67.0 Favored Pre-proline 0 C--N 1.308 -1.204 0 N-CA-C 102.917 -2.994 . . . . 0.0 102.917 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -64.12 174.87 3.62 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 121.827 1.685 . . . . 0.0 110.632 -171.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 5.3 m -148.53 20.4 1.05 Allowed 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 114.614 -1.175 . . . . 0.0 108.701 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 62.46 -172.53 0.16 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.052 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 . . . . . 0 N--CA 1.5 2.046 0 O-C-N 124.277 0.986 . . . . 0.0 110.958 -179.919 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 73.3 m . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.74 0.781 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.518 ' SG ' ' C ' ' A' ' 20' ' ' ARG . 1.4 p -103.98 47.17 0.89 Allowed 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 113.266 -1.788 . . . . 0.0 109.382 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.0 t -47.55 -46.3 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 CA-C-N 113.937 -1.483 . . . . 0.0 113.059 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -118.52 -55.66 2.19 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 104.789 -2.3 . . . . 0.0 104.789 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -61.86 150.81 81.57 Favored Pre-proline 0 C--N 1.307 -1.255 0 CA-C-N 113.192 -1.822 . . . . 0.0 108.424 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -58.94 -48.43 14.48 Favored 'Trans proline' 0 N--CA 1.492 1.441 0 C-N-CA 123.343 2.695 . . . . 0.0 112.891 169.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.419 ' SG ' ' N ' ' A' ' 11' ' ' ALA . 42.0 t 179.49 -62.63 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 60.3 p 40.32 32.52 0.13 Allowed 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 55.3 t -148.06 -44.79 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-N 113.766 -1.561 . . . . 0.0 110.614 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.6 p -118.01 -3.1 11.16 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 124.316 1.01 . . . . 0.0 112.83 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.419 ' N ' ' SG ' ' A' ' 7' ' ' CYS . . . -63.22 -20.14 65.16 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.115 0.483 . . . . 0.0 110.259 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.4 mp -55.74 -38.17 69.45 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-N 114.4 -1.273 . . . . 0.0 113.624 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.32 -4.24 58.18 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 123.903 0.752 . . . . 0.0 112.217 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.65 18.46 10.12 Favored Glycine 0 N--CA 1.497 2.706 0 O-C-N 124.221 0.95 . . . . 0.0 112.556 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.666 ' HB3' ' SG ' ' A' ' 22' ' ' CYS . 2.0 t -75.56 119.87 20.2 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 122.063 0.935 . . . . 0.0 110.088 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.5 m -95.38 118.18 31.67 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 112.914 -1.948 . . . . 0.0 112.419 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.585 ' SG ' ' HA ' ' A' ' 20' ' ' ARG . 42.7 t -62.03 106.01 0.66 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 115.273 1.583 . . . . 0.0 115.273 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.9 m -113.58 133.48 55.25 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 103.934 -2.617 . . . . 0.0 103.934 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.0 p30 46.37 42.12 10.13 Favored 'General case' 0 N--CA 1.506 2.372 0 CA-C-O 122.741 1.258 . . . . 0.0 110.73 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.585 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 0.2 OUTLIER 54.75 38.0 29.37 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 112.341 -2.208 . . . . 0.0 113.354 -179.893 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.478 ' N ' ' SG ' ' A' ' 2' ' ' CYS . 54.4 t -136.4 117.7 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.666 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 0.5 OUTLIER -55.79 129.94 41.4 Favored 'General case' 0 N--CA 1.509 2.493 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 179.893 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.74 105.98 6.36 Favored 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 116.938 2.199 . . . . 0.0 116.938 -178.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.454 ' C ' ' H ' ' A' ' 26' ' ' ILE . 25.5 t-20 -96.94 56.11 1.39 Allowed 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.93 -43.44 3.07 Favored Glycine 0 N--CA 1.484 1.867 0 N-CA-C 106.088 -2.805 . . . . 0.0 106.088 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.454 ' H ' ' C ' ' A' ' 24' ' ' ASN . 3.9 tt -131.37 147.07 64.69 Favored Pre-proline 0 N--CA 1.488 1.474 0 N-CA-C 101.442 -3.54 . . . . 0.0 101.442 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -64.84 174.46 4.62 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 C-N-CA 121.936 1.757 . . . . 0.0 111.429 -166.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.9 m -145.66 21.0 1.49 Allowed 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 114.286 -1.325 . . . . 0.0 108.952 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 66.94 -176.95 0.2 Allowed 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.731 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 . . . . . 0 N--CA 1.499 2.015 0 O-C-N 124.423 1.077 . . . . 0.0 110.98 -179.924 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 51.8 m . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 121.545 0.688 . . . . 0.0 112.266 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.466 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 1.8 m -104.85 36.11 2.55 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 113.422 -1.717 . . . . 0.0 110.268 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.421 HG23 ' H ' ' A' ' 3' ' ' VAL . 18.9 t -24.77 -55.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.667 0 N-CA-C 114.968 1.469 . . . . 0.0 114.968 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -126.54 -55.19 1.43 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 103.491 -2.781 . . . . 0.0 103.491 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.5 pt -71.02 158.18 88.73 Favored Pre-proline 0 C--N 1.307 -1.269 0 CA-C-N 112.667 -2.061 . . . . 0.0 108.35 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -55.19 -174.88 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 123.115 2.543 . . . . 0.0 112.216 162.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.478 ' C ' ' HG1' ' A' ' 8' ' ' THR . 48.4 t -77.68 -52.15 9.43 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.211 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.478 ' HG1' ' C ' ' A' ' 7' ' ' CYS . 59.5 p 45.83 33.36 1.52 Allowed 'General case' 0 N--CA 1.507 2.385 0 O-C-N 125.046 1.466 . . . . 0.0 114.085 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 56.0 t -141.29 -40.34 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 113.438 -1.71 . . . . 0.0 110.291 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.615 HG21 ' O ' ' A' ' 28' ' ' CYS . 72.4 p -124.19 -17.92 6.02 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 124.031 0.832 . . . . 0.0 110.723 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.75 -23.65 2.86 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 123.782 0.676 . . . . 0.0 111.918 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.514 ' H ' HD12 ' A' ' 12' ' ' LEU . 4.2 mp -51.93 -42.67 63.0 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 114.561 -1.2 . . . . 0.0 112.593 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -89.4 -6.61 56.42 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 118.51 20.54 4.24 Favored Glycine 0 N--CA 1.499 2.891 0 O-C-N 123.998 0.811 . . . . 0.0 113.221 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.4 ' SG ' ' HB ' ' A' ' 10' ' ' THR . 83.1 m -81.29 75.56 8.25 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 122.745 1.26 . . . . 0.0 110.972 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.5 m -57.19 124.04 17.41 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 112.217 -2.265 . . . . 0.0 111.481 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.423 ' SG ' ' HB2' ' A' ' 7' ' ' CYS . 48.3 m -62.47 85.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 124.544 1.152 . . . . 0.0 113.562 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.5 m -94.04 125.56 38.74 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.8 p30 46.75 43.4 12.96 Favored 'General case' 0 N--CA 1.503 2.221 0 CA-C-O 122.566 1.174 . . . . 0.0 110.708 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 2' ' ' CYS . 2.7 mtm-85 56.81 36.18 27.33 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-N 112.409 -2.178 . . . . 0.0 111.843 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 63.7 t -136.11 122.1 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.457 ' SG ' ' HB3' ' A' ' 30' ' ' GLU . 3.5 m -57.48 122.08 11.8 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.52 124.09 23.61 Favored 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 116.384 1.994 . . . . 0.0 116.384 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.421 ' C ' ' H ' ' A' ' 26' ' ' ILE . 0.3 OUTLIER -127.9 59.51 1.47 Allowed 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 104.776 -2.305 . . . . 0.0 104.776 179.566 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.51 -39.91 3.1 Favored Glycine 0 N--CA 1.482 1.752 0 N-CA-C 106.716 -2.554 . . . . 0.0 106.716 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.421 ' H ' ' C ' ' A' ' 24' ' ' ASN . 2.0 tt -139.37 146.28 47.85 Favored Pre-proline 0 N--CA 1.489 1.521 0 N-CA-C 102.749 -3.056 . . . . 0.0 102.749 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -64.5 172.87 6.05 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 121.898 1.732 . . . . 0.0 111.128 -168.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.615 ' O ' HG21 ' A' ' 10' ' ' THR . 3.5 m -141.68 23.21 2.12 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 113.773 -1.558 . . . . 0.0 108.057 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 63.68 -176.16 0.16 Allowed 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.017 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.457 ' HB3' ' SG ' ' A' ' 22' ' ' CYS . 12.0 tp10 . . . . . 0 N--CA 1.503 2.21 0 O-C-N 124.095 0.872 . . . . 0.0 110.144 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.496 1.851 0 CA-C-O 121.862 0.839 . . . . 0.0 112.133 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.444 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 0.8 OUTLIER -104.72 39.54 1.67 Allowed 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 113.093 -1.867 . . . . 0.0 110.523 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.416 HG23 ' H ' ' A' ' 3' ' ' VAL . 19.8 t -26.59 -54.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.687 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -125.51 -58.05 1.44 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 103.297 -2.853 . . . . 0.0 103.297 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.5 pt -69.02 156.52 91.37 Favored Pre-proline 0 C--N 1.305 -1.354 0 CA-C-N 112.403 -2.18 . . . . 0.0 108.369 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -58.81 -177.09 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 123.014 2.476 . . . . 0.0 111.262 161.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.466 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 12.7 t -79.03 -43.39 24.36 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.13 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.4 p 39.13 42.15 0.69 Allowed 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.1 t -149.41 -66.26 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 CA-C-N 112.654 -2.066 . . . . 0.0 107.002 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 71.9 p -77.67 -5.2 49.63 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.379 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.31 -19.84 6.11 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.604 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 36.1 mt -53.34 -42.59 66.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 124.274 0.984 . . . . 0.0 111.442 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.491 HD11 ' SG ' ' A' ' 28' ' ' CYS . 1.0 OUTLIER -89.49 -9.57 49.53 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 124.286 0.991 . . . . 0.0 111.436 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.97 35.41 5.58 Favored Glycine 0 N--CA 1.492 2.371 0 O-C-N 124.317 1.011 . . . . 0.0 110.781 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.521 ' SG ' ' C ' ' A' ' 22' ' ' CYS . 0.9 OUTLIER -75.78 90.1 2.88 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 122.992 1.377 . . . . 0.0 112.02 179.932 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.9 m -62.45 119.6 9.46 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 112.324 -2.217 . . . . 0.0 111.293 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.466 ' SG ' ' HB2' ' A' ' 7' ' ' CYS . 36.9 m -63.7 85.21 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 114.634 -1.166 . . . . 0.0 113.974 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.8 m -90.96 126.35 36.05 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.1 p30 46.42 44.62 13.09 Favored 'General case' 0 N--CA 1.505 2.305 0 CA-C-O 122.732 1.253 . . . . 0.0 110.72 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' A' ' 2' ' ' CYS . 7.1 mtm180 56.7 36.7 28.05 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 112.33 -2.214 . . . . 0.0 112.291 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.5 t -136.03 121.81 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.521 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 3.2 m -57.2 118.92 5.55 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.67 137.36 41.72 Favored 'General case' 0 N--CA 1.506 2.36 0 N-CA-C 118.023 2.601 . . . . 0.0 118.023 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.482 ' HB2' ' HA ' ' A' ' 15' ' ' CYS . 0.3 OUTLIER -150.21 61.95 0.97 Allowed 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 179.485 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.41 -50.97 3.62 Favored Glycine 0 N--CA 1.481 1.637 0 N-CA-C 104.966 -3.254 . . . . 0.0 104.966 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.3 pt -125.09 146.4 53.61 Favored Pre-proline 0 C--N 1.308 -1.228 0 N-CA-C 103.853 -2.647 . . . . 0.0 103.853 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -67.25 177.74 3.57 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 122.372 2.048 . . . . 0.0 110.646 -177.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.491 ' SG ' HD11 ' A' ' 13' ' ' LEU . 2.9 m -144.78 25.53 1.45 Allowed 'General case' 0 N--CA 1.501 2.082 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.226 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 65.97 171.78 0.23 Allowed 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.93 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.5 2.067 0 O-C-N 124.426 1.079 . . . . 0.0 110.937 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 77.4 p . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 121.235 0.541 . . . . 0.0 110.829 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.473 ' SG ' ' C ' ' A' ' 20' ' ' ARG . 0.5 OUTLIER -104.8 36.37 2.46 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 114.138 -1.392 . . . . 0.0 111.355 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.443 ' HA ' ' NE ' ' A' ' 20' ' ' ARG . 54.2 t -22.55 -61.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.567 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -120.63 -25.94 5.41 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 113.41 -1.723 . . . . 0.0 107.654 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.457 ' CG1' ' HA ' ' A' ' 2' ' ' CYS . 2.2 pt -80.83 -175.86 0.68 Allowed Pre-proline 0 CA--C 1.562 1.442 0 CA-C-N 113.144 -1.844 . . . . 0.0 110.542 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.414 ' CD ' ' HB ' ' A' ' 5' ' ' ILE . 35.3 Cg_endo -87.24 -53.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.322 0 C-N-CA 124.985 3.79 . . . . 0.0 110.981 173.278 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.52 ' SG ' ' OG1' ' A' ' 10' ' ' THR . 45.5 t 179.34 -49.59 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 124.535 1.147 . . . . 0.0 109.689 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.5 t 36.27 26.68 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 119.621 3.193 . . . . 0.0 119.621 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.0 t -145.38 -55.15 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.635 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.52 ' OG1' ' SG ' ' A' ' 7' ' ' CYS . 41.7 p -95.82 -1.04 50.4 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 124.045 0.84 . . . . 0.0 110.241 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.25 -14.96 43.94 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.482 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.9 mt -54.8 -42.95 72.44 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 114.908 -1.042 . . . . 0.0 112.092 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.38 -2.86 58.57 Favored 'General case' 0 C--N 1.31 -1.13 0 O-C-N 124.108 0.88 . . . . 0.0 111.381 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.3 36.8 6.12 Favored Glycine 0 N--CA 1.494 2.534 0 O-C-N 124.332 1.02 . . . . 0.0 110.808 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.3 t -83.3 90.69 7.17 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.847 1.308 . . . . 0.0 111.843 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.44 ' N ' ' O ' ' A' ' 23' ' ' TYR . 67.7 m -62.39 119.22 8.69 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 112.112 -2.313 . . . . 0.0 112.91 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.528 ' SG ' ' HA ' ' A' ' 20' ' ' ARG . 54.0 t -66.05 132.65 49.03 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 114.888 -1.051 . . . . 0.0 112.629 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.6 m -138.6 130.56 28.15 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 103.524 -2.769 . . . . 0.0 103.524 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.3 p30 46.49 43.12 11.81 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-O 122.816 1.293 . . . . 0.0 110.197 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.528 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 7.7 mtp180 55.87 37.66 29.11 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 112.223 -2.262 . . . . 0.0 112.645 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 63.0 t -135.97 111.76 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 CA-C-N 113.512 -1.676 . . . . 0.0 106.879 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.66 ' HB2' ' SG ' ' A' ' 28' ' ' CYS . 58.0 m -52.64 129.69 30.1 Favored 'General case' 0 N--CA 1.506 2.351 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.44 ' O ' ' N ' ' A' ' 16' ' ' SER . 0.2 OUTLIER -136.08 140.36 43.7 Favored 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 116.106 1.891 . . . . 0.0 116.106 -179.087 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.414 ' C ' ' H ' ' A' ' 26' ' ' ILE . 0.2 OUTLIER -145.12 57.13 1.26 Allowed 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 179.736 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.48 -48.82 3.39 Favored Glycine 0 N--CA 1.48 1.608 0 N-CA-C 104.377 -3.489 . . . . 0.0 104.377 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.414 ' H ' ' C ' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -126.3 145.33 52.26 Favored Pre-proline 0 C--N 1.308 -1.221 0 N-CA-C 102.82 -3.03 . . . . 0.0 102.82 179.492 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -64.87 177.45 2.34 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.243 1.962 . . . . 0.0 111.02 -175.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.66 ' SG ' ' HB2' ' A' ' 22' ' ' CYS . 2.2 p -142.1 9.17 1.89 Allowed 'General case' 0 N--CA 1.502 2.141 0 CA-C-N 114.693 -1.14 . . . . 0.0 108.486 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 28' ' ' CYS . . . 73.52 -176.04 0.16 Allowed 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 . . . . . 0 N--CA 1.502 2.166 0 O-C-N 124.047 0.842 . . . . 0.0 110.042 -179.869 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 31.6 p . . . . . 0 N--CA 1.495 1.822 0 CA-C-O 121.14 0.495 . . . . 0.0 111.055 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.43 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 1.7 m -104.75 36.34 2.46 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 114.275 -1.329 . . . . 0.0 109.726 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.416 ' H ' HG23 ' A' ' 3' ' ' VAL . 20.2 t -23.09 -57.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.616 0 O-C-N 125.106 1.504 . . . . 0.0 114.761 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -125.72 -56.97 1.47 Allowed 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 102.985 -2.969 . . . . 0.0 102.985 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.5 pt -70.02 151.79 96.02 Favored Pre-proline 0 C--N 1.306 -1.324 0 CA-C-N 112.371 -2.195 . . . . 0.0 108.798 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -59.39 -176.8 0.11 Allowed 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 123.066 2.511 . . . . 0.0 111.565 167.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.582 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 34.6 t -78.63 -53.39 7.22 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.0 p 39.05 37.29 0.21 Allowed 'General case' 0 N--CA 1.504 2.236 0 O-C-N 125.006 1.441 . . . . 0.0 114.887 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 51.1 t -141.57 -63.12 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 CA-C-N 112.77 -2.014 . . . . 0.0 106.788 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.434 ' OG1' ' SG ' ' A' ' 7' ' ' CYS . 35.6 p -92.31 -10.02 39.87 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.59 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.8 -19.13 15.54 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.912 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -52.35 -38.8 59.67 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 114.72 -1.127 . . . . 0.0 112.684 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.53 -13.7 36.78 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 123.989 0.806 . . . . 0.0 111.374 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.36 27.75 3.26 Favored Glycine 0 N--CA 1.495 2.567 0 O-C-N 124.449 1.093 . . . . 0.0 111.178 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.459 ' SG ' ' C ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER -80.9 81.72 7.07 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 123.001 1.382 . . . . 0.0 111.819 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 38.7 m -58.02 125.03 21.39 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 112.407 -2.179 . . . . 0.0 113.397 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.582 ' SG ' ' HB2' ' A' ' 7' ' ' CYS . 35.0 m -65.66 82.77 0.06 Allowed 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.3 t -91.11 123.09 34.3 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 45.98 47.01 12.66 Favored 'General case' 0 N--CA 1.504 2.269 0 CA-C-O 122.984 1.373 . . . . 0.0 110.409 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 2' ' ' CYS . 1.9 mtm180 56.53 36.83 28.2 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 111.907 -2.406 . . . . 0.0 112.686 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 69.2 t -136.11 118.79 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.459 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 4.3 m -58.38 123.05 14.82 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.87 133.84 38.17 Favored 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 117.064 2.246 . . . . 0.0 117.064 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.449 ' C ' ' H ' ' A' ' 26' ' ' ILE . 0.3 OUTLIER -144.17 60.71 1.35 Allowed 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 179.536 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.77 -32.1 4.09 Favored Glycine 0 N--CA 1.483 1.813 0 N-CA-C 107.977 -2.049 . . . . 0.0 107.977 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.449 ' H ' ' C ' ' A' ' 24' ' ' ASN . 4.3 tt -149.92 145.42 18.86 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 103.264 -2.865 . . . . 0.0 103.264 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -67.85 177.73 3.98 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.103 1.869 . . . . 0.0 111.108 -171.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.4 m -142.19 19.15 2.09 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.156 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 69.06 172.94 0.3 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 124.377 1.048 . . . . 0.0 110.335 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.501 2.114 0 O-C-N 124.444 1.09 . . . . 0.0 109.55 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 35.8 p . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.181 0.515 . . . . 0.0 111.299 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.425 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 1.6 m -104.67 36.98 2.24 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 114.162 -1.381 . . . . 0.0 109.727 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 19.6 t -25.48 -56.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.681 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -125.07 -57.31 1.52 Allowed 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 103.54 -2.763 . . . . 0.0 103.54 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.2 pt -69.53 152.96 96.14 Favored Pre-proline 0 C--N 1.306 -1.326 0 CA-C-N 112.311 -2.222 . . . . 0.0 108.675 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -59.74 -177.4 0.14 Allowed 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 123.005 2.47 . . . . 0.0 111.661 164.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.553 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 42.1 t -79.34 -50.94 10.09 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.319 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.9 p 37.21 40.99 0.2 Allowed 'General case' 0 N--CA 1.504 2.259 0 O-C-N 125.121 1.513 . . . . 0.0 115.055 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 43.6 t -145.23 -67.87 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-N 112.633 -2.076 . . . . 0.0 106.698 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.435 HG21 ' O ' ' A' ' 28' ' ' CYS . 29.3 p -85.05 -10.37 57.0 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.453 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.49 -17.8 9.45 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.32 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 33.1 mt -54.38 -38.64 66.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 124.332 1.02 . . . . 0.0 112.391 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.44 -8.01 53.9 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 123.91 0.756 . . . . 0.0 111.283 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.22 30.21 4.24 Favored Glycine 0 N--CA 1.494 2.518 0 O-C-N 124.436 1.085 . . . . 0.0 111.33 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.469 ' SG ' ' C ' ' A' ' 22' ' ' CYS . 0.9 OUTLIER -80.98 82.33 6.99 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 122.842 1.306 . . . . 0.0 112.408 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.1 m -60.54 123.68 18.09 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 112.568 -2.106 . . . . 0.0 111.89 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.553 ' SG ' ' HB2' ' A' ' 7' ' ' CYS . 46.7 m -63.04 85.61 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.4 m -92.31 125.8 37.12 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 105.315 -2.106 . . . . 0.0 105.315 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.5 p30 46.6 45.17 14.14 Favored 'General case' 0 N--CA 1.505 2.318 0 CA-C-O 122.785 1.279 . . . . 0.0 110.743 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.425 ' HG2' ' O ' ' A' ' 2' ' ' CYS . 4.4 mtm180 56.24 37.09 28.5 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 112.244 -2.253 . . . . 0.0 112.18 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 55.7 t -136.32 121.05 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.469 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 7.2 m -56.17 122.65 12.21 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.61 136.09 40.75 Favored 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 117.485 2.402 . . . . 0.0 117.485 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.464 ' C ' ' H ' ' A' ' 26' ' ' ILE . 0.3 OUTLIER -145.95 61.15 1.25 Allowed 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 105.477 -2.045 . . . . 0.0 105.477 179.581 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.88 -32.8 3.66 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 108.052 -2.019 . . . . 0.0 108.052 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.464 ' H ' ' C ' ' A' ' 24' ' ' ASN . 3.6 tt -149.93 144.79 18.01 Favored Pre-proline 0 N--CA 1.488 1.457 0 N-CA-C 103.015 -2.957 . . . . 0.0 103.015 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -66.83 177.03 3.79 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.239 1.959 . . . . 0.0 111.646 -170.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.435 ' O ' HG21 ' A' ' 10' ' ' THR . 2.3 m -143.04 23.21 1.88 Allowed 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 114.715 -1.13 . . . . 0.0 108.863 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 69.75 174.65 0.29 Allowed 'General case' 0 N--CA 1.501 2.1 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.461 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 . . . . . 0 N--CA 1.502 2.141 0 O-C-N 124.726 1.266 . . . . 0.0 111.276 -179.923 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.8 p . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.346 0.593 . . . . 0.0 110.06 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.449 ' SG ' ' C ' ' A' ' 20' ' ' ARG . 19.4 p -104.61 57.07 0.7 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 114.013 -1.448 . . . . 0.0 107.844 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.411 HG23 ' H ' ' A' ' 3' ' ' VAL . 4.7 t -42.75 -51.57 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.403 0 N-CA-C 116.952 2.204 . . . . 0.0 116.952 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.412 ' H ' HD13 ' A' ' 5' ' ' ILE . 13.2 m-85 -122.14 -58.25 1.73 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 102.727 -3.064 . . . . 0.0 102.727 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.837 ' H ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -71.5 148.21 92.99 Favored Pre-proline 0 C--N 1.302 -1.485 0 CA-C-N 111.49 -2.595 . . . . 0.0 106.897 179.512 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -58.92 -178.81 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.899 2.399 . . . . 0.0 111.001 168.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.507 ' HB3' ' HB2' ' A' ' 11' ' ' ALA . 42.7 t -73.25 -54.43 8.42 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 114.605 -1.18 . . . . 0.0 111.704 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 68.0 p 41.78 34.45 0.42 Allowed 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 51.6 t -142.92 -65.22 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 113.468 -1.696 . . . . 0.0 106.974 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.442 ' OG1' ' SG ' ' A' ' 7' ' ' CYS . 22.7 p -86.61 -19.13 29.8 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.507 ' HB2' ' HB3' ' A' ' 7' ' ' CYS . . . -59.44 -21.26 59.76 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.357 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 92.6 mt -57.92 -34.24 69.64 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 124.444 1.09 . . . . 0.0 111.175 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.51 -6.87 56.01 Favored 'General case' 0 N--CA 1.48 1.066 0 O-C-N 123.964 0.79 . . . . 0.0 111.153 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.15 12.11 6.53 Favored Glycine 0 N--CA 1.497 2.765 0 O-C-N 124.277 0.985 . . . . 0.0 113.893 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -80.74 85.12 6.14 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 123.254 1.502 . . . . 0.0 113.137 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.1 m -63.03 124.85 22.16 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 112.08 -2.327 . . . . 0.0 110.909 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 29.6 t -64.4 92.48 0.09 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 124.158 0.911 . . . . 0.0 113.142 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 27.8 p -109.66 140.22 43.77 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.3 p30 48.79 37.85 10.65 Favored 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 122.638 1.209 . . . . 0.0 111.028 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.449 ' C ' ' SG ' ' A' ' 2' ' ' CYS . 31.4 mtt180 56.48 31.92 19.78 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-N 112.8 -2.0 . . . . 0.0 112.894 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.2 t -136.2 138.34 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 CA-C-N 112.775 -2.011 . . . . 0.0 107.725 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 29.3 m -63.88 125.89 25.85 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -135.89 120.55 18.33 Favored 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 117.104 2.261 . . . . 0.0 117.104 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.433 ' C ' ' H ' ' A' ' 26' ' ' ILE . 0.3 OUTLIER -123.03 53.6 1.29 Allowed 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 104.056 -2.572 . . . . 0.0 104.056 179.648 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.56 -44.27 2.59 Favored Glycine 0 N--CA 1.479 1.564 0 N-CA-C 104.0 -3.64 . . . . 0.0 104.0 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.516 ' O ' HD12 ' A' ' 26' ' ' ILE . 1.1 pp -133.65 148.29 67.98 Favored Pre-proline 0 N--CA 1.482 1.161 0 N-CA-C 103.726 -2.694 . . . . 0.0 103.726 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -64.33 175.19 3.52 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.061 1.841 . . . . 0.0 112.073 -171.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.0 m -146.28 27.9 1.12 Allowed 'General case' 0 N--CA 1.5 2.045 0 CA-C-N 114.327 -1.306 . . . . 0.0 108.277 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 67.08 175.86 0.25 Allowed 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.759 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 . . . . . 0 N--CA 1.501 2.093 0 O-C-N 124.461 1.101 . . . . 0.0 111.389 -179.979 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.494 1.764 0 CA-C-O 121.576 0.703 . . . . 0.0 111.345 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.437 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 1.4 m -104.8 38.54 1.89 Allowed 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 113.442 -1.708 . . . . 0.0 109.674 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.6 t -26.21 -55.2 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.72 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -125.31 -58.14 1.45 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 103.266 -2.865 . . . . 0.0 103.266 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.2 pt -68.63 154.94 93.95 Favored Pre-proline 0 C--N 1.305 -1.331 0 CA-C-N 112.209 -2.269 . . . . 0.0 108.631 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -57.88 -174.92 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 123.075 2.517 . . . . 0.0 111.339 162.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.524 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 33.8 t -78.98 -51.09 10.1 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.47 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 68.8 p 41.24 34.8 0.35 Allowed 'General case' 0 N--CA 1.505 2.313 0 O-C-N 125.18 1.55 . . . . 0.0 114.787 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.3 t -145.58 -37.02 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-N 113.369 -1.741 . . . . 0.0 109.748 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.9 p -120.18 -15.14 8.73 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 124.493 1.121 . . . . 0.0 109.668 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.34 -19.09 7.82 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.079 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.1 pp -56.71 -34.51 67.54 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 124.05 0.844 . . . . 0.0 113.229 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 pp -89.4 -5.66 57.25 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 123.808 0.693 . . . . 0.0 111.085 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.39 28.02 4.78 Favored Glycine 0 N--CA 1.495 2.62 0 O-C-N 124.46 1.1 . . . . 0.0 111.465 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.483 ' SG ' ' C ' ' A' ' 22' ' ' CYS . 0.6 OUTLIER -83.35 81.06 8.88 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.736 1.255 . . . . 0.0 112.279 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.9 m -59.96 123.72 17.96 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 112.582 -2.099 . . . . 0.0 111.419 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.524 ' SG ' ' HB2' ' A' ' 7' ' ' CYS . 31.1 m -66.7 85.1 0.11 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 114.109 1.152 . . . . 0.0 114.109 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 96.1 p -96.15 132.86 41.13 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.6 p30 46.0 42.18 9.09 Favored 'General case' 0 N--CA 1.503 2.218 0 CA-C-O 122.663 1.221 . . . . 0.0 110.716 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' A' ' 2' ' ' CYS . 3.0 mtm-85 56.0 38.0 29.47 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-N 112.461 -2.154 . . . . 0.0 112.372 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.3 t -136.29 124.77 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.483 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 4.0 m -60.05 122.19 13.73 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.62 133.48 38.29 Favored 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 117.358 2.355 . . . . 0.0 117.358 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.455 ' C ' ' H ' ' A' ' 26' ' ' ILE . 0.3 OUTLIER -142.47 60.35 1.44 Allowed 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 179.576 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.73 -33.62 3.69 Favored Glycine 0 N--CA 1.484 1.844 0 N-CA-C 107.891 -2.084 . . . . 0.0 107.891 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.455 ' H ' ' C ' ' A' ' 24' ' ' ASN . 3.3 tt -149.6 144.56 17.94 Favored Pre-proline 0 N--CA 1.488 1.439 0 N-CA-C 103.168 -2.901 . . . . 0.0 103.168 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -65.99 177.45 3.0 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.266 1.978 . . . . 0.0 112.137 -169.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.7 m -141.82 25.81 1.94 Allowed 'General case' 0 N--CA 1.501 2.108 0 CA-C-N 114.821 -1.082 . . . . 0.0 109.03 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 68.96 166.97 0.27 Allowed 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 114.611 -1.177 . . . . 0.0 111.088 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 N--CA 1.501 2.111 0 O-C-N 124.464 1.102 . . . . 0.0 111.606 -179.956 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 62.1 p . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.635 0.731 . . . . 0.0 109.093 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.474 ' SG ' ' C ' ' A' ' 20' ' ' ARG . 14.6 p -104.37 60.4 0.71 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 113.559 -1.655 . . . . 0.0 107.425 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.479 ' H ' HG23 ' A' ' 3' ' ' VAL . 9.6 t -48.91 -49.0 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 CA-C-N 113.015 -1.902 . . . . 0.0 115.508 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -116.29 -51.11 2.63 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 104.841 -2.281 . . . . 0.0 104.841 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.9 pt -64.9 164.45 21.46 Favored Pre-proline 0 C--N 1.303 -1.433 0 CA-C-N 112.297 -2.229 . . . . 0.0 108.954 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -68.22 -179.96 2.55 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 123.309 2.672 . . . . 0.0 109.716 153.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.415 ' SG ' ' OG1' ' A' ' 10' ' ' THR . 43.0 t -71.89 -63.67 1.09 Allowed 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.76 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.8 p 43.2 42.85 3.67 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 115.281 1.586 . . . . 0.0 115.281 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 79.0 t -144.99 -70.43 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 105.08 -2.193 . . . . 0.0 105.08 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.663 HG21 ' O ' ' A' ' 28' ' ' CYS . 40.5 p -88.76 -7.84 55.51 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.32 -19.18 32.89 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.498 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 39.2 mt -53.82 -39.02 65.16 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 114.758 -1.11 . . . . 0.0 112.411 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.4 -11.42 43.25 Favored 'General case' 0 N--CA 1.483 1.202 0 O-C-N 123.974 0.796 . . . . 0.0 110.944 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 124.82 15.57 3.18 Favored Glycine 0 N--CA 1.497 2.708 0 O-C-N 124.294 0.997 . . . . 0.0 113.167 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.88 90.52 5.31 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 123.276 1.513 . . . . 0.0 112.726 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 65.9 m -71.95 126.5 29.9 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 111.8 -2.454 . . . . 0.0 110.057 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.6 t -62.76 90.24 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 124.049 0.843 . . . . 0.0 112.728 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 12.2 m -104.51 137.79 41.84 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 11.1 p30 48.23 39.62 12.42 Favored 'General case' 0 N--CA 1.502 2.138 0 CA-C-O 122.696 1.236 . . . . 0.0 110.7 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.474 ' C ' ' SG ' ' A' ' 2' ' ' CYS . 30.4 mtt180 56.19 31.93 19.27 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-N 112.63 -2.077 . . . . 0.0 113.306 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 50.1 t -136.38 138.71 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-N 112.944 -1.934 . . . . 0.0 107.855 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 71.8 m -61.52 125.0 22.22 Favored 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -135.87 113.81 11.22 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 117.789 2.514 . . . . 0.0 117.789 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.457 ' C ' ' H ' ' A' ' 26' ' ' ILE . 0.4 OUTLIER -116.67 54.77 0.84 Allowed 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 104.497 -2.409 . . . . 0.0 104.497 179.498 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.62 -37.28 3.31 Favored Glycine 0 N--CA 1.482 1.711 0 N-CA-C 106.706 -2.558 . . . . 0.0 106.706 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.457 ' H ' ' C ' ' A' ' 24' ' ' ASN . 4.0 tt -144.08 143.13 21.53 Favored Pre-proline 0 N--CA 1.488 1.451 0 N-CA-C 102.412 -3.181 . . . . 0.0 102.412 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -65.11 175.63 3.76 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 122.071 1.848 . . . . 0.0 112.661 -166.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.663 ' O ' HG21 ' A' ' 10' ' ' THR . 3.1 m -144.77 30.16 1.2 Allowed 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 114.149 -1.387 . . . . 0.0 108.117 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 64.32 -177.4 0.17 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.461 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 N--CA 1.5 2.04 0 O-C-N 124.372 1.045 . . . . 0.0 110.427 179.974 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.2 p . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.271 0.557 . . . . 0.0 111.255 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.423 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 1.4 m -104.79 37.98 2.02 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 114.057 -1.429 . . . . 0.0 109.504 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.41 HG23 ' H ' ' A' ' 3' ' ' VAL . 18.1 t -25.4 -56.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.623 0 N-CA-C 115.027 1.492 . . . . 0.0 115.027 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -125.04 -56.74 1.54 Allowed 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 103.526 -2.768 . . . . 0.0 103.526 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.6 pt -70.14 153.57 95.2 Favored Pre-proline 0 C--N 1.305 -1.349 0 CA-C-N 112.284 -2.234 . . . . 0.0 108.819 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -59.41 -175.78 0.1 OUTLIER 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.892 2.395 . . . . 0.0 111.211 163.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.532 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 13.8 t -79.47 -52.19 8.37 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.125 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.0 p 40.89 36.37 0.41 Allowed 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 37.2 t -144.46 -41.01 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-N 112.845 -1.98 . . . . 0.0 107.983 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.433 ' OG1' ' SG ' ' A' ' 7' ' ' CYS . 16.0 p -116.38 -0.15 12.63 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 124.415 1.072 . . . . 0.0 108.784 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.11 -25.86 68.29 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.455 ' H ' HD23 ' A' ' 12' ' ' LEU . 1.6 pt? -56.59 -31.75 64.56 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.521 HD11 ' SG ' ' A' ' 28' ' ' CYS . 0.4 OUTLIER -89.55 -9.95 47.94 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 123.451 0.469 . . . . 0.0 110.569 179.843 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.89 25.32 5.7 Favored Glycine 0 N--CA 1.494 2.537 0 O-C-N 124.266 0.979 . . . . 0.0 112.236 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.448 ' SG ' ' C ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER -80.34 86.53 5.69 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.721 1.248 . . . . 0.0 111.348 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 24.0 m -64.69 122.6 17.24 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 112.679 -2.055 . . . . 0.0 111.249 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.532 ' SG ' ' HB2' ' A' ' 7' ' ' CYS . 32.8 m -63.65 84.84 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 124.506 1.129 . . . . 0.0 113.992 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.6 t -92.58 128.33 38.4 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 46.64 44.21 13.4 Favored 'General case' 0 N--CA 1.504 2.226 0 CA-C-O 122.678 1.227 . . . . 0.0 110.811 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.423 ' HG2' ' O ' ' A' ' 2' ' ' CYS . 2.5 mtm-85 56.04 37.39 28.79 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 112.308 -2.224 . . . . 0.0 112.173 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.1 t -136.21 121.08 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.448 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 4.0 m -56.94 123.25 14.45 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.48 111.6 9.63 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 116.682 2.105 . . . . 0.0 116.682 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.45 ' C ' ' H ' ' A' ' 26' ' ' ILE . 0.9 OUTLIER -110.2 53.28 0.7 Allowed 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 179.627 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.5 -38.67 3.19 Favored Glycine 0 N--CA 1.483 1.769 0 N-CA-C 106.282 -2.727 . . . . 0.0 106.282 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.45 ' H ' ' C ' ' A' ' 24' ' ' ASN . 3.5 tt -138.53 144.64 43.23 Favored Pre-proline 0 N--CA 1.489 1.479 0 N-CA-C 102.225 -3.25 . . . . 0.0 102.225 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -65.56 176.37 3.52 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 122.157 1.905 . . . . 0.0 111.888 -167.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.521 ' SG ' HD11 ' A' ' 13' ' ' LEU . 3.2 m -145.76 25.36 1.31 Allowed 'General case' 0 N--CA 1.501 2.122 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.116 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 66.46 173.38 0.24 Allowed 'General case' 0 N--CA 1.5 2.04 0 CA-C-N 114.746 -1.115 . . . . 0.0 110.962 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 . . . . . 0 N--CA 1.501 2.092 0 O-C-N 124.421 1.076 . . . . 0.0 111.664 -179.897 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 12.3 t . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 122.366 1.079 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.535 ' SG ' ' N ' ' A' ' 21' ' ' VAL . 0.7 OUTLIER -106.07 41.3 1.43 Allowed 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 111.975 -2.375 . . . . 0.0 110.607 -179.9 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.415 HG23 ' H ' ' A' ' 3' ' ' VAL . 20.9 t -30.92 -53.71 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.571 0 CA-C-N 113.525 -1.671 . . . . 0.0 113.196 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -124.43 -55.44 1.65 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 104.488 -2.412 . . . . 0.0 104.488 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -61.92 131.06 93.03 Favored Pre-proline 0 C--N 1.307 -1.246 0 CA-C-N 112.968 -1.924 . . . . 0.0 109.368 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -37.55 -48.01 1.88 Allowed 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 123.987 3.125 . . . . 0.0 112.752 172.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.62 ' HB3' ' HB2' ' A' ' 11' ' ' ALA . 45.5 t 179.08 -45.04 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 O-C-N 124.145 0.903 . . . . 0.0 110.023 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.9 t 36.97 24.68 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 118.56 2.8 . . . . 0.0 118.56 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.7 t -146.89 -54.1 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.589 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.495 ' OG1' ' SG ' ' A' ' 7' ' ' CYS . 16.4 p -101.72 -5.24 25.21 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 124.002 0.814 . . . . 0.0 110.956 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.62 ' HB2' ' HB3' ' A' ' 7' ' ' CYS . . . -61.59 -14.2 28.35 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.574 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -55.77 -41.79 74.55 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 114.946 -1.024 . . . . 0.0 111.816 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.44 4.18 49.92 Favored 'General case' 0 N--CA 1.482 1.169 0 O-C-N 124.097 0.873 . . . . 0.0 111.118 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.41 34.5 7.44 Favored Glycine 0 N--CA 1.492 2.426 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.987 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.401 ' SG ' ' HB3' ' A' ' 22' ' ' CYS . 3.2 t -81.33 89.22 6.07 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 122.801 1.286 . . . . 0.0 111.8 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 23' ' ' TYR . 57.8 m -66.8 120.05 12.88 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 112.308 -2.224 . . . . 0.0 111.246 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.57 ' SG ' ' HA ' ' A' ' 20' ' ' ARG . 21.4 t -58.96 146.45 37.92 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.4 m -150.09 124.45 9.57 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 103.6 -2.741 . . . . 0.0 103.6 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.8 p30 45.64 45.25 10.88 Favored 'General case' 0 N--CA 1.505 2.305 0 CA-C-O 122.99 1.376 . . . . 0.0 110.134 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.57 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 4.4 mtm-85 55.34 38.86 30.94 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 112.052 -2.34 . . . . 0.0 112.94 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.535 ' N ' ' SG ' ' A' ' 2' ' ' CYS . 42.5 t -136.18 116.98 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.401 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 34.1 m -53.35 131.52 37.84 Favored 'General case' 0 N--CA 1.511 2.583 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.439 ' O ' ' N ' ' A' ' 16' ' ' SER . 0.2 OUTLIER -135.84 140.45 44.2 Favored 'General case' 0 N--CA 1.504 2.274 0 N-CA-C 116.423 2.009 . . . . 0.0 116.423 -179.336 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -148.8 59.97 1.06 Allowed 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.52 -50.36 3.53 Favored Glycine 0 N--CA 1.482 1.752 0 N-CA-C 104.733 -3.347 . . . . 0.0 104.733 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.2 pt -127.59 148.72 67.86 Favored Pre-proline 0 C--N 1.306 -1.311 0 N-CA-C 102.48 -3.156 . . . . 0.0 102.48 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -65.08 175.76 3.64 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 121.978 1.785 . . . . 0.0 110.34 -176.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.409 ' O ' HG21 ' A' ' 10' ' ' THR . 2.0 m -140.69 20.67 2.34 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-N 114.854 -1.067 . . . . 0.0 108.887 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 69.31 179.1 0.25 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 124.328 1.017 . . . . 0.0 109.278 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 . . . . . 0 N--CA 1.5 2.026 0 O-C-N 124.353 1.033 . . . . 0.0 111.165 -179.941 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 17.0 m . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.564 0.697 . . . . 0.0 111.689 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.522 ' SG ' ' HB2' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -104.67 34.53 3.1 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 113.769 -1.559 . . . . 0.0 110.143 -179.936 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.467 ' H ' HG23 ' A' ' 3' ' ' VAL . 42.1 t -27.54 -53.69 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.754 0 O-C-N 125.023 1.452 . . . . 0.0 113.089 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -125.7 -55.57 1.51 Allowed 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 104.387 -2.449 . . . . 0.0 104.387 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.5 pt -67.68 165.68 28.72 Favored Pre-proline 0 C--N 1.306 -1.302 0 CA-C-N 113.247 -1.797 . . . . 0.0 108.9 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -58.4 -178.37 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 123.043 2.495 . . . . 0.0 111.42 154.127 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.522 ' HB2' ' SG ' ' A' ' 2' ' ' CYS . 0.6 OUTLIER -88.96 -52.24 5.19 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 114.371 -1.286 . . . . 0.0 108.469 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 34.05 54.48 0.57 Allowed 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.5 HG12 HG23 ' A' ' 10' ' ' THR . 26.0 t -150.03 -41.26 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-N 112.849 -1.978 . . . . 0.0 107.287 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.682 HG21 ' O ' ' A' ' 28' ' ' CYS . 33.3 p -123.74 -19.4 5.77 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 114.59 -1.186 . . . . 0.0 109.033 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.45 -27.1 5.88 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.8 pp -54.86 -36.63 65.3 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -89.59 -5.07 57.52 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.62 14.76 5.16 Favored Glycine 0 N--CA 1.5 2.923 0 O-C-N 124.066 0.853 . . . . 0.0 112.6 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.495 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 74.1 m -80.59 87.43 5.76 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 123.95 1.833 . . . . 0.0 109.606 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.0 m -67.19 125.51 26.26 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 111.566 -2.561 . . . . 0.0 112.106 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.4 m -66.41 82.4 0.09 Allowed 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 122.187 0.994 . . . . 0.0 111.796 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.3 m -93.6 123.82 37.18 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.3 p30 47.06 42.37 12.65 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 124.548 1.155 . . . . 0.0 110.402 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 2' ' ' CYS . 0.0 OUTLIER 58.3 36.81 25.86 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 112.475 -2.148 . . . . 0.0 111.815 -179.852 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 74.3 t -136.61 119.99 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 179.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.558 ' SG ' ' OG1' ' A' ' 10' ' ' THR . 0.1 OUTLIER -61.4 124.41 20.53 Favored 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 179.843 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -135.5 125.73 26.34 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -179.345 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -130.63 61.36 1.61 Allowed 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.3 -50.93 3.65 Favored Glycine 0 N--CA 1.48 1.569 0 N-CA-C 104.373 -3.491 . . . . 0.0 104.373 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.68 150.15 60.93 Favored Pre-proline 0 C--N 1.308 -1.217 0 N-CA-C 103.769 -2.678 . . . . 0.0 103.769 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -64.49 175.29 3.56 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.215 1.943 . . . . 0.0 110.503 -173.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.682 ' O ' HG21 ' A' ' 10' ' ' THR . 2.8 m -149.35 19.9 0.95 Allowed 'General case' 0 N--CA 1.497 1.875 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.914 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 62.68 -172.49 0.16 Allowed 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.061 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 . . . . . 0 N--CA 1.498 1.959 0 O-C-N 124.325 1.015 . . . . 0.0 110.561 179.999 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 73.7 p . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.493 0.663 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.482 ' SG ' ' C ' ' A' ' 20' ' ' ARG . 6.2 p -104.77 51.96 0.75 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 113.747 -1.569 . . . . 0.0 109.577 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.443 ' H ' HG23 ' A' ' 3' ' ' VAL . 9.7 t -40.67 -51.41 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.451 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -120.56 -60.18 1.69 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 103.638 -2.727 . . . . 0.0 103.638 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.2 pt -66.74 147.64 98.98 Favored Pre-proline 0 C--N 1.305 -1.345 0 CA-C-N 112.414 -2.175 . . . . 0.0 106.807 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -60.21 -179.75 0.26 Allowed 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.858 2.372 . . . . 0.0 111.104 169.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 40.8 t -65.38 -61.62 2.01 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.933 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.1 p 37.73 38.51 0.17 Allowed 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.47 ' O ' HD23 ' A' ' 12' ' ' LEU . 27.5 t -139.71 -67.44 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-N 112.945 -1.934 . . . . 0.0 106.513 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.661 HG21 ' O ' ' A' ' 28' ' ' CYS . 25.6 p -94.36 -5.1 47.27 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 124.222 0.951 . . . . 0.0 109.087 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.34 -18.8 30.2 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.812 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.47 HD23 ' O ' ' A' ' 9' ' ' VAL . 3.0 pp -54.91 -36.4 65.16 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -89.44 -11.79 42.08 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 123.831 0.707 . . . . 0.0 110.934 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.85 21.46 3.21 Favored Glycine 0 N--CA 1.496 2.641 0 O-C-N 124.417 1.073 . . . . 0.0 112.443 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -83.36 84.92 7.33 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 123.194 1.474 . . . . 0.0 112.348 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.8 m -65.46 127.37 31.53 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 111.777 -2.465 . . . . 0.0 111.339 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 39.6 t -63.32 87.37 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 124.113 0.883 . . . . 0.0 113.162 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.9 m -99.59 131.02 45.86 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.3 p30 47.22 43.55 14.82 Favored 'General case' 0 N--CA 1.504 2.248 0 CA-C-O 122.861 1.315 . . . . 0.0 110.624 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.482 ' C ' ' SG ' ' A' ' 2' ' ' CYS . 5.7 mtm-85 55.29 33.23 20.26 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 112.248 -2.251 . . . . 0.0 113.155 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.1 t -136.35 130.4 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 CA-C-N 113.059 -1.882 . . . . 0.0 107.244 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 74.2 m -59.5 125.15 22.47 Favored 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -135.88 125.39 25.12 Favored 'General case' 0 N--CA 1.503 2.205 0 N-CA-C 117.632 2.456 . . . . 0.0 117.632 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.41 ' C ' ' H ' ' A' ' 26' ' ' ILE . 0.4 OUTLIER -132.9 55.96 1.87 Allowed 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 179.678 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.13 -48.38 3.19 Favored Glycine 0 N--CA 1.482 1.75 0 N-CA-C 104.522 -3.431 . . . . 0.0 104.522 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.41 ' H ' ' C ' ' A' ' 24' ' ' ASN . 1.5 pt -127.41 144.42 50.76 Favored Pre-proline 0 C--N 1.308 -1.233 0 N-CA-C 103.365 -2.828 . . . . 0.0 103.365 179.491 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -65.28 176.3 3.38 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.196 1.931 . . . . 0.0 111.732 -174.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.661 ' O ' HG21 ' A' ' 10' ' ' THR . 2.9 m -146.13 27.04 1.18 Allowed 'General case' 0 N--CA 1.5 2.052 0 CA-C-N 114.671 -1.15 . . . . 0.0 108.185 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 63.35 -176.36 0.15 Allowed 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.539 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 . . . . . 0 N--CA 1.5 2.036 0 O-C-N 124.081 0.863 . . . . 0.0 110.106 -179.992 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 21.0 m . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.952 0.882 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.49 ' SG ' ' N ' ' A' ' 21' ' ' VAL . 0.2 OUTLIER -104.55 42.9 1.15 Allowed 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 112.986 -1.916 . . . . 0.0 110.388 179.983 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.424 HG23 ' H ' ' A' ' 3' ' ' VAL . 15.4 t -33.46 -50.41 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.429 0 CA-C-N 113.256 -1.793 . . . . 0.0 113.555 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -123.41 -58.19 1.62 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 104.756 -2.313 . . . . 0.0 104.756 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -61.2 133.41 92.81 Favored Pre-proline 0 C--N 1.306 -1.311 0 CA-C-N 112.587 -2.097 . . . . 0.0 109.009 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -41.48 -46.24 5.99 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 123.472 2.781 . . . . 0.0 112.427 173.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.424 ' SG ' ' OG1' ' A' ' 10' ' ' THR . 52.9 t 179.11 -57.08 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 O-C-N 124.409 1.068 . . . . 0.0 108.542 179.269 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 71.4 p 38.16 34.63 0.07 Allowed 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 115.961 1.837 . . . . 0.0 115.961 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 50.3 t -144.56 -62.52 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-N 113.621 -1.627 . . . . 0.0 108.707 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.677 HG21 ' O ' ' A' ' 28' ' ' CYS . 15.8 p -98.29 0.56 45.84 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 124.22 0.95 . . . . 0.0 110.514 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.13 -17.37 39.79 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.928 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 48.1 mt -54.92 -44.24 74.05 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 114.448 -1.251 . . . . 0.0 111.52 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.45 2.55 54.36 Favored 'General case' 0 C--N 1.31 -1.139 0 O-C-N 124.174 0.922 . . . . 0.0 111.886 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.34 33.76 7.45 Favored Glycine 0 N--CA 1.494 2.558 0 CA-C-N 115.023 -0.989 . . . . 0.0 112.736 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 2.1 t -80.65 93.31 6.12 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 122.392 1.092 . . . . 0.0 111.449 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 23' ' ' TYR . 67.7 m -73.24 118.07 15.75 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 113.128 -1.851 . . . . 0.0 109.261 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.458 ' SG ' ' HA ' ' A' ' 20' ' ' ARG . 49.3 t -66.45 148.41 51.92 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 60.9 p -150.2 136.62 18.91 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 104.123 -2.547 . . . . 0.0 104.123 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.9 p30 46.53 39.76 7.26 Favored 'General case' 0 N--CA 1.504 2.266 0 CA-C-O 122.652 1.215 . . . . 0.0 110.933 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.458 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 5.0 mtm-85 55.46 39.04 31.05 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 112.624 -2.08 . . . . 0.0 112.501 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.49 ' N ' ' SG ' ' A' ' 2' ' ' CYS . 55.0 t -136.2 116.79 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 59.2 m -51.86 133.45 31.97 Favored 'General case' 0 N--CA 1.512 2.63 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.402 ' O ' ' N ' ' A' ' 16' ' ' SER . 0.2 OUTLIER -135.75 131.56 35.7 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 117.038 2.236 . . . . 0.0 117.038 -179.291 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.446 ' C ' ' H ' ' A' ' 26' ' ' ILE . 0.2 OUTLIER -138.13 62.06 1.58 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 105.553 -2.018 . . . . 0.0 105.553 179.619 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.73 -39.45 3.11 Favored Glycine 0 N--CA 1.485 1.907 0 N-CA-C 107.322 -2.311 . . . . 0.0 107.322 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.446 ' H ' ' C ' ' A' ' 24' ' ' ASN . 2.5 tt -147.44 147.44 28.13 Favored Pre-proline 0 N--CA 1.487 1.408 0 N-CA-C 101.942 -3.355 . . . . 0.0 101.942 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -63.84 176.26 2.49 Favored 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 121.792 1.661 . . . . 0.0 111.63 -168.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.677 ' O ' HG21 ' A' ' 10' ' ' THR . 3.4 m -136.54 21.3 3.13 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 114.436 -1.256 . . . . 0.0 109.045 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 28' ' ' CYS . . . 69.33 174.08 0.29 Allowed 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.254 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 . . . . . 0 N--CA 1.501 2.078 0 O-C-N 124.405 1.066 . . . . 0.0 110.176 -179.854 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 10.7 m . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.9 p -104.68 57.29 0.7 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 114.242 -1.345 . . . . 0.0 109.853 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.404 HG13 ' NH2' ' A' ' 20' ' ' ARG . 54.4 t -34.45 -66.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.387 0 CA-C-N 113.4 -1.727 . . . . 0.0 115.093 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -116.86 -52.95 2.52 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 103.065 -2.939 . . . . 0.0 103.065 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.2 pt -72.23 133.97 83.06 Favored Pre-proline 0 C--N 1.304 -1.395 0 CA-C-N 112.24 -2.255 . . . . 0.0 106.675 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -56.17 179.91 0.09 OUTLIER 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.884 2.389 . . . . 0.0 111.479 173.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.48 ' SG ' ' OG1' ' A' ' 10' ' ' THR . 42.1 t -68.53 -58.08 4.84 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 114.521 -1.218 . . . . 0.0 111.037 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.4 p 36.19 41.29 0.13 Allowed 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 115.759 1.762 . . . . 0.0 115.759 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.5 t -146.97 -67.0 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-N 113.076 -1.875 . . . . 0.0 106.644 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.48 ' OG1' ' SG ' ' A' ' 7' ' ' CYS . 36.6 p -84.49 -11.19 56.61 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.1 -18.6 36.94 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.231 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 88.2 mt -55.0 -37.7 66.92 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.108 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -89.37 -11.48 43.12 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 123.909 0.755 . . . . 0.0 110.931 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 123.06 17.72 3.29 Favored Glycine 0 N--CA 1.497 2.743 0 O-C-N 124.27 0.981 . . . . 0.0 113.138 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.75 88.99 6.73 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 122.993 1.378 . . . . 0.0 113.071 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.6 m -70.61 126.92 30.97 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 112.409 -2.178 . . . . 0.0 110.301 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.7 t -62.28 89.89 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 124.133 0.895 . . . . 0.0 112.689 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.7 t -105.69 134.57 48.59 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.7 p30 47.78 42.72 16.17 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 124.762 1.289 . . . . 0.0 111.251 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.404 ' NH2' HG13 ' A' ' 3' ' ' VAL . 10.7 mtp180 56.86 30.91 18.69 Favored 'General case' 0 N--CA 1.502 2.169 0 CA-C-N 112.58 -2.1 . . . . 0.0 112.948 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 53.7 t -136.29 136.31 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 CA-C-N 113.159 -1.837 . . . . 0.0 108.166 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 84.4 m -62.78 126.98 29.15 Favored 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 105.785 -1.932 . . . . 0.0 105.785 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.82 117.25 14.72 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 118.414 2.746 . . . . 0.0 118.414 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.455 ' C ' ' H ' ' A' ' 26' ' ' ILE . 0.4 OUTLIER -121.96 55.97 1.1 Allowed 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 179.588 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.0 -37.24 3.28 Favored Glycine 0 N--CA 1.484 1.842 0 N-CA-C 107.16 -2.376 . . . . 0.0 107.16 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.455 ' H ' ' C ' ' A' ' 24' ' ' ASN . 4.5 tt -146.06 142.21 17.46 Favored Pre-proline 0 N--CA 1.487 1.408 0 N-CA-C 102.294 -3.225 . . . . 0.0 102.294 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -65.67 174.98 4.79 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.084 1.856 . . . . 0.0 112.749 -166.276 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.2 m -140.26 28.12 2.08 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 113.899 -1.5 . . . . 0.0 107.723 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 66.26 -178.49 0.2 Allowed 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.319 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 . . . . . 0 N--CA 1.501 2.096 0 O-C-N 124.439 1.087 . . . . 0.0 112.189 -179.988 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 52.2 p . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 121.553 0.692 . . . . 0.0 110.5 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.471 ' HB3' ' O ' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -104.79 38.6 1.87 Allowed 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 113.764 -1.562 . . . . 0.0 111.046 -179.954 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.464 ' H ' HG23 ' A' ' 3' ' ' VAL . 12.1 t -23.87 -53.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.527 0 CA-C-N 113.146 -1.843 . . . . 0.0 115.571 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -122.74 -37.48 2.75 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.442 ' CG1' ' HA ' ' A' ' 2' ' ' CYS . 14.9 pt -72.0 178.47 1.31 Allowed Pre-proline 0 CA--C 1.561 1.379 0 CA-C-N 112.789 -2.005 . . . . 0.0 111.188 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.471 ' O ' ' HB3' ' A' ' 2' ' ' CYS . 13.2 Cg_endo -82.03 -52.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 124.106 3.204 . . . . 0.0 110.766 168.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.558 ' HB3' ' HB2' ' A' ' 11' ' ' ALA . 51.9 t 179.04 -59.4 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 124.188 0.93 . . . . 0.0 109.334 179.248 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.2 p 40.38 38.12 0.52 Allowed 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 115.008 1.485 . . . . 0.0 115.008 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.467 HG12 HG23 ' A' ' 10' ' ' THR . 42.1 t -144.29 -63.68 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-N 113.27 -1.786 . . . . 0.0 108.362 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.638 HG21 ' O ' ' A' ' 28' ' ' CYS . 26.1 p -100.42 -14.25 18.39 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 124.102 0.876 . . . . 0.0 110.797 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.558 ' HB2' ' HB3' ' A' ' 7' ' ' CYS . . . -50.81 -20.08 1.17 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 123.743 0.652 . . . . 0.0 112.37 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 35.2 mt -54.19 -45.07 72.08 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 124.297 0.998 . . . . 0.0 112.271 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.623 HD11 ' SG ' ' A' ' 15' ' ' CYS . 0.7 OUTLIER -89.58 13.86 12.98 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 124.182 0.926 . . . . 0.0 112.361 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.68 29.44 16.09 Favored Glycine 0 N--CA 1.495 2.6 0 CA-C-N 115.046 -0.979 . . . . 0.0 113.267 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.623 ' SG ' HD11 ' A' ' 13' ' ' LEU . 78.6 m -81.3 80.11 7.78 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.67 1.224 . . . . 0.0 110.013 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.8 m -66.52 117.48 8.78 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 112.392 -2.185 . . . . 0.0 110.407 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.629 ' SG ' ' HA ' ' A' ' 20' ' ' ARG . 48.6 t -63.23 144.43 56.94 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 114.567 -1.197 . . . . 0.0 113.993 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.5 m -147.3 130.15 16.18 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 103.443 -2.799 . . . . 0.0 103.443 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.2 p30 45.6 41.59 7.22 Favored 'General case' 0 N--CA 1.506 2.335 0 CA-C-O 122.769 1.271 . . . . 0.0 110.154 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.629 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 0.2 OUTLIER 56.3 41.33 29.28 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 112.346 -2.206 . . . . 0.0 112.741 -179.878 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 78.9 t -136.07 111.84 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 105.685 -1.968 . . . . 0.0 105.685 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 59.5 m -52.44 127.46 22.52 Favored 'General case' 0 N--CA 1.507 2.389 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -135.58 113.67 11.29 Favored 'General case' 0 N--CA 1.509 2.487 0 N-CA-C 117.293 2.331 . . . . 0.0 117.293 -179.251 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.474 ' C ' ' H ' ' A' ' 26' ' ' ILE . 1.6 t-20 -106.26 54.47 0.69 Allowed 'General case' 0 N--CA 1.506 2.348 0 N-CA-C 103.948 -2.612 . . . . 0.0 103.948 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.84 -43.07 2.96 Favored Glycine 0 N--CA 1.482 1.741 0 N-CA-C 104.77 -3.332 . . . . 0.0 104.77 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.474 ' H ' ' C ' ' A' ' 24' ' ' ASN . 2.6 pt -125.08 150.53 67.0 Favored Pre-proline 0 C--N 1.308 -1.204 0 N-CA-C 102.917 -2.994 . . . . 0.0 102.917 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -64.12 174.87 3.62 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 121.827 1.685 . . . . 0.0 110.632 -171.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.638 ' O ' HG21 ' A' ' 10' ' ' THR . 5.3 m -148.53 20.4 1.05 Allowed 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 114.614 -1.175 . . . . 0.0 108.701 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 62.46 -172.53 0.16 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.052 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 . . . . . 0 N--CA 1.5 2.046 0 O-C-N 124.277 0.986 . . . . 0.0 110.958 -179.919 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 73.3 m . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.74 0.781 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.518 ' SG ' ' C ' ' A' ' 20' ' ' ARG . 1.4 p -103.98 47.17 0.89 Allowed 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 113.266 -1.788 . . . . 0.0 109.382 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.41 ' HA ' ' HG2' ' A' ' 20' ' ' ARG . 24.0 t -47.55 -46.3 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 CA-C-N 113.937 -1.483 . . . . 0.0 113.059 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -118.52 -55.66 2.19 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 104.789 -2.3 . . . . 0.0 104.789 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.4 ' O ' ' HB2' ' A' ' 2' ' ' CYS . 0.4 OUTLIER -61.86 150.81 81.57 Favored Pre-proline 0 C--N 1.307 -1.255 0 CA-C-N 113.192 -1.822 . . . . 0.0 108.424 179.635 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -58.94 -48.43 14.48 Favored 'Trans proline' 0 N--CA 1.492 1.441 0 C-N-CA 123.343 2.695 . . . . 0.0 112.891 169.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.419 ' SG ' ' N ' ' A' ' 11' ' ' ALA . 42.0 t 179.49 -62.63 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 60.3 p 40.32 32.52 0.13 Allowed 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 55.3 t -148.06 -44.79 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-N 113.766 -1.561 . . . . 0.0 110.614 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.704 HG21 ' O ' ' A' ' 28' ' ' CYS . 2.6 p -118.01 -3.1 11.16 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 124.316 1.01 . . . . 0.0 112.83 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.419 ' N ' ' SG ' ' A' ' 7' ' ' CYS . . . -63.22 -20.14 65.16 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.115 0.483 . . . . 0.0 110.259 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.446 ' H ' HD12 ' A' ' 12' ' ' LEU . 3.4 mp -55.74 -38.17 69.45 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-N 114.4 -1.273 . . . . 0.0 113.624 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.32 -4.24 58.18 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 123.903 0.752 . . . . 0.0 112.217 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.65 18.46 10.12 Favored Glycine 0 N--CA 1.497 2.706 0 O-C-N 124.221 0.95 . . . . 0.0 112.556 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.715 ' HB3' ' SG ' ' A' ' 22' ' ' CYS . 2.0 t -75.56 119.87 20.2 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 122.063 0.935 . . . . 0.0 110.088 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.5 m -95.38 118.18 31.67 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 112.914 -1.948 . . . . 0.0 112.419 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.612 ' SG ' ' HA ' ' A' ' 20' ' ' ARG . 42.7 t -62.03 106.01 0.66 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 115.273 1.583 . . . . 0.0 115.273 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.9 m -113.58 133.48 55.25 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 103.934 -2.617 . . . . 0.0 103.934 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.0 p30 46.37 42.12 10.13 Favored 'General case' 0 N--CA 1.506 2.372 0 CA-C-O 122.741 1.258 . . . . 0.0 110.73 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.612 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 0.2 OUTLIER 54.75 38.0 29.37 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 112.341 -2.208 . . . . 0.0 113.354 -179.893 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.478 ' N ' ' SG ' ' A' ' 2' ' ' CYS . 54.4 t -136.4 117.7 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.715 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 0.5 OUTLIER -55.79 129.94 41.4 Favored 'General case' 0 N--CA 1.509 2.493 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 179.893 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.74 105.98 6.36 Favored 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 116.938 2.199 . . . . 0.0 116.938 -178.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.436 ' C ' ' H ' ' A' ' 26' ' ' ILE . 0.3 OUTLIER -96.94 56.11 1.39 Allowed 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 179.599 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.93 -43.44 3.07 Favored Glycine 0 N--CA 1.484 1.867 0 N-CA-C 106.088 -2.805 . . . . 0.0 106.088 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.436 ' H ' ' C ' ' A' ' 24' ' ' ASN . 3.9 tt -131.37 147.07 64.69 Favored Pre-proline 0 N--CA 1.488 1.474 0 N-CA-C 101.442 -3.54 . . . . 0.0 101.442 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -64.84 174.46 4.62 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 C-N-CA 121.936 1.757 . . . . 0.0 111.429 -166.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.704 ' O ' HG21 ' A' ' 10' ' ' THR . 1.9 m -145.66 21.0 1.49 Allowed 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 114.286 -1.325 . . . . 0.0 108.952 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 66.94 -176.95 0.2 Allowed 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.731 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 . . . . . 0 N--CA 1.499 2.015 0 O-C-N 124.423 1.077 . . . . 0.0 110.98 -179.924 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 51.8 m . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 121.545 0.688 . . . . 0.0 112.266 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.466 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 1.8 m -104.85 36.11 2.55 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 113.422 -1.717 . . . . 0.0 110.268 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.421 HG23 ' H ' ' A' ' 3' ' ' VAL . 18.9 t -24.77 -55.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.667 0 N-CA-C 114.968 1.469 . . . . 0.0 114.968 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -126.54 -55.19 1.43 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 103.491 -2.781 . . . . 0.0 103.491 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.5 pt -71.02 158.18 88.73 Favored Pre-proline 0 C--N 1.307 -1.269 0 CA-C-N 112.667 -2.061 . . . . 0.0 108.35 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -55.19 -174.88 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 123.115 2.543 . . . . 0.0 112.216 162.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.478 ' C ' ' HG1' ' A' ' 8' ' ' THR . 48.4 t -77.68 -52.15 9.43 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.211 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.478 ' HG1' ' C ' ' A' ' 7' ' ' CYS . 59.5 p 45.83 33.36 1.52 Allowed 'General case' 0 N--CA 1.507 2.385 0 O-C-N 125.046 1.466 . . . . 0.0 114.085 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 56.0 t -141.29 -40.34 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 113.438 -1.71 . . . . 0.0 110.291 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.615 HG21 ' O ' ' A' ' 28' ' ' CYS . 72.4 p -124.19 -17.92 6.02 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 124.031 0.832 . . . . 0.0 110.723 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.75 -23.65 2.86 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 123.782 0.676 . . . . 0.0 111.918 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.514 ' H ' HD12 ' A' ' 12' ' ' LEU . 4.2 mp -51.93 -42.67 63.0 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 114.561 -1.2 . . . . 0.0 112.593 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -89.4 -6.61 56.42 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 118.51 20.54 4.24 Favored Glycine 0 N--CA 1.499 2.891 0 O-C-N 123.998 0.811 . . . . 0.0 113.221 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.4 ' SG ' ' HB ' ' A' ' 10' ' ' THR . 83.1 m -81.29 75.56 8.25 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 122.745 1.26 . . . . 0.0 110.972 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.5 m -57.19 124.04 17.41 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 112.217 -2.265 . . . . 0.0 111.481 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.423 ' SG ' ' HB2' ' A' ' 7' ' ' CYS . 48.3 m -62.47 85.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 124.544 1.152 . . . . 0.0 113.562 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.5 m -94.04 125.56 38.74 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.8 p30 46.75 43.4 12.96 Favored 'General case' 0 N--CA 1.503 2.221 0 CA-C-O 122.566 1.174 . . . . 0.0 110.708 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 2' ' ' CYS . 2.7 mtm-85 56.81 36.18 27.33 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-N 112.409 -2.178 . . . . 0.0 111.843 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 63.7 t -136.11 122.1 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.457 ' SG ' ' HB3' ' A' ' 30' ' ' GLU . 3.5 m -57.48 122.08 11.8 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.52 124.09 23.61 Favored 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 116.384 1.994 . . . . 0.0 116.384 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.421 ' C ' ' H ' ' A' ' 26' ' ' ILE . 0.3 OUTLIER -127.9 59.51 1.47 Allowed 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 104.776 -2.305 . . . . 0.0 104.776 179.566 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.51 -39.91 3.1 Favored Glycine 0 N--CA 1.482 1.752 0 N-CA-C 106.716 -2.554 . . . . 0.0 106.716 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.421 ' H ' ' C ' ' A' ' 24' ' ' ASN . 2.0 tt -139.37 146.28 47.85 Favored Pre-proline 0 N--CA 1.489 1.521 0 N-CA-C 102.749 -3.056 . . . . 0.0 102.749 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -64.5 172.87 6.05 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 121.898 1.732 . . . . 0.0 111.128 -168.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.615 ' O ' HG21 ' A' ' 10' ' ' THR . 3.5 m -141.68 23.21 2.12 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 113.773 -1.558 . . . . 0.0 108.057 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 63.68 -176.16 0.16 Allowed 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.017 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.457 ' HB3' ' SG ' ' A' ' 22' ' ' CYS . 12.0 tp10 . . . . . 0 N--CA 1.503 2.21 0 O-C-N 124.095 0.872 . . . . 0.0 110.144 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.496 1.851 0 CA-C-O 121.862 0.839 . . . . 0.0 112.133 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.444 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 0.8 OUTLIER -104.72 39.54 1.67 Allowed 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 113.093 -1.867 . . . . 0.0 110.523 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.416 HG23 ' H ' ' A' ' 3' ' ' VAL . 19.8 t -26.59 -54.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.687 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -125.51 -58.05 1.44 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 103.297 -2.853 . . . . 0.0 103.297 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.5 pt -69.02 156.52 91.37 Favored Pre-proline 0 C--N 1.305 -1.354 0 CA-C-N 112.403 -2.18 . . . . 0.0 108.369 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -58.81 -177.09 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 123.014 2.476 . . . . 0.0 111.262 161.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.466 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 12.7 t -79.03 -43.39 24.36 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.13 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.4 p 39.13 42.15 0.69 Allowed 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.1 t -149.41 -66.26 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 CA-C-N 112.654 -2.066 . . . . 0.0 107.002 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 71.9 p -77.67 -5.2 49.63 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.379 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.31 -19.84 6.11 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.604 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 36.1 mt -53.34 -42.59 66.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 124.274 0.984 . . . . 0.0 111.442 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.491 HD11 ' SG ' ' A' ' 28' ' ' CYS . 1.0 OUTLIER -89.49 -9.57 49.53 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 124.286 0.991 . . . . 0.0 111.436 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.97 35.41 5.58 Favored Glycine 0 N--CA 1.492 2.371 0 O-C-N 124.317 1.011 . . . . 0.0 110.781 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.521 ' SG ' ' C ' ' A' ' 22' ' ' CYS . 0.9 OUTLIER -75.78 90.1 2.88 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 122.992 1.377 . . . . 0.0 112.02 179.932 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.9 m -62.45 119.6 9.46 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 112.324 -2.217 . . . . 0.0 111.293 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.466 ' SG ' ' HB2' ' A' ' 7' ' ' CYS . 36.9 m -63.7 85.21 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 114.634 -1.166 . . . . 0.0 113.974 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.8 m -90.96 126.35 36.05 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.1 p30 46.42 44.62 13.09 Favored 'General case' 0 N--CA 1.505 2.305 0 CA-C-O 122.732 1.253 . . . . 0.0 110.72 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' A' ' 2' ' ' CYS . 7.1 mtm180 56.7 36.7 28.05 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 112.33 -2.214 . . . . 0.0 112.291 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.5 t -136.03 121.81 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.521 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 3.2 m -57.2 118.92 5.55 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.67 137.36 41.72 Favored 'General case' 0 N--CA 1.506 2.36 0 N-CA-C 118.023 2.601 . . . . 0.0 118.023 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.482 ' HB2' ' HA ' ' A' ' 15' ' ' CYS . 0.3 OUTLIER -150.21 61.95 0.97 Allowed 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 179.485 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.41 -50.97 3.62 Favored Glycine 0 N--CA 1.481 1.637 0 N-CA-C 104.966 -3.254 . . . . 0.0 104.966 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.3 pt -125.09 146.4 53.61 Favored Pre-proline 0 C--N 1.308 -1.228 0 N-CA-C 103.853 -2.647 . . . . 0.0 103.853 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -67.25 177.74 3.57 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 122.372 2.048 . . . . 0.0 110.646 -177.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.491 ' SG ' HD11 ' A' ' 13' ' ' LEU . 2.9 m -144.78 25.53 1.45 Allowed 'General case' 0 N--CA 1.501 2.082 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.226 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 65.97 171.78 0.23 Allowed 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.93 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.5 2.067 0 O-C-N 124.426 1.079 . . . . 0.0 110.937 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 77.4 p . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 121.235 0.541 . . . . 0.0 110.829 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.473 ' SG ' ' C ' ' A' ' 20' ' ' ARG . 0.5 OUTLIER -104.8 36.37 2.46 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 114.138 -1.392 . . . . 0.0 111.355 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.443 ' HA ' ' NE ' ' A' ' 20' ' ' ARG . 54.2 t -22.55 -61.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.567 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -120.63 -25.94 5.41 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 113.41 -1.723 . . . . 0.0 107.654 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.457 ' CG1' ' HA ' ' A' ' 2' ' ' CYS . 2.2 pt -80.83 -175.86 0.68 Allowed Pre-proline 0 CA--C 1.562 1.442 0 CA-C-N 113.144 -1.844 . . . . 0.0 110.542 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.414 ' CD ' ' HB ' ' A' ' 5' ' ' ILE . 35.3 Cg_endo -87.24 -53.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.322 0 C-N-CA 124.985 3.79 . . . . 0.0 110.981 173.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.52 ' SG ' ' OG1' ' A' ' 10' ' ' THR . 45.5 t 179.34 -49.59 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 124.535 1.147 . . . . 0.0 109.689 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.5 t 36.27 26.68 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 119.621 3.193 . . . . 0.0 119.621 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.0 t -145.38 -55.15 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.635 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.52 ' OG1' ' SG ' ' A' ' 7' ' ' CYS . 41.7 p -95.82 -1.04 50.4 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 124.045 0.84 . . . . 0.0 110.241 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.25 -14.96 43.94 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.482 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.9 mt -54.8 -42.95 72.44 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 114.908 -1.042 . . . . 0.0 112.092 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.38 -2.86 58.57 Favored 'General case' 0 C--N 1.31 -1.13 0 O-C-N 124.108 0.88 . . . . 0.0 111.381 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.3 36.8 6.12 Favored Glycine 0 N--CA 1.494 2.534 0 O-C-N 124.332 1.02 . . . . 0.0 110.808 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.3 t -83.3 90.69 7.17 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.847 1.308 . . . . 0.0 111.843 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.44 ' N ' ' O ' ' A' ' 23' ' ' TYR . 67.7 m -62.39 119.22 8.69 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 112.112 -2.313 . . . . 0.0 112.91 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.528 ' SG ' ' HA ' ' A' ' 20' ' ' ARG . 54.0 t -66.05 132.65 49.03 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 114.888 -1.051 . . . . 0.0 112.629 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.6 m -138.6 130.56 28.15 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 103.524 -2.769 . . . . 0.0 103.524 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.3 p30 46.49 43.12 11.81 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-O 122.816 1.293 . . . . 0.0 110.197 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.528 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 7.7 mtp180 55.87 37.66 29.11 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 112.223 -2.262 . . . . 0.0 112.645 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 63.0 t -135.97 111.76 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 CA-C-N 113.512 -1.676 . . . . 0.0 106.879 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.66 ' HB2' ' SG ' ' A' ' 28' ' ' CYS . 58.0 m -52.64 129.69 30.1 Favored 'General case' 0 N--CA 1.506 2.351 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.44 ' O ' ' N ' ' A' ' 16' ' ' SER . 0.2 OUTLIER -136.08 140.36 43.7 Favored 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 116.106 1.891 . . . . 0.0 116.106 -179.087 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.414 ' C ' ' H ' ' A' ' 26' ' ' ILE . 0.2 OUTLIER -145.12 57.13 1.26 Allowed 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 179.736 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.48 -48.82 3.39 Favored Glycine 0 N--CA 1.48 1.608 0 N-CA-C 104.377 -3.489 . . . . 0.0 104.377 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.414 ' H ' ' C ' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -126.3 145.33 52.26 Favored Pre-proline 0 C--N 1.308 -1.221 0 N-CA-C 102.82 -3.03 . . . . 0.0 102.82 179.492 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -64.87 177.45 2.34 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.243 1.962 . . . . 0.0 111.02 -175.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.66 ' SG ' ' HB2' ' A' ' 22' ' ' CYS . 2.2 p -142.1 9.17 1.89 Allowed 'General case' 0 N--CA 1.502 2.141 0 CA-C-N 114.693 -1.14 . . . . 0.0 108.486 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 28' ' ' CYS . . . 73.52 -176.04 0.16 Allowed 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 . . . . . 0 N--CA 1.502 2.166 0 O-C-N 124.047 0.842 . . . . 0.0 110.042 -179.869 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 31.6 p . . . . . 0 N--CA 1.495 1.822 0 CA-C-O 121.14 0.495 . . . . 0.0 111.055 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.43 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 1.7 m -104.75 36.34 2.46 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 114.275 -1.329 . . . . 0.0 109.726 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.416 ' H ' HG23 ' A' ' 3' ' ' VAL . 20.2 t -23.09 -57.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.616 0 O-C-N 125.106 1.504 . . . . 0.0 114.761 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -125.72 -56.97 1.47 Allowed 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 102.985 -2.969 . . . . 0.0 102.985 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.5 pt -70.02 151.79 96.02 Favored Pre-proline 0 C--N 1.306 -1.324 0 CA-C-N 112.371 -2.195 . . . . 0.0 108.798 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -59.39 -176.8 0.11 Allowed 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 123.066 2.511 . . . . 0.0 111.565 167.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.582 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 34.6 t -78.63 -53.39 7.22 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.0 p 39.05 37.29 0.21 Allowed 'General case' 0 N--CA 1.504 2.236 0 O-C-N 125.006 1.441 . . . . 0.0 114.887 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 51.1 t -141.57 -63.12 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 CA-C-N 112.77 -2.014 . . . . 0.0 106.788 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.434 ' OG1' ' SG ' ' A' ' 7' ' ' CYS . 35.6 p -92.31 -10.02 39.87 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.59 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.8 -19.13 15.54 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.912 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -52.35 -38.8 59.67 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 114.72 -1.127 . . . . 0.0 112.684 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.53 -13.7 36.78 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 123.989 0.806 . . . . 0.0 111.374 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.36 27.75 3.26 Favored Glycine 0 N--CA 1.495 2.567 0 O-C-N 124.449 1.093 . . . . 0.0 111.178 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.459 ' SG ' ' C ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER -80.9 81.72 7.07 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 123.001 1.382 . . . . 0.0 111.819 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 38.7 m -58.02 125.03 21.39 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 112.407 -2.179 . . . . 0.0 113.397 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.582 ' SG ' ' HB2' ' A' ' 7' ' ' CYS . 35.0 m -65.66 82.77 0.06 Allowed 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.3 t -91.11 123.09 34.3 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 45.98 47.01 12.66 Favored 'General case' 0 N--CA 1.504 2.269 0 CA-C-O 122.984 1.373 . . . . 0.0 110.409 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 2' ' ' CYS . 1.9 mtm180 56.53 36.83 28.2 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 111.907 -2.406 . . . . 0.0 112.686 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 69.2 t -136.11 118.79 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.459 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 4.3 m -58.38 123.05 14.82 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.87 133.84 38.17 Favored 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 117.064 2.246 . . . . 0.0 117.064 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.449 ' C ' ' H ' ' A' ' 26' ' ' ILE . 0.3 OUTLIER -144.17 60.71 1.35 Allowed 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 179.536 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.77 -32.1 4.09 Favored Glycine 0 N--CA 1.483 1.813 0 N-CA-C 107.977 -2.049 . . . . 0.0 107.977 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.449 ' H ' ' C ' ' A' ' 24' ' ' ASN . 4.3 tt -149.92 145.42 18.86 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 103.264 -2.865 . . . . 0.0 103.264 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -67.85 177.73 3.98 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.103 1.869 . . . . 0.0 111.108 -171.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.4 m -142.19 19.15 2.09 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.156 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 69.06 172.94 0.3 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 124.377 1.048 . . . . 0.0 110.335 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.501 2.114 0 O-C-N 124.444 1.09 . . . . 0.0 109.55 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 35.8 p . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.181 0.515 . . . . 0.0 111.299 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.425 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 1.6 m -104.67 36.98 2.24 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 114.162 -1.381 . . . . 0.0 109.727 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 19.6 t -25.48 -56.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.681 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -125.07 -57.31 1.52 Allowed 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 103.54 -2.763 . . . . 0.0 103.54 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.2 pt -69.53 152.96 96.14 Favored Pre-proline 0 C--N 1.306 -1.326 0 CA-C-N 112.311 -2.222 . . . . 0.0 108.675 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -59.74 -177.4 0.14 Allowed 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 123.005 2.47 . . . . 0.0 111.661 164.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.553 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 42.1 t -79.34 -50.94 10.09 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.319 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.9 p 37.21 40.99 0.2 Allowed 'General case' 0 N--CA 1.504 2.259 0 O-C-N 125.121 1.513 . . . . 0.0 115.055 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 43.6 t -145.23 -67.87 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-N 112.633 -2.076 . . . . 0.0 106.698 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.435 HG21 ' O ' ' A' ' 28' ' ' CYS . 29.3 p -85.05 -10.37 57.0 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.453 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.49 -17.8 9.45 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.32 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 33.1 mt -54.38 -38.64 66.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 124.332 1.02 . . . . 0.0 112.391 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.44 -8.01 53.9 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 123.91 0.756 . . . . 0.0 111.283 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.22 30.21 4.24 Favored Glycine 0 N--CA 1.494 2.518 0 O-C-N 124.436 1.085 . . . . 0.0 111.33 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.469 ' SG ' ' C ' ' A' ' 22' ' ' CYS . 0.9 OUTLIER -80.98 82.33 6.99 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 122.842 1.306 . . . . 0.0 112.408 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.1 m -60.54 123.68 18.09 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 112.568 -2.106 . . . . 0.0 111.89 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.553 ' SG ' ' HB2' ' A' ' 7' ' ' CYS . 46.7 m -63.04 85.61 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.4 m -92.31 125.8 37.12 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 105.315 -2.106 . . . . 0.0 105.315 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.5 p30 46.6 45.17 14.14 Favored 'General case' 0 N--CA 1.505 2.318 0 CA-C-O 122.785 1.279 . . . . 0.0 110.743 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.425 ' HG2' ' O ' ' A' ' 2' ' ' CYS . 4.4 mtm180 56.24 37.09 28.5 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 112.244 -2.253 . . . . 0.0 112.18 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 55.7 t -136.32 121.05 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.469 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 7.2 m -56.17 122.65 12.21 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.61 136.09 40.75 Favored 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 117.485 2.402 . . . . 0.0 117.485 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.464 ' C ' ' H ' ' A' ' 26' ' ' ILE . 0.3 OUTLIER -145.95 61.15 1.25 Allowed 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 105.477 -2.045 . . . . 0.0 105.477 179.581 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.88 -32.8 3.66 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 108.052 -2.019 . . . . 0.0 108.052 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.464 ' H ' ' C ' ' A' ' 24' ' ' ASN . 3.6 tt -149.93 144.79 18.01 Favored Pre-proline 0 N--CA 1.488 1.457 0 N-CA-C 103.015 -2.957 . . . . 0.0 103.015 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -66.83 177.03 3.79 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.239 1.959 . . . . 0.0 111.646 -170.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.435 ' O ' HG21 ' A' ' 10' ' ' THR . 2.3 m -143.04 23.21 1.88 Allowed 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 114.715 -1.13 . . . . 0.0 108.863 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 69.75 174.65 0.29 Allowed 'General case' 0 N--CA 1.501 2.1 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.461 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 . . . . . 0 N--CA 1.502 2.141 0 O-C-N 124.726 1.266 . . . . 0.0 111.276 -179.923 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.8 p . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.346 0.593 . . . . 0.0 110.06 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.449 ' SG ' ' C ' ' A' ' 20' ' ' ARG . 19.4 p -104.61 57.07 0.7 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 114.013 -1.448 . . . . 0.0 107.844 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.411 HG23 ' H ' ' A' ' 3' ' ' VAL . 4.7 t -42.75 -51.57 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.403 0 N-CA-C 116.952 2.204 . . . . 0.0 116.952 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.412 ' H ' HD13 ' A' ' 5' ' ' ILE . 13.2 m-85 -122.14 -58.25 1.73 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 102.727 -3.064 . . . . 0.0 102.727 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.837 ' H ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -71.5 148.21 92.99 Favored Pre-proline 0 C--N 1.302 -1.485 0 CA-C-N 111.49 -2.595 . . . . 0.0 106.897 179.512 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -58.92 -178.81 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.899 2.399 . . . . 0.0 111.001 168.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.507 ' HB3' ' HB2' ' A' ' 11' ' ' ALA . 42.7 t -73.25 -54.43 8.42 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 114.605 -1.18 . . . . 0.0 111.704 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 68.0 p 41.78 34.45 0.42 Allowed 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 51.6 t -142.92 -65.22 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 113.468 -1.696 . . . . 0.0 106.974 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.442 ' OG1' ' SG ' ' A' ' 7' ' ' CYS . 22.7 p -86.61 -19.13 29.8 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.507 ' HB2' ' HB3' ' A' ' 7' ' ' CYS . . . -59.44 -21.26 59.76 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.357 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 92.6 mt -57.92 -34.24 69.64 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 124.444 1.09 . . . . 0.0 111.175 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.51 -6.87 56.01 Favored 'General case' 0 N--CA 1.48 1.066 0 O-C-N 123.964 0.79 . . . . 0.0 111.153 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.15 12.11 6.53 Favored Glycine 0 N--CA 1.497 2.765 0 O-C-N 124.277 0.985 . . . . 0.0 113.893 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -80.74 85.12 6.14 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 123.254 1.502 . . . . 0.0 113.137 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.1 m -63.03 124.85 22.16 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 112.08 -2.327 . . . . 0.0 110.909 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 29.6 t -64.4 92.48 0.09 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 124.158 0.911 . . . . 0.0 113.142 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 27.8 p -109.66 140.22 43.77 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.3 p30 48.79 37.85 10.65 Favored 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 122.638 1.209 . . . . 0.0 111.028 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.449 ' C ' ' SG ' ' A' ' 2' ' ' CYS . 31.4 mtt180 56.48 31.92 19.78 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-N 112.8 -2.0 . . . . 0.0 112.894 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.2 t -136.2 138.34 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 CA-C-N 112.775 -2.011 . . . . 0.0 107.725 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 29.3 m -63.88 125.89 25.85 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -135.89 120.55 18.33 Favored 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 117.104 2.261 . . . . 0.0 117.104 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.433 ' C ' ' H ' ' A' ' 26' ' ' ILE . 0.3 OUTLIER -123.03 53.6 1.29 Allowed 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 104.056 -2.572 . . . . 0.0 104.056 179.648 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.56 -44.27 2.59 Favored Glycine 0 N--CA 1.479 1.564 0 N-CA-C 104.0 -3.64 . . . . 0.0 104.0 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.516 ' O ' HD12 ' A' ' 26' ' ' ILE . 1.1 pp -133.65 148.29 67.98 Favored Pre-proline 0 N--CA 1.482 1.161 0 N-CA-C 103.726 -2.694 . . . . 0.0 103.726 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -64.33 175.19 3.52 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.061 1.841 . . . . 0.0 112.073 -171.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.0 m -146.28 27.9 1.12 Allowed 'General case' 0 N--CA 1.5 2.045 0 CA-C-N 114.327 -1.306 . . . . 0.0 108.277 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 67.08 175.86 0.25 Allowed 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.759 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 . . . . . 0 N--CA 1.501 2.093 0 O-C-N 124.461 1.101 . . . . 0.0 111.389 -179.979 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.494 1.764 0 CA-C-O 121.576 0.703 . . . . 0.0 111.345 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.437 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 1.4 m -104.8 38.54 1.89 Allowed 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 113.442 -1.708 . . . . 0.0 109.674 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.6 t -26.21 -55.2 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.72 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -125.31 -58.14 1.45 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 103.266 -2.865 . . . . 0.0 103.266 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.2 pt -68.63 154.94 93.95 Favored Pre-proline 0 C--N 1.305 -1.331 0 CA-C-N 112.209 -2.269 . . . . 0.0 108.631 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -57.88 -174.92 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 123.075 2.517 . . . . 0.0 111.339 162.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.524 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 33.8 t -78.98 -51.09 10.1 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.47 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 68.8 p 41.24 34.8 0.35 Allowed 'General case' 0 N--CA 1.505 2.313 0 O-C-N 125.18 1.55 . . . . 0.0 114.787 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.3 t -145.58 -37.02 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-N 113.369 -1.741 . . . . 0.0 109.748 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.9 p -120.18 -15.14 8.73 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 124.493 1.121 . . . . 0.0 109.668 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.34 -19.09 7.82 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.079 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.1 pp -56.71 -34.51 67.54 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 124.05 0.844 . . . . 0.0 113.229 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 pp -89.4 -5.66 57.25 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 123.808 0.693 . . . . 0.0 111.085 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.39 28.02 4.78 Favored Glycine 0 N--CA 1.495 2.62 0 O-C-N 124.46 1.1 . . . . 0.0 111.465 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.483 ' SG ' ' C ' ' A' ' 22' ' ' CYS . 0.6 OUTLIER -83.35 81.06 8.88 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.736 1.255 . . . . 0.0 112.279 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.9 m -59.96 123.72 17.96 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 112.582 -2.099 . . . . 0.0 111.419 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.524 ' SG ' ' HB2' ' A' ' 7' ' ' CYS . 31.1 m -66.7 85.1 0.11 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 114.109 1.152 . . . . 0.0 114.109 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 96.1 p -96.15 132.86 41.13 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.6 p30 46.0 42.18 9.09 Favored 'General case' 0 N--CA 1.503 2.218 0 CA-C-O 122.663 1.221 . . . . 0.0 110.716 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' A' ' 2' ' ' CYS . 3.0 mtm-85 56.0 38.0 29.47 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-N 112.461 -2.154 . . . . 0.0 112.372 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.3 t -136.29 124.77 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.483 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 4.0 m -60.05 122.19 13.73 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.62 133.48 38.29 Favored 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 117.358 2.355 . . . . 0.0 117.358 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.455 ' C ' ' H ' ' A' ' 26' ' ' ILE . 0.3 OUTLIER -142.47 60.35 1.44 Allowed 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 179.576 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.73 -33.62 3.69 Favored Glycine 0 N--CA 1.484 1.844 0 N-CA-C 107.891 -2.084 . . . . 0.0 107.891 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.455 ' H ' ' C ' ' A' ' 24' ' ' ASN . 3.3 tt -149.6 144.56 17.94 Favored Pre-proline 0 N--CA 1.488 1.439 0 N-CA-C 103.168 -2.901 . . . . 0.0 103.168 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -65.99 177.45 3.0 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.266 1.978 . . . . 0.0 112.137 -169.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.7 m -141.82 25.81 1.94 Allowed 'General case' 0 N--CA 1.501 2.108 0 CA-C-N 114.821 -1.082 . . . . 0.0 109.03 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 68.96 166.97 0.27 Allowed 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 114.611 -1.177 . . . . 0.0 111.088 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 N--CA 1.501 2.111 0 O-C-N 124.464 1.102 . . . . 0.0 111.606 -179.956 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 62.1 p . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.635 0.731 . . . . 0.0 109.093 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.474 ' SG ' ' C ' ' A' ' 20' ' ' ARG . 14.6 p -104.37 60.4 0.71 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 113.559 -1.655 . . . . 0.0 107.425 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.479 ' H ' HG23 ' A' ' 3' ' ' VAL . 9.6 t -48.91 -49.0 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 CA-C-N 113.015 -1.902 . . . . 0.0 115.508 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -116.29 -51.11 2.63 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 104.841 -2.281 . . . . 0.0 104.841 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.9 pt -64.9 164.45 21.46 Favored Pre-proline 0 C--N 1.303 -1.433 0 CA-C-N 112.297 -2.229 . . . . 0.0 108.954 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -68.22 -179.96 2.55 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 123.309 2.672 . . . . 0.0 109.716 153.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.415 ' SG ' ' OG1' ' A' ' 10' ' ' THR . 43.0 t -71.89 -63.67 1.09 Allowed 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.76 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.8 p 43.2 42.85 3.67 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 115.281 1.586 . . . . 0.0 115.281 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 79.0 t -144.99 -70.43 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 105.08 -2.193 . . . . 0.0 105.08 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.663 HG21 ' O ' ' A' ' 28' ' ' CYS . 40.5 p -88.76 -7.84 55.51 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.32 -19.18 32.89 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.498 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 39.2 mt -53.82 -39.02 65.16 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 114.758 -1.11 . . . . 0.0 112.411 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.4 -11.42 43.25 Favored 'General case' 0 N--CA 1.483 1.202 0 O-C-N 123.974 0.796 . . . . 0.0 110.944 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 124.82 15.57 3.18 Favored Glycine 0 N--CA 1.497 2.708 0 O-C-N 124.294 0.997 . . . . 0.0 113.167 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.88 90.52 5.31 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 123.276 1.513 . . . . 0.0 112.726 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 65.9 m -71.95 126.5 29.9 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 111.8 -2.454 . . . . 0.0 110.057 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.6 t -62.76 90.24 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 124.049 0.843 . . . . 0.0 112.728 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 12.2 m -104.51 137.79 41.84 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 11.1 p30 48.23 39.62 12.42 Favored 'General case' 0 N--CA 1.502 2.138 0 CA-C-O 122.696 1.236 . . . . 0.0 110.7 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.474 ' C ' ' SG ' ' A' ' 2' ' ' CYS . 30.4 mtt180 56.19 31.93 19.27 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-N 112.63 -2.077 . . . . 0.0 113.306 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 50.1 t -136.38 138.71 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-N 112.944 -1.934 . . . . 0.0 107.855 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 71.8 m -61.52 125.0 22.22 Favored 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -135.87 113.81 11.22 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 117.789 2.514 . . . . 0.0 117.789 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.457 ' C ' ' H ' ' A' ' 26' ' ' ILE . 0.4 OUTLIER -116.67 54.77 0.84 Allowed 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 104.497 -2.409 . . . . 0.0 104.497 179.498 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.62 -37.28 3.31 Favored Glycine 0 N--CA 1.482 1.711 0 N-CA-C 106.706 -2.558 . . . . 0.0 106.706 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.457 ' H ' ' C ' ' A' ' 24' ' ' ASN . 4.0 tt -144.08 143.13 21.53 Favored Pre-proline 0 N--CA 1.488 1.451 0 N-CA-C 102.412 -3.181 . . . . 0.0 102.412 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -65.11 175.63 3.76 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 122.071 1.848 . . . . 0.0 112.661 -166.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.663 ' O ' HG21 ' A' ' 10' ' ' THR . 3.1 m -144.77 30.16 1.2 Allowed 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 114.149 -1.387 . . . . 0.0 108.117 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 64.32 -177.4 0.17 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.461 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 N--CA 1.5 2.04 0 O-C-N 124.372 1.045 . . . . 0.0 110.427 179.974 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.2 p . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.271 0.557 . . . . 0.0 111.255 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.423 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 1.4 m -104.79 37.98 2.02 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 114.057 -1.429 . . . . 0.0 109.504 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.41 HG23 ' H ' ' A' ' 3' ' ' VAL . 18.1 t -25.4 -56.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.623 0 N-CA-C 115.027 1.492 . . . . 0.0 115.027 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -125.04 -56.74 1.54 Allowed 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 103.526 -2.768 . . . . 0.0 103.526 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.6 pt -70.14 153.57 95.2 Favored Pre-proline 0 C--N 1.305 -1.349 0 CA-C-N 112.284 -2.234 . . . . 0.0 108.819 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -59.41 -175.78 0.1 OUTLIER 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.892 2.395 . . . . 0.0 111.211 163.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.532 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 13.8 t -79.47 -52.19 8.37 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.125 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.0 p 40.89 36.37 0.41 Allowed 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 37.2 t -144.46 -41.01 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-N 112.845 -1.98 . . . . 0.0 107.983 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.433 ' OG1' ' SG ' ' A' ' 7' ' ' CYS . 16.0 p -116.38 -0.15 12.63 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 124.415 1.072 . . . . 0.0 108.784 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.11 -25.86 68.29 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.455 ' H ' HD23 ' A' ' 12' ' ' LEU . 1.6 pt? -56.59 -31.75 64.56 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.521 HD11 ' SG ' ' A' ' 28' ' ' CYS . 0.4 OUTLIER -89.55 -9.95 47.94 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 123.451 0.469 . . . . 0.0 110.569 179.843 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.89 25.32 5.7 Favored Glycine 0 N--CA 1.494 2.537 0 O-C-N 124.266 0.979 . . . . 0.0 112.236 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.448 ' SG ' ' C ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER -80.34 86.53 5.69 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.721 1.248 . . . . 0.0 111.348 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 24.0 m -64.69 122.6 17.24 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 112.679 -2.055 . . . . 0.0 111.249 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.532 ' SG ' ' HB2' ' A' ' 7' ' ' CYS . 32.8 m -63.65 84.84 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 124.506 1.129 . . . . 0.0 113.992 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.6 t -92.58 128.33 38.4 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 46.64 44.21 13.4 Favored 'General case' 0 N--CA 1.504 2.226 0 CA-C-O 122.678 1.227 . . . . 0.0 110.811 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.423 ' HG2' ' O ' ' A' ' 2' ' ' CYS . 2.5 mtm-85 56.04 37.39 28.79 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 112.308 -2.224 . . . . 0.0 112.173 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.1 t -136.21 121.08 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.448 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 4.0 m -56.94 123.25 14.45 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.48 111.6 9.63 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 116.682 2.105 . . . . 0.0 116.682 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.45 ' C ' ' H ' ' A' ' 26' ' ' ILE . 0.9 OUTLIER -110.2 53.28 0.7 Allowed 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 179.627 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.5 -38.67 3.19 Favored Glycine 0 N--CA 1.483 1.769 0 N-CA-C 106.282 -2.727 . . . . 0.0 106.282 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.45 ' H ' ' C ' ' A' ' 24' ' ' ASN . 3.5 tt -138.53 144.64 43.23 Favored Pre-proline 0 N--CA 1.489 1.479 0 N-CA-C 102.225 -3.25 . . . . 0.0 102.225 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -65.56 176.37 3.52 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 122.157 1.905 . . . . 0.0 111.888 -167.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.521 ' SG ' HD11 ' A' ' 13' ' ' LEU . 3.2 m -145.76 25.36 1.31 Allowed 'General case' 0 N--CA 1.501 2.122 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.116 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 66.46 173.38 0.24 Allowed 'General case' 0 N--CA 1.5 2.04 0 CA-C-N 114.746 -1.115 . . . . 0.0 110.962 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 . . . . . 0 N--CA 1.501 2.092 0 O-C-N 124.421 1.076 . . . . 0.0 111.664 -179.897 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 12.3 t . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 122.366 1.079 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.535 ' SG ' ' N ' ' A' ' 21' ' ' VAL . 0.7 OUTLIER -106.07 41.3 1.43 Allowed 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 111.975 -2.375 . . . . 0.0 110.607 -179.9 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.415 HG23 ' H ' ' A' ' 3' ' ' VAL . 20.9 t -30.92 -53.71 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.571 0 CA-C-N 113.525 -1.671 . . . . 0.0 113.196 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -124.43 -55.44 1.65 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 104.488 -2.412 . . . . 0.0 104.488 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -61.92 131.06 93.03 Favored Pre-proline 0 C--N 1.307 -1.246 0 CA-C-N 112.968 -1.924 . . . . 0.0 109.368 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -37.55 -48.01 1.88 Allowed 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 123.987 3.125 . . . . 0.0 112.752 172.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.62 ' HB3' ' HB2' ' A' ' 11' ' ' ALA . 45.5 t 179.08 -45.04 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 O-C-N 124.145 0.903 . . . . 0.0 110.023 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.9 t 36.97 24.68 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 118.56 2.8 . . . . 0.0 118.56 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.7 t -146.89 -54.1 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.589 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.495 ' OG1' ' SG ' ' A' ' 7' ' ' CYS . 16.4 p -101.72 -5.24 25.21 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 124.002 0.814 . . . . 0.0 110.956 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.62 ' HB2' ' HB3' ' A' ' 7' ' ' CYS . . . -61.59 -14.2 28.35 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.574 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -55.77 -41.79 74.55 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 114.946 -1.024 . . . . 0.0 111.816 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.44 4.18 49.92 Favored 'General case' 0 N--CA 1.482 1.169 0 O-C-N 124.097 0.873 . . . . 0.0 111.118 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.41 34.5 7.44 Favored Glycine 0 N--CA 1.492 2.426 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.987 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.401 ' SG ' ' HB3' ' A' ' 22' ' ' CYS . 3.2 t -81.33 89.22 6.07 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 122.801 1.286 . . . . 0.0 111.8 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 23' ' ' TYR . 57.8 m -66.8 120.05 12.88 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 112.308 -2.224 . . . . 0.0 111.246 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.57 ' SG ' ' HA ' ' A' ' 20' ' ' ARG . 21.4 t -58.96 146.45 37.92 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.4 m -150.09 124.45 9.57 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 103.6 -2.741 . . . . 0.0 103.6 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.8 p30 45.64 45.25 10.88 Favored 'General case' 0 N--CA 1.505 2.305 0 CA-C-O 122.99 1.376 . . . . 0.0 110.134 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.57 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 4.4 mtm-85 55.34 38.86 30.94 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 112.052 -2.34 . . . . 0.0 112.94 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.535 ' N ' ' SG ' ' A' ' 2' ' ' CYS . 42.5 t -136.18 116.98 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.401 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 34.1 m -53.35 131.52 37.84 Favored 'General case' 0 N--CA 1.511 2.583 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.439 ' O ' ' N ' ' A' ' 16' ' ' SER . 0.2 OUTLIER -135.84 140.45 44.2 Favored 'General case' 0 N--CA 1.504 2.274 0 N-CA-C 116.423 2.009 . . . . 0.0 116.423 -179.336 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -148.8 59.97 1.06 Allowed 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.52 -50.36 3.53 Favored Glycine 0 N--CA 1.482 1.752 0 N-CA-C 104.733 -3.347 . . . . 0.0 104.733 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.2 pt -127.59 148.72 67.86 Favored Pre-proline 0 C--N 1.306 -1.311 0 N-CA-C 102.48 -3.156 . . . . 0.0 102.48 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -65.08 175.76 3.64 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 121.978 1.785 . . . . 0.0 110.34 -176.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.409 ' O ' HG21 ' A' ' 10' ' ' THR . 2.0 m -140.69 20.67 2.34 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-N 114.854 -1.067 . . . . 0.0 108.887 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 69.31 179.1 0.25 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 124.328 1.017 . . . . 0.0 109.278 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 . . . . . 0 N--CA 1.5 2.026 0 O-C-N 124.353 1.033 . . . . 0.0 111.165 -179.941 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 17.0 m . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.564 0.697 . . . . 0.0 111.689 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.522 ' SG ' ' HB2' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -104.67 34.53 3.1 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 113.769 -1.559 . . . . 0.0 110.143 -179.936 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.467 ' H ' HG23 ' A' ' 3' ' ' VAL . 42.1 t -27.54 -53.69 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.754 0 O-C-N 125.023 1.452 . . . . 0.0 113.089 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -125.7 -55.57 1.51 Allowed 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 104.387 -2.449 . . . . 0.0 104.387 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.5 pt -67.68 165.68 28.72 Favored Pre-proline 0 C--N 1.306 -1.302 0 CA-C-N 113.247 -1.797 . . . . 0.0 108.9 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -58.4 -178.37 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 123.043 2.495 . . . . 0.0 111.42 154.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.522 ' HB2' ' SG ' ' A' ' 2' ' ' CYS . 0.6 OUTLIER -88.96 -52.24 5.19 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 114.371 -1.286 . . . . 0.0 108.469 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 34.05 54.48 0.57 Allowed 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.5 HG12 HG23 ' A' ' 10' ' ' THR . 26.0 t -150.03 -41.26 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-N 112.849 -1.978 . . . . 0.0 107.287 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.682 HG21 ' O ' ' A' ' 28' ' ' CYS . 33.3 p -123.74 -19.4 5.77 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 114.59 -1.186 . . . . 0.0 109.033 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.45 -27.1 5.88 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.8 pp -54.86 -36.63 65.3 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -89.59 -5.07 57.52 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.62 14.76 5.16 Favored Glycine 0 N--CA 1.5 2.923 0 O-C-N 124.066 0.853 . . . . 0.0 112.6 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.495 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 74.1 m -80.59 87.43 5.76 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 123.95 1.833 . . . . 0.0 109.606 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.0 m -67.19 125.51 26.26 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 111.566 -2.561 . . . . 0.0 112.106 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.4 m -66.41 82.4 0.09 Allowed 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 122.187 0.994 . . . . 0.0 111.796 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.3 m -93.6 123.82 37.18 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.3 p30 47.06 42.37 12.65 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 124.548 1.155 . . . . 0.0 110.402 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 2' ' ' CYS . 0.0 OUTLIER 58.3 36.81 25.86 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 112.475 -2.148 . . . . 0.0 111.815 -179.852 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 74.3 t -136.61 119.99 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 179.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.558 ' SG ' ' OG1' ' A' ' 10' ' ' THR . 0.1 OUTLIER -61.4 124.41 20.53 Favored 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 179.843 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -135.5 125.73 26.34 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -179.345 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -130.63 61.36 1.61 Allowed 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.3 -50.93 3.65 Favored Glycine 0 N--CA 1.48 1.569 0 N-CA-C 104.373 -3.491 . . . . 0.0 104.373 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.68 150.15 60.93 Favored Pre-proline 0 C--N 1.308 -1.217 0 N-CA-C 103.769 -2.678 . . . . 0.0 103.769 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -64.49 175.29 3.56 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.215 1.943 . . . . 0.0 110.503 -173.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.682 ' O ' HG21 ' A' ' 10' ' ' THR . 2.8 m -149.35 19.9 0.95 Allowed 'General case' 0 N--CA 1.497 1.875 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.914 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 62.68 -172.49 0.16 Allowed 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.061 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 . . . . . 0 N--CA 1.498 1.959 0 O-C-N 124.325 1.015 . . . . 0.0 110.561 179.999 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 73.7 p . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.493 0.663 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.482 ' SG ' ' C ' ' A' ' 20' ' ' ARG . 6.2 p -104.77 51.96 0.75 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 113.747 -1.569 . . . . 0.0 109.577 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.443 ' H ' HG23 ' A' ' 3' ' ' VAL . 9.7 t -40.67 -51.41 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.451 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -120.56 -60.18 1.69 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 103.638 -2.727 . . . . 0.0 103.638 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.2 pt -66.74 147.64 98.98 Favored Pre-proline 0 C--N 1.305 -1.345 0 CA-C-N 112.414 -2.175 . . . . 0.0 106.807 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -60.21 -179.75 0.26 Allowed 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.858 2.372 . . . . 0.0 111.104 169.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 40.8 t -65.38 -61.62 2.01 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.933 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.1 p 37.73 38.51 0.17 Allowed 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.47 ' O ' HD23 ' A' ' 12' ' ' LEU . 27.5 t -139.71 -67.44 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-N 112.945 -1.934 . . . . 0.0 106.513 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.661 HG21 ' O ' ' A' ' 28' ' ' CYS . 25.6 p -94.36 -5.1 47.27 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 124.222 0.951 . . . . 0.0 109.087 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.34 -18.8 30.2 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.812 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.47 HD23 ' O ' ' A' ' 9' ' ' VAL . 3.0 pp -54.91 -36.4 65.16 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -89.44 -11.79 42.08 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 123.831 0.707 . . . . 0.0 110.934 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.85 21.46 3.21 Favored Glycine 0 N--CA 1.496 2.641 0 O-C-N 124.417 1.073 . . . . 0.0 112.443 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -83.36 84.92 7.33 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 123.194 1.474 . . . . 0.0 112.348 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.8 m -65.46 127.37 31.53 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 111.777 -2.465 . . . . 0.0 111.339 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 39.6 t -63.32 87.37 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 124.113 0.883 . . . . 0.0 113.162 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.9 m -99.59 131.02 45.86 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.3 p30 47.22 43.55 14.82 Favored 'General case' 0 N--CA 1.504 2.248 0 CA-C-O 122.861 1.315 . . . . 0.0 110.624 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.482 ' C ' ' SG ' ' A' ' 2' ' ' CYS . 5.7 mtm-85 55.29 33.23 20.26 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 112.248 -2.251 . . . . 0.0 113.155 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.1 t -136.35 130.4 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 CA-C-N 113.059 -1.882 . . . . 0.0 107.244 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 74.2 m -59.5 125.15 22.47 Favored 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -135.88 125.39 25.12 Favored 'General case' 0 N--CA 1.503 2.205 0 N-CA-C 117.632 2.456 . . . . 0.0 117.632 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.41 ' C ' ' H ' ' A' ' 26' ' ' ILE . 0.4 OUTLIER -132.9 55.96 1.87 Allowed 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 179.678 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.13 -48.38 3.19 Favored Glycine 0 N--CA 1.482 1.75 0 N-CA-C 104.522 -3.431 . . . . 0.0 104.522 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.41 ' H ' ' C ' ' A' ' 24' ' ' ASN . 1.5 pt -127.41 144.42 50.76 Favored Pre-proline 0 C--N 1.308 -1.233 0 N-CA-C 103.365 -2.828 . . . . 0.0 103.365 179.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -65.28 176.3 3.38 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.196 1.931 . . . . 0.0 111.732 -174.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.661 ' O ' HG21 ' A' ' 10' ' ' THR . 2.9 m -146.13 27.04 1.18 Allowed 'General case' 0 N--CA 1.5 2.052 0 CA-C-N 114.671 -1.15 . . . . 0.0 108.185 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 63.35 -176.36 0.15 Allowed 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.539 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 . . . . . 0 N--CA 1.5 2.036 0 O-C-N 124.081 0.863 . . . . 0.0 110.106 -179.992 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 21.0 m . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.952 0.882 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.49 ' SG ' ' N ' ' A' ' 21' ' ' VAL . 0.2 OUTLIER -104.55 42.9 1.15 Allowed 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 112.986 -1.916 . . . . 0.0 110.388 179.983 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.424 HG23 ' H ' ' A' ' 3' ' ' VAL . 15.4 t -33.46 -50.41 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.429 0 CA-C-N 113.256 -1.793 . . . . 0.0 113.555 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -123.41 -58.19 1.62 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 104.756 -2.313 . . . . 0.0 104.756 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -61.2 133.41 92.81 Favored Pre-proline 0 C--N 1.306 -1.311 0 CA-C-N 112.587 -2.097 . . . . 0.0 109.009 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -41.48 -46.24 5.99 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 123.472 2.781 . . . . 0.0 112.427 173.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.424 ' SG ' ' OG1' ' A' ' 10' ' ' THR . 52.9 t 179.11 -57.08 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 O-C-N 124.409 1.068 . . . . 0.0 108.542 179.269 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 71.4 p 38.16 34.63 0.07 Allowed 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 115.961 1.837 . . . . 0.0 115.961 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 50.3 t -144.56 -62.52 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-N 113.621 -1.627 . . . . 0.0 108.707 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.677 HG21 ' O ' ' A' ' 28' ' ' CYS . 15.8 p -98.29 0.56 45.84 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 124.22 0.95 . . . . 0.0 110.514 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.13 -17.37 39.79 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.928 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 48.1 mt -54.92 -44.24 74.05 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 114.448 -1.251 . . . . 0.0 111.52 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.45 2.55 54.36 Favored 'General case' 0 C--N 1.31 -1.139 0 O-C-N 124.174 0.922 . . . . 0.0 111.886 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.34 33.76 7.45 Favored Glycine 0 N--CA 1.494 2.558 0 CA-C-N 115.023 -0.989 . . . . 0.0 112.736 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 2.1 t -80.65 93.31 6.12 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 122.392 1.092 . . . . 0.0 111.449 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 23' ' ' TYR . 67.7 m -73.24 118.07 15.75 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 113.128 -1.851 . . . . 0.0 109.261 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.458 ' SG ' ' HA ' ' A' ' 20' ' ' ARG . 49.3 t -66.45 148.41 51.92 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 60.9 p -150.2 136.62 18.91 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 104.123 -2.547 . . . . 0.0 104.123 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.9 p30 46.53 39.76 7.26 Favored 'General case' 0 N--CA 1.504 2.266 0 CA-C-O 122.652 1.215 . . . . 0.0 110.933 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.458 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 5.0 mtm-85 55.46 39.04 31.05 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 112.624 -2.08 . . . . 0.0 112.501 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.49 ' N ' ' SG ' ' A' ' 2' ' ' CYS . 55.0 t -136.2 116.79 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 59.2 m -51.86 133.45 31.97 Favored 'General case' 0 N--CA 1.512 2.63 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.402 ' O ' ' N ' ' A' ' 16' ' ' SER . 0.2 OUTLIER -135.75 131.56 35.7 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 117.038 2.236 . . . . 0.0 117.038 -179.291 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.446 ' C ' ' H ' ' A' ' 26' ' ' ILE . 0.2 OUTLIER -138.13 62.06 1.58 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 105.553 -2.018 . . . . 0.0 105.553 179.619 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.73 -39.45 3.11 Favored Glycine 0 N--CA 1.485 1.907 0 N-CA-C 107.322 -2.311 . . . . 0.0 107.322 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.446 ' H ' ' C ' ' A' ' 24' ' ' ASN . 2.5 tt -147.44 147.44 28.13 Favored Pre-proline 0 N--CA 1.487 1.408 0 N-CA-C 101.942 -3.355 . . . . 0.0 101.942 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -63.84 176.26 2.49 Favored 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 121.792 1.661 . . . . 0.0 111.63 -168.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.677 ' O ' HG21 ' A' ' 10' ' ' THR . 3.4 m -136.54 21.3 3.13 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 114.436 -1.256 . . . . 0.0 109.045 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 28' ' ' CYS . . . 69.33 174.08 0.29 Allowed 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.254 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 . . . . . 0 N--CA 1.501 2.078 0 O-C-N 124.405 1.066 . . . . 0.0 110.176 -179.854 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 10.7 m . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.9 p -104.68 57.29 0.7 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 114.242 -1.345 . . . . 0.0 109.853 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.404 HG13 ' NH2' ' A' ' 20' ' ' ARG . 54.4 t -34.45 -66.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.387 0 CA-C-N 113.4 -1.727 . . . . 0.0 115.093 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -116.86 -52.95 2.52 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 103.065 -2.939 . . . . 0.0 103.065 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.2 pt -72.23 133.97 83.06 Favored Pre-proline 0 C--N 1.304 -1.395 0 CA-C-N 112.24 -2.255 . . . . 0.0 106.675 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -56.17 179.91 0.09 OUTLIER 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.884 2.389 . . . . 0.0 111.479 173.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.48 ' SG ' ' OG1' ' A' ' 10' ' ' THR . 42.1 t -68.53 -58.08 4.84 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 114.521 -1.218 . . . . 0.0 111.037 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.4 p 36.19 41.29 0.13 Allowed 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 115.759 1.762 . . . . 0.0 115.759 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.5 t -146.97 -67.0 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-N 113.076 -1.875 . . . . 0.0 106.644 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.48 ' OG1' ' SG ' ' A' ' 7' ' ' CYS . 36.6 p -84.49 -11.19 56.61 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.1 -18.6 36.94 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.231 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 88.2 mt -55.0 -37.7 66.92 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.108 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -89.37 -11.48 43.12 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 123.909 0.755 . . . . 0.0 110.931 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 123.06 17.72 3.29 Favored Glycine 0 N--CA 1.497 2.743 0 O-C-N 124.27 0.981 . . . . 0.0 113.138 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.75 88.99 6.73 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 122.993 1.378 . . . . 0.0 113.071 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.6 m -70.61 126.92 30.97 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 112.409 -2.178 . . . . 0.0 110.301 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.7 t -62.28 89.89 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 124.133 0.895 . . . . 0.0 112.689 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.7 t -105.69 134.57 48.59 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.7 p30 47.78 42.72 16.17 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 124.762 1.289 . . . . 0.0 111.251 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.404 ' NH2' HG13 ' A' ' 3' ' ' VAL . 10.7 mtp180 56.86 30.91 18.69 Favored 'General case' 0 N--CA 1.502 2.169 0 CA-C-N 112.58 -2.1 . . . . 0.0 112.948 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 53.7 t -136.29 136.31 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 CA-C-N 113.159 -1.837 . . . . 0.0 108.166 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 84.4 m -62.78 126.98 29.15 Favored 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 105.785 -1.932 . . . . 0.0 105.785 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.82 117.25 14.72 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 118.414 2.746 . . . . 0.0 118.414 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.455 ' C ' ' H ' ' A' ' 26' ' ' ILE . 0.4 OUTLIER -121.96 55.97 1.1 Allowed 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 179.588 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.0 -37.24 3.28 Favored Glycine 0 N--CA 1.484 1.842 0 N-CA-C 107.16 -2.376 . . . . 0.0 107.16 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.455 ' H ' ' C ' ' A' ' 24' ' ' ASN . 4.5 tt -146.06 142.21 17.46 Favored Pre-proline 0 N--CA 1.487 1.408 0 N-CA-C 102.294 -3.225 . . . . 0.0 102.294 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -65.67 174.98 4.79 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.084 1.856 . . . . 0.0 112.749 -166.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.2 m -140.26 28.12 2.08 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 113.899 -1.5 . . . . 0.0 107.723 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 66.26 -178.49 0.2 Allowed 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.319 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 . . . . . 0 N--CA 1.501 2.096 0 O-C-N 124.439 1.087 . . . . 0.0 112.189 -179.988 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 52.2 p . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 121.553 0.692 . . . . 0.0 110.5 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.471 ' HB3' ' O ' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -104.79 38.6 1.87 Allowed 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 113.764 -1.562 . . . . 0.0 111.046 -179.954 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.464 ' H ' HG23 ' A' ' 3' ' ' VAL . 12.1 t -23.87 -53.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.527 0 CA-C-N 113.146 -1.843 . . . . 0.0 115.571 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -122.74 -37.48 2.75 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.442 ' CG1' ' HA ' ' A' ' 2' ' ' CYS . 14.9 pt -72.0 178.47 1.31 Allowed Pre-proline 0 CA--C 1.561 1.379 0 CA-C-N 112.789 -2.005 . . . . 0.0 111.188 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.471 ' O ' ' HB3' ' A' ' 2' ' ' CYS . 13.2 Cg_endo -82.03 -52.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 124.106 3.204 . . . . 0.0 110.766 168.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.558 ' HB3' ' HB2' ' A' ' 11' ' ' ALA . 51.9 t 179.04 -59.4 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 124.188 0.93 . . . . 0.0 109.334 179.248 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.2 p 40.38 38.12 0.52 Allowed 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 115.008 1.485 . . . . 0.0 115.008 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.467 HG12 HG23 ' A' ' 10' ' ' THR . 42.1 t -144.29 -63.68 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-N 113.27 -1.786 . . . . 0.0 108.362 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.638 HG21 ' O ' ' A' ' 28' ' ' CYS . 26.1 p -100.42 -14.25 18.39 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 124.102 0.876 . . . . 0.0 110.797 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.558 ' HB2' ' HB3' ' A' ' 7' ' ' CYS . . . -50.81 -20.08 1.17 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 123.743 0.652 . . . . 0.0 112.37 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 35.2 mt -54.19 -45.07 72.08 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 124.297 0.998 . . . . 0.0 112.271 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.623 HD11 ' SG ' ' A' ' 15' ' ' CYS . 0.7 OUTLIER -89.58 13.86 12.98 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 124.182 0.926 . . . . 0.0 112.361 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.68 29.44 16.09 Favored Glycine 0 N--CA 1.495 2.6 0 CA-C-N 115.046 -0.979 . . . . 0.0 113.267 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.623 ' SG ' HD11 ' A' ' 13' ' ' LEU . 78.6 m -81.3 80.11 7.78 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.67 1.224 . . . . 0.0 110.013 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.8 m -66.52 117.48 8.78 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 112.392 -2.185 . . . . 0.0 110.407 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.629 ' SG ' ' HA ' ' A' ' 20' ' ' ARG . 48.6 t -63.23 144.43 56.94 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 114.567 -1.197 . . . . 0.0 113.993 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.5 m -147.3 130.15 16.18 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 103.443 -2.799 . . . . 0.0 103.443 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.2 p30 45.6 41.59 7.22 Favored 'General case' 0 N--CA 1.506 2.335 0 CA-C-O 122.769 1.271 . . . . 0.0 110.154 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.629 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 0.2 OUTLIER 56.3 41.33 29.28 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 112.346 -2.206 . . . . 0.0 112.741 -179.878 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 78.9 t -136.07 111.84 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 105.685 -1.968 . . . . 0.0 105.685 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 59.5 m -52.44 127.46 22.52 Favored 'General case' 0 N--CA 1.507 2.389 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -135.58 113.67 11.29 Favored 'General case' 0 N--CA 1.509 2.487 0 N-CA-C 117.293 2.331 . . . . 0.0 117.293 -179.251 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.474 ' C ' ' H ' ' A' ' 26' ' ' ILE . 1.6 t-20 -106.26 54.47 0.69 Allowed 'General case' 0 N--CA 1.506 2.348 0 N-CA-C 103.948 -2.612 . . . . 0.0 103.948 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.84 -43.07 2.96 Favored Glycine 0 N--CA 1.482 1.741 0 N-CA-C 104.77 -3.332 . . . . 0.0 104.77 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.474 ' H ' ' C ' ' A' ' 24' ' ' ASN . 2.6 pt -125.08 150.53 67.0 Favored Pre-proline 0 C--N 1.308 -1.204 0 N-CA-C 102.917 -2.994 . . . . 0.0 102.917 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -64.12 174.87 3.62 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 121.827 1.685 . . . . 0.0 110.632 -171.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.638 ' O ' HG21 ' A' ' 10' ' ' THR . 5.3 m -148.53 20.4 1.05 Allowed 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 114.614 -1.175 . . . . 0.0 108.701 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 62.46 -172.53 0.16 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.052 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 . . . . . 0 N--CA 1.5 2.046 0 O-C-N 124.277 0.986 . . . . 0.0 110.958 -179.919 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 73.3 m . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.74 0.781 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.518 ' SG ' ' C ' ' A' ' 20' ' ' ARG . 1.4 p -103.98 47.17 0.89 Allowed 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 113.266 -1.788 . . . . 0.0 109.382 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.41 ' HA ' ' HG2' ' A' ' 20' ' ' ARG . 24.0 t -47.55 -46.3 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 CA-C-N 113.937 -1.483 . . . . 0.0 113.059 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -118.52 -55.66 2.19 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 104.789 -2.3 . . . . 0.0 104.789 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.4 ' O ' ' HB2' ' A' ' 2' ' ' CYS . 0.4 OUTLIER -61.86 150.81 81.57 Favored Pre-proline 0 C--N 1.307 -1.255 0 CA-C-N 113.192 -1.822 . . . . 0.0 108.424 179.635 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -58.94 -48.43 14.48 Favored 'Trans proline' 0 N--CA 1.492 1.441 0 C-N-CA 123.343 2.695 . . . . 0.0 112.891 169.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.419 ' SG ' ' N ' ' A' ' 11' ' ' ALA . 42.0 t 179.49 -62.63 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 60.3 p 40.32 32.52 0.13 Allowed 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 55.3 t -148.06 -44.79 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-N 113.766 -1.561 . . . . 0.0 110.614 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.704 HG21 ' O ' ' A' ' 28' ' ' CYS . 2.6 p -118.01 -3.1 11.16 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 124.316 1.01 . . . . 0.0 112.83 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.419 ' N ' ' SG ' ' A' ' 7' ' ' CYS . . . -63.22 -20.14 65.16 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.115 0.483 . . . . 0.0 110.259 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.446 ' H ' HD12 ' A' ' 12' ' ' LEU . 3.4 mp -55.74 -38.17 69.45 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-N 114.4 -1.273 . . . . 0.0 113.624 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.32 -4.24 58.18 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 123.903 0.752 . . . . 0.0 112.217 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.65 18.46 10.12 Favored Glycine 0 N--CA 1.497 2.706 0 O-C-N 124.221 0.95 . . . . 0.0 112.556 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.715 ' HB3' ' SG ' ' A' ' 22' ' ' CYS . 2.0 t -75.56 119.87 20.2 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 122.063 0.935 . . . . 0.0 110.088 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.5 m -95.38 118.18 31.67 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 112.914 -1.948 . . . . 0.0 112.419 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.612 ' SG ' ' HA ' ' A' ' 20' ' ' ARG . 42.7 t -62.03 106.01 0.66 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 115.273 1.583 . . . . 0.0 115.273 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.9 m -113.58 133.48 55.25 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 103.934 -2.617 . . . . 0.0 103.934 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.0 p30 46.37 42.12 10.13 Favored 'General case' 0 N--CA 1.506 2.372 0 CA-C-O 122.741 1.258 . . . . 0.0 110.73 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.612 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 0.2 OUTLIER 54.75 38.0 29.37 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 112.341 -2.208 . . . . 0.0 113.354 -179.893 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.478 ' N ' ' SG ' ' A' ' 2' ' ' CYS . 54.4 t -136.4 117.7 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.715 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 0.5 OUTLIER -55.79 129.94 41.4 Favored 'General case' 0 N--CA 1.509 2.493 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 179.893 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.74 105.98 6.36 Favored 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 116.938 2.199 . . . . 0.0 116.938 -178.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.436 ' C ' ' H ' ' A' ' 26' ' ' ILE . 0.3 OUTLIER -96.94 56.11 1.39 Allowed 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 179.599 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.93 -43.44 3.07 Favored Glycine 0 N--CA 1.484 1.867 0 N-CA-C 106.088 -2.805 . . . . 0.0 106.088 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.436 ' H ' ' C ' ' A' ' 24' ' ' ASN . 3.9 tt -131.37 147.07 64.69 Favored Pre-proline 0 N--CA 1.488 1.474 0 N-CA-C 101.442 -3.54 . . . . 0.0 101.442 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -64.84 174.46 4.62 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 C-N-CA 121.936 1.757 . . . . 0.0 111.429 -166.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.704 ' O ' HG21 ' A' ' 10' ' ' THR . 1.9 m -145.66 21.0 1.49 Allowed 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 114.286 -1.325 . . . . 0.0 108.952 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 66.94 -176.95 0.2 Allowed 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.731 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 . . . . . 0 N--CA 1.499 2.015 0 O-C-N 124.423 1.077 . . . . 0.0 110.98 -179.924 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 51.8 m . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 121.545 0.688 . . . . 0.0 112.266 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.466 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 1.8 m -104.85 36.11 2.55 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 113.422 -1.717 . . . . 0.0 110.268 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.421 HG23 ' H ' ' A' ' 3' ' ' VAL . 18.9 t -24.77 -55.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.667 0 N-CA-C 114.968 1.469 . . . . 0.0 114.968 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -126.54 -55.19 1.43 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 103.491 -2.781 . . . . 0.0 103.491 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.5 pt -71.02 158.18 88.73 Favored Pre-proline 0 C--N 1.307 -1.269 0 CA-C-N 112.667 -2.061 . . . . 0.0 108.35 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -55.19 -174.88 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 123.115 2.543 . . . . 0.0 112.216 162.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.478 ' C ' ' HG1' ' A' ' 8' ' ' THR . 48.4 t -77.68 -52.15 9.43 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.211 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.478 ' HG1' ' C ' ' A' ' 7' ' ' CYS . 59.5 p 45.83 33.36 1.52 Allowed 'General case' 0 N--CA 1.507 2.385 0 O-C-N 125.046 1.466 . . . . 0.0 114.085 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 56.0 t -141.29 -40.34 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 113.438 -1.71 . . . . 0.0 110.291 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.615 HG21 ' O ' ' A' ' 28' ' ' CYS . 72.4 p -124.19 -17.92 6.02 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 124.031 0.832 . . . . 0.0 110.723 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.75 -23.65 2.86 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 123.782 0.676 . . . . 0.0 111.918 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.514 ' H ' HD12 ' A' ' 12' ' ' LEU . 4.2 mp -51.93 -42.67 63.0 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 114.561 -1.2 . . . . 0.0 112.593 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.594 HD12 HD22 ' A' ' 24' ' ' ASN . 0.7 OUTLIER -89.4 -6.61 56.42 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -179.873 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 118.51 20.54 4.24 Favored Glycine 0 N--CA 1.499 2.891 0 O-C-N 123.998 0.811 . . . . 0.0 113.221 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.4 ' SG ' ' HB ' ' A' ' 10' ' ' THR . 83.1 m -81.29 75.56 8.25 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 122.745 1.26 . . . . 0.0 110.972 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.5 m -57.19 124.04 17.41 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 112.217 -2.265 . . . . 0.0 111.481 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.423 ' SG ' ' HB2' ' A' ' 7' ' ' CYS . 48.3 m -62.47 85.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 124.544 1.152 . . . . 0.0 113.562 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.5 m -94.04 125.56 38.74 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.8 p30 46.75 43.4 12.96 Favored 'General case' 0 N--CA 1.503 2.221 0 CA-C-O 122.566 1.174 . . . . 0.0 110.708 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 2' ' ' CYS . 2.7 mtm-85 56.81 36.18 27.33 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-N 112.409 -2.178 . . . . 0.0 111.843 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 63.7 t -136.11 122.1 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.457 ' SG ' ' HB3' ' A' ' 30' ' ' GLU . 3.5 m -57.48 122.08 11.8 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.52 124.09 23.61 Favored 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 116.384 1.994 . . . . 0.0 116.384 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.594 HD22 HD12 ' A' ' 13' ' ' LEU . 42.5 t-20 -127.9 59.51 1.47 Allowed 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 104.776 -2.305 . . . . 0.0 104.776 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.51 -39.91 3.1 Favored Glycine 0 N--CA 1.482 1.752 0 N-CA-C 106.716 -2.554 . . . . 0.0 106.716 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.421 ' H ' ' C ' ' A' ' 24' ' ' ASN . 2.0 tt -139.37 146.28 47.85 Favored Pre-proline 0 N--CA 1.489 1.521 0 N-CA-C 102.749 -3.056 . . . . 0.0 102.749 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -64.5 172.87 6.05 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 121.898 1.732 . . . . 0.0 111.128 -168.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.615 ' O ' HG21 ' A' ' 10' ' ' THR . 3.5 m -141.68 23.21 2.12 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 113.773 -1.558 . . . . 0.0 108.057 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 63.68 -176.16 0.16 Allowed 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.017 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.457 ' HB3' ' SG ' ' A' ' 22' ' ' CYS . 12.0 tp10 . . . . . 0 N--CA 1.503 2.21 0 O-C-N 124.095 0.872 . . . . 0.0 110.144 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.496 1.851 0 CA-C-O 121.862 0.839 . . . . 0.0 112.133 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.444 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 0.8 OUTLIER -104.72 39.54 1.67 Allowed 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 113.093 -1.867 . . . . 0.0 110.523 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.416 HG23 ' H ' ' A' ' 3' ' ' VAL . 19.8 t -26.59 -54.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.687 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -125.51 -58.05 1.44 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 103.297 -2.853 . . . . 0.0 103.297 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.5 pt -69.02 156.52 91.37 Favored Pre-proline 0 C--N 1.305 -1.354 0 CA-C-N 112.403 -2.18 . . . . 0.0 108.369 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -58.81 -177.09 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 123.014 2.476 . . . . 0.0 111.262 161.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.466 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 12.7 t -79.03 -43.39 24.36 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.13 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.4 p 39.13 42.15 0.69 Allowed 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.1 t -149.41 -66.26 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 CA-C-N 112.654 -2.066 . . . . 0.0 107.002 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 71.9 p -77.67 -5.2 49.63 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.379 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.31 -19.84 6.11 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.604 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 36.1 mt -53.34 -42.59 66.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 124.274 0.984 . . . . 0.0 111.442 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.66 HD12 HD22 ' A' ' 24' ' ' ASN . 1.0 OUTLIER -89.49 -9.57 49.53 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 124.286 0.991 . . . . 0.0 111.436 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.97 35.41 5.58 Favored Glycine 0 N--CA 1.492 2.371 0 O-C-N 124.317 1.011 . . . . 0.0 110.781 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.521 ' SG ' ' C ' ' A' ' 22' ' ' CYS . 0.9 OUTLIER -75.78 90.1 2.88 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 122.992 1.377 . . . . 0.0 112.02 179.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.9 m -62.45 119.6 9.46 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 112.324 -2.217 . . . . 0.0 111.293 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.466 ' SG ' ' HB2' ' A' ' 7' ' ' CYS . 36.9 m -63.7 85.21 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 114.634 -1.166 . . . . 0.0 113.974 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.8 m -90.96 126.35 36.05 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.1 p30 46.42 44.62 13.09 Favored 'General case' 0 N--CA 1.505 2.305 0 CA-C-O 122.732 1.253 . . . . 0.0 110.72 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' A' ' 2' ' ' CYS . 7.1 mtm180 56.7 36.7 28.05 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 112.33 -2.214 . . . . 0.0 112.291 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.5 t -136.03 121.81 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.521 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 3.2 m -57.2 118.92 5.55 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.67 137.36 41.72 Favored 'General case' 0 N--CA 1.506 2.36 0 N-CA-C 118.023 2.601 . . . . 0.0 118.023 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.66 HD22 HD12 ' A' ' 13' ' ' LEU . 43.6 t-20 -150.21 61.95 0.97 Allowed 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.41 -50.97 3.62 Favored Glycine 0 N--CA 1.481 1.637 0 N-CA-C 104.966 -3.254 . . . . 0.0 104.966 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.3 pt -125.09 146.4 53.61 Favored Pre-proline 0 C--N 1.308 -1.228 0 N-CA-C 103.853 -2.647 . . . . 0.0 103.853 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -67.25 177.74 3.57 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 122.372 2.048 . . . . 0.0 110.646 -177.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.491 ' SG ' HD11 ' A' ' 13' ' ' LEU . 2.9 m -144.78 25.53 1.45 Allowed 'General case' 0 N--CA 1.501 2.082 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.226 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 65.97 171.78 0.23 Allowed 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.93 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.5 2.067 0 O-C-N 124.426 1.079 . . . . 0.0 110.937 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 77.4 p . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 121.235 0.541 . . . . 0.0 110.829 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.473 ' SG ' ' C ' ' A' ' 20' ' ' ARG . 0.5 OUTLIER -104.8 36.37 2.46 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 114.138 -1.392 . . . . 0.0 111.355 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.443 ' HA ' ' NE ' ' A' ' 20' ' ' ARG . 54.2 t -22.55 -61.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.567 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -120.63 -25.94 5.41 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 113.41 -1.723 . . . . 0.0 107.654 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.457 ' CG1' ' HA ' ' A' ' 2' ' ' CYS . 2.2 pt -80.83 -175.86 0.68 Allowed Pre-proline 0 CA--C 1.562 1.442 0 CA-C-N 113.144 -1.844 . . . . 0.0 110.542 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.414 ' CD ' ' HB ' ' A' ' 5' ' ' ILE . 35.3 Cg_endo -87.24 -53.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.322 0 C-N-CA 124.985 3.79 . . . . 0.0 110.981 173.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.52 ' SG ' ' OG1' ' A' ' 10' ' ' THR . 45.5 t 179.34 -49.59 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 124.535 1.147 . . . . 0.0 109.689 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.5 t 36.27 26.68 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 119.621 3.193 . . . . 0.0 119.621 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.0 t -145.38 -55.15 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.635 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.52 ' OG1' ' SG ' ' A' ' 7' ' ' CYS . 41.7 p -95.82 -1.04 50.4 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 124.045 0.84 . . . . 0.0 110.241 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.25 -14.96 43.94 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.482 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.9 mt -54.8 -42.95 72.44 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 114.908 -1.042 . . . . 0.0 112.092 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.697 HD12 HD22 ' A' ' 24' ' ' ASN . 0.6 OUTLIER -89.38 -2.86 58.57 Favored 'General case' 0 C--N 1.31 -1.13 0 O-C-N 124.108 0.88 . . . . 0.0 111.381 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.3 36.8 6.12 Favored Glycine 0 N--CA 1.494 2.534 0 O-C-N 124.332 1.02 . . . . 0.0 110.808 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.3 t -83.3 90.69 7.17 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.847 1.308 . . . . 0.0 111.843 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.44 ' N ' ' O ' ' A' ' 23' ' ' TYR . 67.7 m -62.39 119.22 8.69 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 112.112 -2.313 . . . . 0.0 112.91 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.528 ' SG ' ' HA ' ' A' ' 20' ' ' ARG . 54.0 t -66.05 132.65 49.03 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 114.888 -1.051 . . . . 0.0 112.629 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.6 m -138.6 130.56 28.15 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 103.524 -2.769 . . . . 0.0 103.524 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.3 p30 46.49 43.12 11.81 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-O 122.816 1.293 . . . . 0.0 110.197 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.528 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 7.7 mtp180 55.87 37.66 29.11 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 112.223 -2.262 . . . . 0.0 112.645 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 63.0 t -135.97 111.76 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 CA-C-N 113.512 -1.676 . . . . 0.0 106.879 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.66 ' HB2' ' SG ' ' A' ' 28' ' ' CYS . 58.0 m -52.64 129.69 30.1 Favored 'General case' 0 N--CA 1.506 2.351 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.44 ' O ' ' N ' ' A' ' 16' ' ' SER . 0.2 OUTLIER -136.08 140.36 43.7 Favored 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 116.106 1.891 . . . . 0.0 116.106 -179.087 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.697 HD22 HD12 ' A' ' 13' ' ' LEU . 11.4 t-20 -145.12 57.13 1.26 Allowed 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.48 -48.82 3.39 Favored Glycine 0 N--CA 1.48 1.608 0 N-CA-C 104.377 -3.489 . . . . 0.0 104.377 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.414 ' H ' ' C ' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -126.3 145.33 52.26 Favored Pre-proline 0 C--N 1.308 -1.221 0 N-CA-C 102.82 -3.03 . . . . 0.0 102.82 179.492 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -64.87 177.45 2.34 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.243 1.962 . . . . 0.0 111.02 -175.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.66 ' SG ' ' HB2' ' A' ' 22' ' ' CYS . 2.2 p -142.1 9.17 1.89 Allowed 'General case' 0 N--CA 1.502 2.141 0 CA-C-N 114.693 -1.14 . . . . 0.0 108.486 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 28' ' ' CYS . . . 73.52 -176.04 0.16 Allowed 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 . . . . . 0 N--CA 1.502 2.166 0 O-C-N 124.047 0.842 . . . . 0.0 110.042 -179.869 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 31.6 p . . . . . 0 N--CA 1.495 1.822 0 CA-C-O 121.14 0.495 . . . . 0.0 111.055 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.43 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 1.7 m -104.75 36.34 2.46 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 114.275 -1.329 . . . . 0.0 109.726 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.416 ' H ' HG23 ' A' ' 3' ' ' VAL . 20.2 t -23.09 -57.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.616 0 O-C-N 125.106 1.504 . . . . 0.0 114.761 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -125.72 -56.97 1.47 Allowed 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 102.985 -2.969 . . . . 0.0 102.985 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.5 pt -70.02 151.79 96.02 Favored Pre-proline 0 C--N 1.306 -1.324 0 CA-C-N 112.371 -2.195 . . . . 0.0 108.798 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -59.39 -176.8 0.11 Allowed 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 123.066 2.511 . . . . 0.0 111.565 167.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.582 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 34.6 t -78.63 -53.39 7.22 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.0 p 39.05 37.29 0.21 Allowed 'General case' 0 N--CA 1.504 2.236 0 O-C-N 125.006 1.441 . . . . 0.0 114.887 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 51.1 t -141.57 -63.12 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 CA-C-N 112.77 -2.014 . . . . 0.0 106.788 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.434 ' OG1' ' SG ' ' A' ' 7' ' ' CYS . 35.6 p -92.31 -10.02 39.87 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.59 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.8 -19.13 15.54 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.912 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -52.35 -38.8 59.67 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 114.72 -1.127 . . . . 0.0 112.684 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.784 HD12 HD22 ' A' ' 24' ' ' ASN . 0.8 OUTLIER -89.53 -13.7 36.78 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 123.989 0.806 . . . . 0.0 111.374 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.36 27.75 3.26 Favored Glycine 0 N--CA 1.495 2.567 0 O-C-N 124.449 1.093 . . . . 0.0 111.178 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.459 ' SG ' ' C ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER -80.9 81.72 7.07 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 123.001 1.382 . . . . 0.0 111.819 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 38.7 m -58.02 125.03 21.39 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 112.407 -2.179 . . . . 0.0 113.397 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.582 ' SG ' ' HB2' ' A' ' 7' ' ' CYS . 35.0 m -65.66 82.77 0.06 Allowed 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.3 t -91.11 123.09 34.3 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.3 p30 45.98 47.01 12.66 Favored 'General case' 0 N--CA 1.504 2.269 0 CA-C-O 122.984 1.373 . . . . 0.0 110.409 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 2' ' ' CYS . 1.9 mtm180 56.53 36.83 28.2 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 111.907 -2.406 . . . . 0.0 112.686 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 69.2 t -136.11 118.79 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.459 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 4.3 m -58.38 123.05 14.82 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.87 133.84 38.17 Favored 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 117.064 2.246 . . . . 0.0 117.064 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.784 HD22 HD12 ' A' ' 13' ' ' LEU . 22.1 t-20 -144.17 60.71 1.35 Allowed 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.77 -32.1 4.09 Favored Glycine 0 N--CA 1.483 1.813 0 N-CA-C 107.977 -2.049 . . . . 0.0 107.977 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.449 ' H ' ' C ' ' A' ' 24' ' ' ASN . 4.3 tt -149.92 145.42 18.86 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 103.264 -2.865 . . . . 0.0 103.264 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -67.85 177.73 3.98 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.103 1.869 . . . . 0.0 111.108 -171.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.4 m -142.19 19.15 2.09 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.156 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 69.06 172.94 0.3 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 124.377 1.048 . . . . 0.0 110.335 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.501 2.114 0 O-C-N 124.444 1.09 . . . . 0.0 109.55 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 35.8 p . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.181 0.515 . . . . 0.0 111.299 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.425 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 1.6 m -104.67 36.98 2.24 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 114.162 -1.381 . . . . 0.0 109.727 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 19.6 t -25.48 -56.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.681 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -125.07 -57.31 1.52 Allowed 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 103.54 -2.763 . . . . 0.0 103.54 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.2 pt -69.53 152.96 96.14 Favored Pre-proline 0 C--N 1.306 -1.326 0 CA-C-N 112.311 -2.222 . . . . 0.0 108.675 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -59.74 -177.4 0.14 Allowed 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 123.005 2.47 . . . . 0.0 111.661 164.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.553 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 42.1 t -79.34 -50.94 10.09 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.319 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.9 p 37.21 40.99 0.2 Allowed 'General case' 0 N--CA 1.504 2.259 0 O-C-N 125.121 1.513 . . . . 0.0 115.055 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 43.6 t -145.23 -67.87 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-N 112.633 -2.076 . . . . 0.0 106.698 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.435 HG21 ' O ' ' A' ' 28' ' ' CYS . 29.3 p -85.05 -10.37 57.0 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.453 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.49 -17.8 9.45 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.32 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 33.1 mt -54.38 -38.64 66.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 124.332 1.02 . . . . 0.0 112.391 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.776 HD12 HD22 ' A' ' 24' ' ' ASN . 0.9 OUTLIER -89.44 -8.01 53.9 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 123.91 0.756 . . . . 0.0 111.283 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.22 30.21 4.24 Favored Glycine 0 N--CA 1.494 2.518 0 O-C-N 124.436 1.085 . . . . 0.0 111.33 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.469 ' SG ' ' C ' ' A' ' 22' ' ' CYS . 0.9 OUTLIER -80.98 82.33 6.99 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 122.842 1.306 . . . . 0.0 112.408 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.1 m -60.54 123.68 18.09 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 112.568 -2.106 . . . . 0.0 111.89 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.553 ' SG ' ' HB2' ' A' ' 7' ' ' CYS . 46.7 m -63.04 85.61 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.4 m -92.31 125.8 37.12 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 105.315 -2.106 . . . . 0.0 105.315 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.5 p30 46.6 45.17 14.14 Favored 'General case' 0 N--CA 1.505 2.318 0 CA-C-O 122.785 1.279 . . . . 0.0 110.743 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.425 ' HG2' ' O ' ' A' ' 2' ' ' CYS . 4.4 mtm180 56.24 37.09 28.5 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 112.244 -2.253 . . . . 0.0 112.18 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 55.7 t -136.32 121.05 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.469 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 7.2 m -56.17 122.65 12.21 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.61 136.09 40.75 Favored 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 117.485 2.402 . . . . 0.0 117.485 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.776 HD22 HD12 ' A' ' 13' ' ' LEU . 19.9 t-20 -145.95 61.15 1.25 Allowed 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 105.477 -2.045 . . . . 0.0 105.477 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.88 -32.8 3.66 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 108.052 -2.019 . . . . 0.0 108.052 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.464 ' H ' ' C ' ' A' ' 24' ' ' ASN . 3.6 tt -149.93 144.79 18.01 Favored Pre-proline 0 N--CA 1.488 1.457 0 N-CA-C 103.015 -2.957 . . . . 0.0 103.015 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -66.83 177.03 3.79 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.239 1.959 . . . . 0.0 111.646 -170.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.435 ' O ' HG21 ' A' ' 10' ' ' THR . 2.3 m -143.04 23.21 1.88 Allowed 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 114.715 -1.13 . . . . 0.0 108.863 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 69.75 174.65 0.29 Allowed 'General case' 0 N--CA 1.501 2.1 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.461 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 . . . . . 0 N--CA 1.502 2.141 0 O-C-N 124.726 1.266 . . . . 0.0 111.276 -179.923 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.8 p . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.346 0.593 . . . . 0.0 110.06 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.449 ' SG ' ' C ' ' A' ' 20' ' ' ARG . 19.4 p -104.61 57.07 0.7 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 114.013 -1.448 . . . . 0.0 107.844 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.411 HG23 ' H ' ' A' ' 3' ' ' VAL . 4.7 t -42.75 -51.57 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.403 0 N-CA-C 116.952 2.204 . . . . 0.0 116.952 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.412 ' H ' HD13 ' A' ' 5' ' ' ILE . 13.2 m-85 -122.14 -58.25 1.73 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 102.727 -3.064 . . . . 0.0 102.727 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.837 ' H ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -71.5 148.21 92.99 Favored Pre-proline 0 C--N 1.302 -1.485 0 CA-C-N 111.49 -2.595 . . . . 0.0 106.897 179.512 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -58.92 -178.81 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.899 2.399 . . . . 0.0 111.001 168.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.507 ' HB3' ' HB2' ' A' ' 11' ' ' ALA . 42.7 t -73.25 -54.43 8.42 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 114.605 -1.18 . . . . 0.0 111.704 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 68.0 p 41.78 34.45 0.42 Allowed 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 51.6 t -142.92 -65.22 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 113.468 -1.696 . . . . 0.0 106.974 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.442 ' OG1' ' SG ' ' A' ' 7' ' ' CYS . 22.7 p -86.61 -19.13 29.8 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.507 ' HB2' ' HB3' ' A' ' 7' ' ' CYS . . . -59.44 -21.26 59.76 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.357 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 92.6 mt -57.92 -34.24 69.64 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 124.444 1.09 . . . . 0.0 111.175 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.443 ' CD1' HD22 ' A' ' 24' ' ' ASN . 0.5 OUTLIER -89.51 -6.87 56.01 Favored 'General case' 0 N--CA 1.48 1.066 0 O-C-N 123.964 0.79 . . . . 0.0 111.153 179.809 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.15 12.11 6.53 Favored Glycine 0 N--CA 1.497 2.765 0 O-C-N 124.277 0.985 . . . . 0.0 113.893 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -80.74 85.12 6.14 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 123.254 1.502 . . . . 0.0 113.137 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.1 m -63.03 124.85 22.16 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 112.08 -2.327 . . . . 0.0 110.909 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 29.6 t -64.4 92.48 0.09 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 124.158 0.911 . . . . 0.0 113.142 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 27.8 p -109.66 140.22 43.77 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.3 p30 48.79 37.85 10.65 Favored 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 122.638 1.209 . . . . 0.0 111.028 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.449 ' C ' ' SG ' ' A' ' 2' ' ' CYS . 31.4 mtt180 56.48 31.92 19.78 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-N 112.8 -2.0 . . . . 0.0 112.894 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.2 t -136.2 138.34 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 CA-C-N 112.775 -2.011 . . . . 0.0 107.725 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 29.3 m -63.88 125.89 25.85 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -135.89 120.55 18.33 Favored 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 117.104 2.261 . . . . 0.0 117.104 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.443 HD22 ' CD1' ' A' ' 13' ' ' LEU . 27.7 t-20 -123.03 53.6 1.29 Allowed 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 104.056 -2.572 . . . . 0.0 104.056 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.56 -44.27 2.59 Favored Glycine 0 N--CA 1.479 1.564 0 N-CA-C 104.0 -3.64 . . . . 0.0 104.0 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.516 ' O ' HD12 ' A' ' 26' ' ' ILE . 1.1 pp -133.65 148.29 67.98 Favored Pre-proline 0 N--CA 1.482 1.161 0 N-CA-C 103.726 -2.694 . . . . 0.0 103.726 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -64.33 175.19 3.52 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.061 1.841 . . . . 0.0 112.073 -171.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.0 m -146.28 27.9 1.12 Allowed 'General case' 0 N--CA 1.5 2.045 0 CA-C-N 114.327 -1.306 . . . . 0.0 108.277 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 67.08 175.86 0.25 Allowed 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.759 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 . . . . . 0 N--CA 1.501 2.093 0 O-C-N 124.461 1.101 . . . . 0.0 111.389 -179.979 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.494 1.764 0 CA-C-O 121.576 0.703 . . . . 0.0 111.345 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.437 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 1.4 m -104.8 38.54 1.89 Allowed 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 113.442 -1.708 . . . . 0.0 109.674 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.6 t -26.21 -55.2 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.72 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -125.31 -58.14 1.45 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 103.266 -2.865 . . . . 0.0 103.266 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.2 pt -68.63 154.94 93.95 Favored Pre-proline 0 C--N 1.305 -1.331 0 CA-C-N 112.209 -2.269 . . . . 0.0 108.631 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -57.88 -174.92 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 123.075 2.517 . . . . 0.0 111.339 162.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.524 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 33.8 t -78.98 -51.09 10.1 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.47 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 68.8 p 41.24 34.8 0.35 Allowed 'General case' 0 N--CA 1.505 2.313 0 O-C-N 125.18 1.55 . . . . 0.0 114.787 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.3 t -145.58 -37.02 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-N 113.369 -1.741 . . . . 0.0 109.748 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.9 p -120.18 -15.14 8.73 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 124.493 1.121 . . . . 0.0 109.668 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.34 -19.09 7.82 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.079 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.1 pp -56.71 -34.51 67.54 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 124.05 0.844 . . . . 0.0 113.229 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.756 HD12 HD22 ' A' ' 24' ' ' ASN . 1.1 pp -89.4 -5.66 57.25 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 123.808 0.693 . . . . 0.0 111.085 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.39 28.02 4.78 Favored Glycine 0 N--CA 1.495 2.62 0 O-C-N 124.46 1.1 . . . . 0.0 111.465 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.483 ' SG ' ' C ' ' A' ' 22' ' ' CYS . 0.6 OUTLIER -83.35 81.06 8.88 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.736 1.255 . . . . 0.0 112.279 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.9 m -59.96 123.72 17.96 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 112.582 -2.099 . . . . 0.0 111.419 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.524 ' SG ' ' HB2' ' A' ' 7' ' ' CYS . 31.1 m -66.7 85.1 0.11 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 114.109 1.152 . . . . 0.0 114.109 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 96.1 p -96.15 132.86 41.13 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.6 p30 46.0 42.18 9.09 Favored 'General case' 0 N--CA 1.503 2.218 0 CA-C-O 122.663 1.221 . . . . 0.0 110.716 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' A' ' 2' ' ' CYS . 3.0 mtm-85 56.0 38.0 29.47 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-N 112.461 -2.154 . . . . 0.0 112.372 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.3 t -136.29 124.77 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.483 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 4.0 m -60.05 122.19 13.73 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.62 133.48 38.29 Favored 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 117.358 2.355 . . . . 0.0 117.358 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.756 HD22 HD12 ' A' ' 13' ' ' LEU . 32.3 t-20 -142.47 60.35 1.44 Allowed 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.73 -33.62 3.69 Favored Glycine 0 N--CA 1.484 1.844 0 N-CA-C 107.891 -2.084 . . . . 0.0 107.891 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.455 ' H ' ' C ' ' A' ' 24' ' ' ASN . 3.3 tt -149.6 144.56 17.94 Favored Pre-proline 0 N--CA 1.488 1.439 0 N-CA-C 103.168 -2.901 . . . . 0.0 103.168 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -65.99 177.45 3.0 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.266 1.978 . . . . 0.0 112.137 -169.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.7 m -141.82 25.81 1.94 Allowed 'General case' 0 N--CA 1.501 2.108 0 CA-C-N 114.821 -1.082 . . . . 0.0 109.03 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 68.96 166.97 0.27 Allowed 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 114.611 -1.177 . . . . 0.0 111.088 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 N--CA 1.501 2.111 0 O-C-N 124.464 1.102 . . . . 0.0 111.606 -179.956 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 62.1 p . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.635 0.731 . . . . 0.0 109.093 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.474 ' SG ' ' C ' ' A' ' 20' ' ' ARG . 14.6 p -104.37 60.4 0.71 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 113.559 -1.655 . . . . 0.0 107.425 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.479 ' H ' HG23 ' A' ' 3' ' ' VAL . 9.6 t -48.91 -49.0 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 CA-C-N 113.015 -1.902 . . . . 0.0 115.508 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -116.29 -51.11 2.63 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 104.841 -2.281 . . . . 0.0 104.841 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.9 pt -64.9 164.45 21.46 Favored Pre-proline 0 C--N 1.303 -1.433 0 CA-C-N 112.297 -2.229 . . . . 0.0 108.954 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -68.22 -179.96 2.55 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 123.309 2.672 . . . . 0.0 109.716 153.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.415 ' SG ' ' OG1' ' A' ' 10' ' ' THR . 43.0 t -71.89 -63.67 1.09 Allowed 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.76 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.8 p 43.2 42.85 3.67 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 115.281 1.586 . . . . 0.0 115.281 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 79.0 t -144.99 -70.43 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 105.08 -2.193 . . . . 0.0 105.08 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.663 HG21 ' O ' ' A' ' 28' ' ' CYS . 40.5 p -88.76 -7.84 55.51 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.32 -19.18 32.89 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.498 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 39.2 mt -53.82 -39.02 65.16 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 114.758 -1.11 . . . . 0.0 112.411 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.717 HD12 HD22 ' A' ' 24' ' ' ASN . 0.6 OUTLIER -89.4 -11.42 43.25 Favored 'General case' 0 N--CA 1.483 1.202 0 O-C-N 123.974 0.796 . . . . 0.0 110.944 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 124.82 15.57 3.18 Favored Glycine 0 N--CA 1.497 2.708 0 O-C-N 124.294 0.997 . . . . 0.0 113.167 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.88 90.52 5.31 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 123.276 1.513 . . . . 0.0 112.726 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 65.9 m -71.95 126.5 29.9 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 111.8 -2.454 . . . . 0.0 110.057 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.6 t -62.76 90.24 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 124.049 0.843 . . . . 0.0 112.728 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 12.2 m -104.51 137.79 41.84 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 11.1 p30 48.23 39.62 12.42 Favored 'General case' 0 N--CA 1.502 2.138 0 CA-C-O 122.696 1.236 . . . . 0.0 110.7 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.474 ' C ' ' SG ' ' A' ' 2' ' ' CYS . 30.4 mtt180 56.19 31.93 19.27 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-N 112.63 -2.077 . . . . 0.0 113.306 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 50.1 t -136.38 138.71 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-N 112.944 -1.934 . . . . 0.0 107.855 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 71.8 m -61.52 125.0 22.22 Favored 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -135.87 113.81 11.22 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 117.789 2.514 . . . . 0.0 117.789 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.717 HD22 HD12 ' A' ' 13' ' ' LEU . 38.3 t-20 -116.67 54.77 0.84 Allowed 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 104.497 -2.409 . . . . 0.0 104.497 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.62 -37.28 3.31 Favored Glycine 0 N--CA 1.482 1.711 0 N-CA-C 106.706 -2.558 . . . . 0.0 106.706 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.457 ' H ' ' C ' ' A' ' 24' ' ' ASN . 4.0 tt -144.08 143.13 21.53 Favored Pre-proline 0 N--CA 1.488 1.451 0 N-CA-C 102.412 -3.181 . . . . 0.0 102.412 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -65.11 175.63 3.76 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 122.071 1.848 . . . . 0.0 112.661 -166.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.663 ' O ' HG21 ' A' ' 10' ' ' THR . 3.1 m -144.77 30.16 1.2 Allowed 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 114.149 -1.387 . . . . 0.0 108.117 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 64.32 -177.4 0.17 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.461 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 N--CA 1.5 2.04 0 O-C-N 124.372 1.045 . . . . 0.0 110.427 179.974 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.2 p . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.271 0.557 . . . . 0.0 111.255 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.423 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 1.4 m -104.79 37.98 2.02 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 114.057 -1.429 . . . . 0.0 109.504 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.41 HG23 ' H ' ' A' ' 3' ' ' VAL . 18.1 t -25.4 -56.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.623 0 N-CA-C 115.027 1.492 . . . . 0.0 115.027 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -125.04 -56.74 1.54 Allowed 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 103.526 -2.768 . . . . 0.0 103.526 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.6 pt -70.14 153.57 95.2 Favored Pre-proline 0 C--N 1.305 -1.349 0 CA-C-N 112.284 -2.234 . . . . 0.0 108.819 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -59.41 -175.78 0.1 OUTLIER 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.892 2.395 . . . . 0.0 111.211 163.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.532 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 13.8 t -79.47 -52.19 8.37 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.125 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.0 p 40.89 36.37 0.41 Allowed 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 37.2 t -144.46 -41.01 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-N 112.845 -1.98 . . . . 0.0 107.983 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.433 ' OG1' ' SG ' ' A' ' 7' ' ' CYS . 16.0 p -116.38 -0.15 12.63 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 124.415 1.072 . . . . 0.0 108.784 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.11 -25.86 68.29 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.455 ' H ' HD23 ' A' ' 12' ' ' LEU . 1.6 pt? -56.59 -31.75 64.56 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.871 HD12 HD22 ' A' ' 24' ' ' ASN . 0.4 OUTLIER -89.55 -9.95 47.94 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 123.451 0.469 . . . . 0.0 110.569 179.843 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.89 25.32 5.7 Favored Glycine 0 N--CA 1.494 2.537 0 O-C-N 124.266 0.979 . . . . 0.0 112.236 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.448 ' SG ' ' C ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER -80.34 86.53 5.69 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.721 1.248 . . . . 0.0 111.348 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 24.0 m -64.69 122.6 17.24 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 112.679 -2.055 . . . . 0.0 111.249 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.532 ' SG ' ' HB2' ' A' ' 7' ' ' CYS . 32.8 m -63.65 84.84 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 124.506 1.129 . . . . 0.0 113.992 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.6 t -92.58 128.33 38.4 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.7 p30 46.64 44.21 13.4 Favored 'General case' 0 N--CA 1.504 2.226 0 CA-C-O 122.678 1.227 . . . . 0.0 110.811 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.423 ' HG2' ' O ' ' A' ' 2' ' ' CYS . 2.5 mtm-85 56.04 37.39 28.79 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 112.308 -2.224 . . . . 0.0 112.173 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.1 t -136.21 121.08 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.448 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 4.0 m -56.94 123.25 14.45 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.48 111.6 9.63 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 116.682 2.105 . . . . 0.0 116.682 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.871 HD22 HD12 ' A' ' 13' ' ' LEU . 45.5 t30 -110.2 53.28 0.7 Allowed 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.5 -38.67 3.19 Favored Glycine 0 N--CA 1.483 1.769 0 N-CA-C 106.282 -2.727 . . . . 0.0 106.282 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.45 ' H ' ' C ' ' A' ' 24' ' ' ASN . 3.5 tt -138.53 144.64 43.23 Favored Pre-proline 0 N--CA 1.489 1.479 0 N-CA-C 102.225 -3.25 . . . . 0.0 102.225 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -65.56 176.37 3.52 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 122.157 1.905 . . . . 0.0 111.888 -167.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.521 ' SG ' HD11 ' A' ' 13' ' ' LEU . 3.2 m -145.76 25.36 1.31 Allowed 'General case' 0 N--CA 1.501 2.122 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.116 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 66.46 173.38 0.24 Allowed 'General case' 0 N--CA 1.5 2.04 0 CA-C-N 114.746 -1.115 . . . . 0.0 110.962 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 . . . . . 0 N--CA 1.501 2.092 0 O-C-N 124.421 1.076 . . . . 0.0 111.664 -179.897 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 12.3 t . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 122.366 1.079 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.535 ' SG ' ' N ' ' A' ' 21' ' ' VAL . 0.7 OUTLIER -106.07 41.3 1.43 Allowed 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 111.975 -2.375 . . . . 0.0 110.607 -179.9 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.415 HG23 ' H ' ' A' ' 3' ' ' VAL . 20.9 t -30.92 -53.71 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.571 0 CA-C-N 113.525 -1.671 . . . . 0.0 113.196 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -124.43 -55.44 1.65 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 104.488 -2.412 . . . . 0.0 104.488 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -61.92 131.06 93.03 Favored Pre-proline 0 C--N 1.307 -1.246 0 CA-C-N 112.968 -1.924 . . . . 0.0 109.368 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -37.55 -48.01 1.88 Allowed 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 123.987 3.125 . . . . 0.0 112.752 172.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.62 ' HB3' ' HB2' ' A' ' 11' ' ' ALA . 45.5 t 179.08 -45.04 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 O-C-N 124.145 0.903 . . . . 0.0 110.023 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.9 t 36.97 24.68 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 118.56 2.8 . . . . 0.0 118.56 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.7 t -146.89 -54.1 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.589 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.495 ' OG1' ' SG ' ' A' ' 7' ' ' CYS . 16.4 p -101.72 -5.24 25.21 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 124.002 0.814 . . . . 0.0 110.956 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.62 ' HB2' ' HB3' ' A' ' 7' ' ' CYS . . . -61.59 -14.2 28.35 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.574 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -55.77 -41.79 74.55 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 114.946 -1.024 . . . . 0.0 111.816 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.62 HD12 HD22 ' A' ' 24' ' ' ASN . 0.8 OUTLIER -89.44 4.18 49.92 Favored 'General case' 0 N--CA 1.482 1.169 0 O-C-N 124.097 0.873 . . . . 0.0 111.118 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.41 34.5 7.44 Favored Glycine 0 N--CA 1.492 2.426 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.987 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.401 ' SG ' ' HB3' ' A' ' 22' ' ' CYS . 3.2 t -81.33 89.22 6.07 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 122.801 1.286 . . . . 0.0 111.8 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 23' ' ' TYR . 57.8 m -66.8 120.05 12.88 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 112.308 -2.224 . . . . 0.0 111.246 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.57 ' SG ' ' HA ' ' A' ' 20' ' ' ARG . 21.4 t -58.96 146.45 37.92 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.4 m -150.09 124.45 9.57 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 103.6 -2.741 . . . . 0.0 103.6 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.8 p30 45.64 45.25 10.88 Favored 'General case' 0 N--CA 1.505 2.305 0 CA-C-O 122.99 1.376 . . . . 0.0 110.134 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.57 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 4.4 mtm-85 55.34 38.86 30.94 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 112.052 -2.34 . . . . 0.0 112.94 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.535 ' N ' ' SG ' ' A' ' 2' ' ' CYS . 42.5 t -136.18 116.98 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.401 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 34.1 m -53.35 131.52 37.84 Favored 'General case' 0 N--CA 1.511 2.583 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.439 ' O ' ' N ' ' A' ' 16' ' ' SER . 0.2 OUTLIER -135.84 140.45 44.2 Favored 'General case' 0 N--CA 1.504 2.274 0 N-CA-C 116.423 2.009 . . . . 0.0 116.423 -179.336 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.62 HD22 HD12 ' A' ' 13' ' ' LEU . 11.8 t-20 -148.8 59.97 1.06 Allowed 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.52 -50.36 3.53 Favored Glycine 0 N--CA 1.482 1.752 0 N-CA-C 104.733 -3.347 . . . . 0.0 104.733 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.2 pt -127.59 148.72 67.86 Favored Pre-proline 0 C--N 1.306 -1.311 0 N-CA-C 102.48 -3.156 . . . . 0.0 102.48 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -65.08 175.76 3.64 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 121.978 1.785 . . . . 0.0 110.34 -176.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.409 ' O ' HG21 ' A' ' 10' ' ' THR . 2.0 m -140.69 20.67 2.34 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-N 114.854 -1.067 . . . . 0.0 108.887 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 69.31 179.1 0.25 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 124.328 1.017 . . . . 0.0 109.278 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 . . . . . 0 N--CA 1.5 2.026 0 O-C-N 124.353 1.033 . . . . 0.0 111.165 -179.941 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 17.0 m . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.564 0.697 . . . . 0.0 111.689 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.522 ' SG ' ' HB2' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -104.67 34.53 3.1 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 113.769 -1.559 . . . . 0.0 110.143 -179.936 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.467 ' H ' HG23 ' A' ' 3' ' ' VAL . 42.1 t -27.54 -53.69 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.754 0 O-C-N 125.023 1.452 . . . . 0.0 113.089 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -125.7 -55.57 1.51 Allowed 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 104.387 -2.449 . . . . 0.0 104.387 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.5 pt -67.68 165.68 28.72 Favored Pre-proline 0 C--N 1.306 -1.302 0 CA-C-N 113.247 -1.797 . . . . 0.0 108.9 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -58.4 -178.37 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 123.043 2.495 . . . . 0.0 111.42 154.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.522 ' HB2' ' SG ' ' A' ' 2' ' ' CYS . 0.6 OUTLIER -88.96 -52.24 5.19 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 114.371 -1.286 . . . . 0.0 108.469 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 34.05 54.48 0.57 Allowed 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.5 HG12 HG23 ' A' ' 10' ' ' THR . 26.0 t -150.03 -41.26 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-N 112.849 -1.978 . . . . 0.0 107.287 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.682 HG21 ' O ' ' A' ' 28' ' ' CYS . 33.3 p -123.74 -19.4 5.77 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 114.59 -1.186 . . . . 0.0 109.033 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.45 -27.1 5.88 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.8 pp -54.86 -36.63 65.3 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.678 HD12 HD22 ' A' ' 24' ' ' ASN . 0.7 OUTLIER -89.59 -5.07 57.52 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -179.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.62 14.76 5.16 Favored Glycine 0 N--CA 1.5 2.923 0 O-C-N 124.066 0.853 . . . . 0.0 112.6 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.495 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 74.1 m -80.59 87.43 5.76 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 123.95 1.833 . . . . 0.0 109.606 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.0 m -67.19 125.51 26.26 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 111.566 -2.561 . . . . 0.0 112.106 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.4 m -66.41 82.4 0.09 Allowed 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 122.187 0.994 . . . . 0.0 111.796 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.3 m -93.6 123.82 37.18 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.3 p30 47.06 42.37 12.65 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 124.548 1.155 . . . . 0.0 110.402 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 2' ' ' CYS . 0.0 OUTLIER 58.3 36.81 25.86 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 112.475 -2.148 . . . . 0.0 111.815 -179.852 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 74.3 t -136.61 119.99 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 179.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.558 ' SG ' ' OG1' ' A' ' 10' ' ' THR . 0.1 OUTLIER -61.4 124.41 20.53 Favored 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 179.843 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -135.5 125.73 26.34 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -179.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.678 HD22 HD12 ' A' ' 13' ' ' LEU . 45.7 t-20 -130.63 61.36 1.61 Allowed 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.3 -50.93 3.65 Favored Glycine 0 N--CA 1.48 1.569 0 N-CA-C 104.373 -3.491 . . . . 0.0 104.373 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.68 150.15 60.93 Favored Pre-proline 0 C--N 1.308 -1.217 0 N-CA-C 103.769 -2.678 . . . . 0.0 103.769 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -64.49 175.29 3.56 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.215 1.943 . . . . 0.0 110.503 -173.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.682 ' O ' HG21 ' A' ' 10' ' ' THR . 2.8 m -149.35 19.9 0.95 Allowed 'General case' 0 N--CA 1.497 1.875 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.914 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 62.68 -172.49 0.16 Allowed 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.061 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 . . . . . 0 N--CA 1.498 1.959 0 O-C-N 124.325 1.015 . . . . 0.0 110.561 179.999 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 73.7 p . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.493 0.663 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.482 ' SG ' ' C ' ' A' ' 20' ' ' ARG . 6.2 p -104.77 51.96 0.75 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 113.747 -1.569 . . . . 0.0 109.577 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.443 ' H ' HG23 ' A' ' 3' ' ' VAL . 9.7 t -40.67 -51.41 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.451 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -120.56 -60.18 1.69 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 103.638 -2.727 . . . . 0.0 103.638 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.2 pt -66.74 147.64 98.98 Favored Pre-proline 0 C--N 1.305 -1.345 0 CA-C-N 112.414 -2.175 . . . . 0.0 106.807 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -60.21 -179.75 0.26 Allowed 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.858 2.372 . . . . 0.0 111.104 169.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 40.8 t -65.38 -61.62 2.01 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.933 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.1 p 37.73 38.51 0.17 Allowed 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.47 ' O ' HD23 ' A' ' 12' ' ' LEU . 27.5 t -139.71 -67.44 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-N 112.945 -1.934 . . . . 0.0 106.513 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.661 HG21 ' O ' ' A' ' 28' ' ' CYS . 25.6 p -94.36 -5.1 47.27 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 124.222 0.951 . . . . 0.0 109.087 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.34 -18.8 30.2 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.812 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.47 HD23 ' O ' ' A' ' 9' ' ' VAL . 3.0 pp -54.91 -36.4 65.16 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.762 HD12 HD22 ' A' ' 24' ' ' ASN . 0.7 OUTLIER -89.44 -11.79 42.08 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 123.831 0.707 . . . . 0.0 110.934 179.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.85 21.46 3.21 Favored Glycine 0 N--CA 1.496 2.641 0 O-C-N 124.417 1.073 . . . . 0.0 112.443 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -83.36 84.92 7.33 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 123.194 1.474 . . . . 0.0 112.348 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.8 m -65.46 127.37 31.53 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 111.777 -2.465 . . . . 0.0 111.339 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 39.6 t -63.32 87.37 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 124.113 0.883 . . . . 0.0 113.162 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.9 m -99.59 131.02 45.86 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.3 p30 47.22 43.55 14.82 Favored 'General case' 0 N--CA 1.504 2.248 0 CA-C-O 122.861 1.315 . . . . 0.0 110.624 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.482 ' C ' ' SG ' ' A' ' 2' ' ' CYS . 5.7 mtm-85 55.29 33.23 20.26 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 112.248 -2.251 . . . . 0.0 113.155 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.1 t -136.35 130.4 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 CA-C-N 113.059 -1.882 . . . . 0.0 107.244 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 74.2 m -59.5 125.15 22.47 Favored 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -135.88 125.39 25.12 Favored 'General case' 0 N--CA 1.503 2.205 0 N-CA-C 117.632 2.456 . . . . 0.0 117.632 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.762 HD22 HD12 ' A' ' 13' ' ' LEU . 37.8 t-20 -132.9 55.96 1.87 Allowed 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.13 -48.38 3.19 Favored Glycine 0 N--CA 1.482 1.75 0 N-CA-C 104.522 -3.431 . . . . 0.0 104.522 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.41 ' H ' ' C ' ' A' ' 24' ' ' ASN . 1.5 pt -127.41 144.42 50.76 Favored Pre-proline 0 C--N 1.308 -1.233 0 N-CA-C 103.365 -2.828 . . . . 0.0 103.365 179.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -65.28 176.3 3.38 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.196 1.931 . . . . 0.0 111.732 -174.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.661 ' O ' HG21 ' A' ' 10' ' ' THR . 2.9 m -146.13 27.04 1.18 Allowed 'General case' 0 N--CA 1.5 2.052 0 CA-C-N 114.671 -1.15 . . . . 0.0 108.185 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 63.35 -176.36 0.15 Allowed 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.539 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 . . . . . 0 N--CA 1.5 2.036 0 O-C-N 124.081 0.863 . . . . 0.0 110.106 -179.992 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 21.0 m . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.952 0.882 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.49 ' SG ' ' N ' ' A' ' 21' ' ' VAL . 0.2 OUTLIER -104.55 42.9 1.15 Allowed 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 112.986 -1.916 . . . . 0.0 110.388 179.983 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.424 HG23 ' H ' ' A' ' 3' ' ' VAL . 15.4 t -33.46 -50.41 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.429 0 CA-C-N 113.256 -1.793 . . . . 0.0 113.555 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -123.41 -58.19 1.62 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 104.756 -2.313 . . . . 0.0 104.756 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -61.2 133.41 92.81 Favored Pre-proline 0 C--N 1.306 -1.311 0 CA-C-N 112.587 -2.097 . . . . 0.0 109.009 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -41.48 -46.24 5.99 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 123.472 2.781 . . . . 0.0 112.427 173.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.424 ' SG ' ' OG1' ' A' ' 10' ' ' THR . 52.9 t 179.11 -57.08 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 O-C-N 124.409 1.068 . . . . 0.0 108.542 179.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 71.4 p 38.16 34.63 0.07 Allowed 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 115.961 1.837 . . . . 0.0 115.961 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 50.3 t -144.56 -62.52 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-N 113.621 -1.627 . . . . 0.0 108.707 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.677 HG21 ' O ' ' A' ' 28' ' ' CYS . 15.8 p -98.29 0.56 45.84 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 124.22 0.95 . . . . 0.0 110.514 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.13 -17.37 39.79 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.928 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 48.1 mt -54.92 -44.24 74.05 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 114.448 -1.251 . . . . 0.0 111.52 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.579 HD12 HD22 ' A' ' 24' ' ' ASN . 0.6 OUTLIER -89.45 2.55 54.36 Favored 'General case' 0 C--N 1.31 -1.139 0 O-C-N 124.174 0.922 . . . . 0.0 111.886 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.34 33.76 7.45 Favored Glycine 0 N--CA 1.494 2.558 0 CA-C-N 115.023 -0.989 . . . . 0.0 112.736 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 2.1 t -80.65 93.31 6.12 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 122.392 1.092 . . . . 0.0 111.449 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 23' ' ' TYR . 67.7 m -73.24 118.07 15.75 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 113.128 -1.851 . . . . 0.0 109.261 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.458 ' SG ' ' HA ' ' A' ' 20' ' ' ARG . 49.3 t -66.45 148.41 51.92 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 60.9 p -150.2 136.62 18.91 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 104.123 -2.547 . . . . 0.0 104.123 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.9 p30 46.53 39.76 7.26 Favored 'General case' 0 N--CA 1.504 2.266 0 CA-C-O 122.652 1.215 . . . . 0.0 110.933 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.458 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 5.0 mtm-85 55.46 39.04 31.05 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 112.624 -2.08 . . . . 0.0 112.501 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.49 ' N ' ' SG ' ' A' ' 2' ' ' CYS . 55.0 t -136.2 116.79 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 59.2 m -51.86 133.45 31.97 Favored 'General case' 0 N--CA 1.512 2.63 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.402 ' O ' ' N ' ' A' ' 16' ' ' SER . 0.2 OUTLIER -135.75 131.56 35.7 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 117.038 2.236 . . . . 0.0 117.038 -179.291 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.579 HD22 HD12 ' A' ' 13' ' ' LEU . 11.4 t-20 -138.13 62.06 1.58 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 105.553 -2.018 . . . . 0.0 105.553 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.73 -39.45 3.11 Favored Glycine 0 N--CA 1.485 1.907 0 N-CA-C 107.322 -2.311 . . . . 0.0 107.322 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.446 ' H ' ' C ' ' A' ' 24' ' ' ASN . 2.5 tt -147.44 147.44 28.13 Favored Pre-proline 0 N--CA 1.487 1.408 0 N-CA-C 101.942 -3.355 . . . . 0.0 101.942 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -63.84 176.26 2.49 Favored 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 121.792 1.661 . . . . 0.0 111.63 -168.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.677 ' O ' HG21 ' A' ' 10' ' ' THR . 3.4 m -136.54 21.3 3.13 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 114.436 -1.256 . . . . 0.0 109.045 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 28' ' ' CYS . . . 69.33 174.08 0.29 Allowed 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.254 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 . . . . . 0 N--CA 1.501 2.078 0 O-C-N 124.405 1.066 . . . . 0.0 110.176 -179.854 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 10.7 m . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.9 p -104.68 57.29 0.7 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 114.242 -1.345 . . . . 0.0 109.853 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.404 HG13 ' NH2' ' A' ' 20' ' ' ARG . 54.4 t -34.45 -66.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.387 0 CA-C-N 113.4 -1.727 . . . . 0.0 115.093 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -116.86 -52.95 2.52 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 103.065 -2.939 . . . . 0.0 103.065 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.2 pt -72.23 133.97 83.06 Favored Pre-proline 0 C--N 1.304 -1.395 0 CA-C-N 112.24 -2.255 . . . . 0.0 106.675 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -56.17 179.91 0.09 OUTLIER 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.884 2.389 . . . . 0.0 111.479 173.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.48 ' SG ' ' OG1' ' A' ' 10' ' ' THR . 42.1 t -68.53 -58.08 4.84 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 114.521 -1.218 . . . . 0.0 111.037 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.4 p 36.19 41.29 0.13 Allowed 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 115.759 1.762 . . . . 0.0 115.759 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.5 t -146.97 -67.0 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-N 113.076 -1.875 . . . . 0.0 106.644 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.48 ' OG1' ' SG ' ' A' ' 7' ' ' CYS . 36.6 p -84.49 -11.19 56.61 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.1 -18.6 36.94 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.231 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 88.2 mt -55.0 -37.7 66.92 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.108 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.761 HD12 HD22 ' A' ' 24' ' ' ASN . 0.7 OUTLIER -89.37 -11.48 43.12 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 123.909 0.755 . . . . 0.0 110.931 179.911 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 123.06 17.72 3.29 Favored Glycine 0 N--CA 1.497 2.743 0 O-C-N 124.27 0.981 . . . . 0.0 113.138 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.75 88.99 6.73 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 122.993 1.378 . . . . 0.0 113.071 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.6 m -70.61 126.92 30.97 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 112.409 -2.178 . . . . 0.0 110.301 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.7 t -62.28 89.89 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 124.133 0.895 . . . . 0.0 112.689 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.7 t -105.69 134.57 48.59 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.7 p30 47.78 42.72 16.17 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 124.762 1.289 . . . . 0.0 111.251 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.404 ' NH2' HG13 ' A' ' 3' ' ' VAL . 10.7 mtp180 56.86 30.91 18.69 Favored 'General case' 0 N--CA 1.502 2.169 0 CA-C-N 112.58 -2.1 . . . . 0.0 112.948 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 53.7 t -136.29 136.31 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 CA-C-N 113.159 -1.837 . . . . 0.0 108.166 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 84.4 m -62.78 126.98 29.15 Favored 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 105.785 -1.932 . . . . 0.0 105.785 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.82 117.25 14.72 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 118.414 2.746 . . . . 0.0 118.414 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.761 HD22 HD12 ' A' ' 13' ' ' LEU . 41.5 t-20 -121.96 55.97 1.1 Allowed 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.0 -37.24 3.28 Favored Glycine 0 N--CA 1.484 1.842 0 N-CA-C 107.16 -2.376 . . . . 0.0 107.16 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.455 ' H ' ' C ' ' A' ' 24' ' ' ASN . 4.5 tt -146.06 142.21 17.46 Favored Pre-proline 0 N--CA 1.487 1.408 0 N-CA-C 102.294 -3.225 . . . . 0.0 102.294 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -65.67 174.98 4.79 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.084 1.856 . . . . 0.0 112.749 -166.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.2 m -140.26 28.12 2.08 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 113.899 -1.5 . . . . 0.0 107.723 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 66.26 -178.49 0.2 Allowed 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.319 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 . . . . . 0 N--CA 1.501 2.096 0 O-C-N 124.439 1.087 . . . . 0.0 112.189 -179.988 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 52.2 p . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 121.553 0.692 . . . . 0.0 110.5 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.471 ' HB3' ' O ' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -104.79 38.6 1.87 Allowed 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 113.764 -1.562 . . . . 0.0 111.046 -179.954 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.464 ' H ' HG23 ' A' ' 3' ' ' VAL . 12.1 t -23.87 -53.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.527 0 CA-C-N 113.146 -1.843 . . . . 0.0 115.571 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -122.74 -37.48 2.75 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.442 ' CG1' ' HA ' ' A' ' 2' ' ' CYS . 14.9 pt -72.0 178.47 1.31 Allowed Pre-proline 0 CA--C 1.561 1.379 0 CA-C-N 112.789 -2.005 . . . . 0.0 111.188 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.471 ' O ' ' HB3' ' A' ' 2' ' ' CYS . 13.2 Cg_endo -82.03 -52.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 124.106 3.204 . . . . 0.0 110.766 168.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.558 ' HB3' ' HB2' ' A' ' 11' ' ' ALA . 51.9 t 179.04 -59.4 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 124.188 0.93 . . . . 0.0 109.334 179.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.2 p 40.38 38.12 0.52 Allowed 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 115.008 1.485 . . . . 0.0 115.008 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.467 HG12 HG23 ' A' ' 10' ' ' THR . 42.1 t -144.29 -63.68 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-N 113.27 -1.786 . . . . 0.0 108.362 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.638 HG21 ' O ' ' A' ' 28' ' ' CYS . 26.1 p -100.42 -14.25 18.39 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 124.102 0.876 . . . . 0.0 110.797 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.558 ' HB2' ' HB3' ' A' ' 7' ' ' CYS . . . -50.81 -20.08 1.17 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 123.743 0.652 . . . . 0.0 112.37 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 35.2 mt -54.19 -45.07 72.08 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 124.297 0.998 . . . . 0.0 112.271 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.719 HD12 HD22 ' A' ' 24' ' ' ASN . 0.7 OUTLIER -89.58 13.86 12.98 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 124.182 0.926 . . . . 0.0 112.361 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.68 29.44 16.09 Favored Glycine 0 N--CA 1.495 2.6 0 CA-C-N 115.046 -0.979 . . . . 0.0 113.267 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.623 ' SG ' HD11 ' A' ' 13' ' ' LEU . 78.6 m -81.3 80.11 7.78 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.67 1.224 . . . . 0.0 110.013 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.8 m -66.52 117.48 8.78 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 112.392 -2.185 . . . . 0.0 110.407 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.629 ' SG ' ' HA ' ' A' ' 20' ' ' ARG . 48.6 t -63.23 144.43 56.94 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 114.567 -1.197 . . . . 0.0 113.993 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.5 m -147.3 130.15 16.18 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 103.443 -2.799 . . . . 0.0 103.443 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.2 p30 45.6 41.59 7.22 Favored 'General case' 0 N--CA 1.506 2.335 0 CA-C-O 122.769 1.271 . . . . 0.0 110.154 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.629 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 0.2 OUTLIER 56.3 41.33 29.28 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 112.346 -2.206 . . . . 0.0 112.741 -179.878 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 78.9 t -136.07 111.84 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 105.685 -1.968 . . . . 0.0 105.685 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 59.5 m -52.44 127.46 22.52 Favored 'General case' 0 N--CA 1.507 2.389 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -135.58 113.67 11.29 Favored 'General case' 0 N--CA 1.509 2.487 0 N-CA-C 117.293 2.331 . . . . 0.0 117.293 -179.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.719 HD22 HD12 ' A' ' 13' ' ' LEU . 52.8 t30 -106.26 54.47 0.69 Allowed 'General case' 0 N--CA 1.506 2.348 0 N-CA-C 103.948 -2.612 . . . . 0.0 103.948 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.84 -43.07 2.96 Favored Glycine 0 N--CA 1.482 1.741 0 N-CA-C 104.77 -3.332 . . . . 0.0 104.77 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.474 ' H ' ' C ' ' A' ' 24' ' ' ASN . 2.6 pt -125.08 150.53 67.0 Favored Pre-proline 0 C--N 1.308 -1.204 0 N-CA-C 102.917 -2.994 . . . . 0.0 102.917 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -64.12 174.87 3.62 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 121.827 1.685 . . . . 0.0 110.632 -171.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.638 ' O ' HG21 ' A' ' 10' ' ' THR . 5.3 m -148.53 20.4 1.05 Allowed 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 114.614 -1.175 . . . . 0.0 108.701 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 62.46 -172.53 0.16 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.052 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 . . . . . 0 N--CA 1.5 2.046 0 O-C-N 124.277 0.986 . . . . 0.0 110.958 -179.919 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 73.3 m . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.74 0.781 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.518 ' SG ' ' C ' ' A' ' 20' ' ' ARG . 1.4 p -103.98 47.17 0.89 Allowed 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 113.266 -1.788 . . . . 0.0 109.382 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.41 ' HA ' ' HG2' ' A' ' 20' ' ' ARG . 24.0 t -47.55 -46.3 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 CA-C-N 113.937 -1.483 . . . . 0.0 113.059 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -118.52 -55.66 2.19 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 104.789 -2.3 . . . . 0.0 104.789 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.4 ' O ' ' HB2' ' A' ' 2' ' ' CYS . 0.4 OUTLIER -61.86 150.81 81.57 Favored Pre-proline 0 C--N 1.307 -1.255 0 CA-C-N 113.192 -1.822 . . . . 0.0 108.424 179.635 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -58.94 -48.43 14.48 Favored 'Trans proline' 0 N--CA 1.492 1.441 0 C-N-CA 123.343 2.695 . . . . 0.0 112.891 169.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.419 ' SG ' ' N ' ' A' ' 11' ' ' ALA . 42.0 t 179.49 -62.63 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 60.3 p 40.32 32.52 0.13 Allowed 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 55.3 t -148.06 -44.79 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-N 113.766 -1.561 . . . . 0.0 110.614 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.704 HG21 ' O ' ' A' ' 28' ' ' CYS . 2.6 p -118.01 -3.1 11.16 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 124.316 1.01 . . . . 0.0 112.83 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.419 ' N ' ' SG ' ' A' ' 7' ' ' CYS . . . -63.22 -20.14 65.16 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.115 0.483 . . . . 0.0 110.259 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.446 ' H ' HD12 ' A' ' 12' ' ' LEU . 3.4 mp -55.74 -38.17 69.45 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-N 114.4 -1.273 . . . . 0.0 113.624 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.827 HD12 HD22 ' A' ' 24' ' ' ASN . 0.6 OUTLIER -89.32 -4.24 58.18 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 123.903 0.752 . . . . 0.0 112.217 -179.958 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.65 18.46 10.12 Favored Glycine 0 N--CA 1.497 2.706 0 O-C-N 124.221 0.95 . . . . 0.0 112.556 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.715 ' HB3' ' SG ' ' A' ' 22' ' ' CYS . 2.0 t -75.56 119.87 20.2 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 122.063 0.935 . . . . 0.0 110.088 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.5 m -95.38 118.18 31.67 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 112.914 -1.948 . . . . 0.0 112.419 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.612 ' SG ' ' HA ' ' A' ' 20' ' ' ARG . 42.7 t -62.03 106.01 0.66 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 115.273 1.583 . . . . 0.0 115.273 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.9 m -113.58 133.48 55.25 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 103.934 -2.617 . . . . 0.0 103.934 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.0 p30 46.37 42.12 10.13 Favored 'General case' 0 N--CA 1.506 2.372 0 CA-C-O 122.741 1.258 . . . . 0.0 110.73 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.612 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 0.2 OUTLIER 54.75 38.0 29.37 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 112.341 -2.208 . . . . 0.0 113.354 -179.893 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.478 ' N ' ' SG ' ' A' ' 2' ' ' CYS . 54.4 t -136.4 117.7 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.715 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 0.5 OUTLIER -55.79 129.94 41.4 Favored 'General case' 0 N--CA 1.509 2.493 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 179.893 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.74 105.98 6.36 Favored 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 116.938 2.199 . . . . 0.0 116.938 -178.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.827 HD22 HD12 ' A' ' 13' ' ' LEU . 25.5 t-20 -96.94 56.11 1.39 Allowed 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.93 -43.44 3.07 Favored Glycine 0 N--CA 1.484 1.867 0 N-CA-C 106.088 -2.805 . . . . 0.0 106.088 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.436 ' H ' ' C ' ' A' ' 24' ' ' ASN . 3.9 tt -131.37 147.07 64.69 Favored Pre-proline 0 N--CA 1.488 1.474 0 N-CA-C 101.442 -3.54 . . . . 0.0 101.442 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -64.84 174.46 4.62 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 C-N-CA 121.936 1.757 . . . . 0.0 111.429 -166.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.704 ' O ' HG21 ' A' ' 10' ' ' THR . 1.9 m -145.66 21.0 1.49 Allowed 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 114.286 -1.325 . . . . 0.0 108.952 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 66.94 -176.95 0.2 Allowed 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.731 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 . . . . . 0 N--CA 1.499 2.015 0 O-C-N 124.423 1.077 . . . . 0.0 110.98 -179.924 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 51.8 m . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 121.545 0.688 . . . . 0.0 112.266 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.466 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 1.8 m -104.85 36.11 2.55 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 113.422 -1.717 . . . . 0.0 110.268 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.421 HG23 ' H ' ' A' ' 3' ' ' VAL . 18.9 t -24.77 -55.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.667 0 N-CA-C 114.968 1.469 . . . . 0.0 114.968 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -126.54 -55.19 1.43 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 103.491 -2.781 . . . . 0.0 103.491 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.5 pt -71.02 158.18 88.73 Favored Pre-proline 0 C--N 1.307 -1.269 0 CA-C-N 112.667 -2.061 . . . . 0.0 108.35 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -55.19 -174.88 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 123.115 2.543 . . . . 0.0 112.216 162.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.478 ' C ' ' HG1' ' A' ' 8' ' ' THR . 48.4 t -77.68 -52.15 9.43 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.211 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.478 ' HG1' ' C ' ' A' ' 7' ' ' CYS . 59.5 p 45.83 33.36 1.52 Allowed 'General case' 0 N--CA 1.507 2.385 0 O-C-N 125.046 1.466 . . . . 0.0 114.085 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 56.0 t -141.29 -40.34 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 113.438 -1.71 . . . . 0.0 110.291 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.615 HG21 ' O ' ' A' ' 28' ' ' CYS . 72.4 p -124.19 -17.92 6.02 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 124.031 0.832 . . . . 0.0 110.723 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.75 -23.65 2.86 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 123.782 0.676 . . . . 0.0 111.918 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.514 ' H ' HD12 ' A' ' 12' ' ' LEU . 4.2 mp -51.93 -42.67 63.0 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 114.561 -1.2 . . . . 0.0 112.593 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.594 HD12 HD22 ' A' ' 24' ' ' ASN . 0.7 OUTLIER -89.4 -6.61 56.42 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -179.873 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 118.51 20.54 4.24 Favored Glycine 0 N--CA 1.499 2.891 0 O-C-N 123.998 0.811 . . . . 0.0 113.221 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.4 ' SG ' ' HB ' ' A' ' 10' ' ' THR . 83.1 m -81.29 75.56 8.25 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 122.745 1.26 . . . . 0.0 110.972 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.5 m -57.19 124.04 17.41 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 112.217 -2.265 . . . . 0.0 111.481 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.423 ' SG ' ' HB2' ' A' ' 7' ' ' CYS . 48.3 m -62.47 85.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 124.544 1.152 . . . . 0.0 113.562 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.5 m -94.04 125.56 38.74 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.8 p30 46.75 43.4 12.96 Favored 'General case' 0 N--CA 1.503 2.221 0 CA-C-O 122.566 1.174 . . . . 0.0 110.708 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 2' ' ' CYS . 2.7 mtm-85 56.81 36.18 27.33 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-N 112.409 -2.178 . . . . 0.0 111.843 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 63.7 t -136.11 122.1 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.457 ' SG ' ' HB3' ' A' ' 30' ' ' GLU . 3.5 m -57.48 122.08 11.8 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.52 124.09 23.61 Favored 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 116.384 1.994 . . . . 0.0 116.384 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.594 HD22 HD12 ' A' ' 13' ' ' LEU . 42.5 t-20 -127.9 59.51 1.47 Allowed 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 104.776 -2.305 . . . . 0.0 104.776 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.51 -39.91 3.1 Favored Glycine 0 N--CA 1.482 1.752 0 N-CA-C 106.716 -2.554 . . . . 0.0 106.716 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.421 ' H ' ' C ' ' A' ' 24' ' ' ASN . 2.0 tt -139.37 146.28 47.85 Favored Pre-proline 0 N--CA 1.489 1.521 0 N-CA-C 102.749 -3.056 . . . . 0.0 102.749 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -64.5 172.87 6.05 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 121.898 1.732 . . . . 0.0 111.128 -168.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.615 ' O ' HG21 ' A' ' 10' ' ' THR . 3.5 m -141.68 23.21 2.12 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 113.773 -1.558 . . . . 0.0 108.057 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 63.68 -176.16 0.16 Allowed 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.017 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.457 ' HB3' ' SG ' ' A' ' 22' ' ' CYS . 12.0 tp10 . . . . . 0 N--CA 1.503 2.21 0 O-C-N 124.095 0.872 . . . . 0.0 110.144 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.496 1.851 0 CA-C-O 121.862 0.839 . . . . 0.0 112.133 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.444 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 0.8 OUTLIER -104.72 39.54 1.67 Allowed 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 113.093 -1.867 . . . . 0.0 110.523 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.416 HG23 ' H ' ' A' ' 3' ' ' VAL . 19.8 t -26.59 -54.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.687 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -125.51 -58.05 1.44 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 103.297 -2.853 . . . . 0.0 103.297 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.5 pt -69.02 156.52 91.37 Favored Pre-proline 0 C--N 1.305 -1.354 0 CA-C-N 112.403 -2.18 . . . . 0.0 108.369 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -58.81 -177.09 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 123.014 2.476 . . . . 0.0 111.262 161.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.466 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 12.7 t -79.03 -43.39 24.36 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.13 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.4 p 39.13 42.15 0.69 Allowed 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.1 t -149.41 -66.26 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 CA-C-N 112.654 -2.066 . . . . 0.0 107.002 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 71.9 p -77.67 -5.2 49.63 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.379 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.31 -19.84 6.11 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.604 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 36.1 mt -53.34 -42.59 66.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 124.274 0.984 . . . . 0.0 111.442 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.66 HD12 HD22 ' A' ' 24' ' ' ASN . 1.0 OUTLIER -89.49 -9.57 49.53 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 124.286 0.991 . . . . 0.0 111.436 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.97 35.41 5.58 Favored Glycine 0 N--CA 1.492 2.371 0 O-C-N 124.317 1.011 . . . . 0.0 110.781 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.521 ' SG ' ' C ' ' A' ' 22' ' ' CYS . 0.9 OUTLIER -75.78 90.1 2.88 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 122.992 1.377 . . . . 0.0 112.02 179.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.9 m -62.45 119.6 9.46 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 112.324 -2.217 . . . . 0.0 111.293 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.466 ' SG ' ' HB2' ' A' ' 7' ' ' CYS . 36.9 m -63.7 85.21 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 114.634 -1.166 . . . . 0.0 113.974 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.8 m -90.96 126.35 36.05 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.1 p30 46.42 44.62 13.09 Favored 'General case' 0 N--CA 1.505 2.305 0 CA-C-O 122.732 1.253 . . . . 0.0 110.72 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' A' ' 2' ' ' CYS . 7.1 mtm180 56.7 36.7 28.05 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 112.33 -2.214 . . . . 0.0 112.291 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.5 t -136.03 121.81 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.521 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 3.2 m -57.2 118.92 5.55 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.67 137.36 41.72 Favored 'General case' 0 N--CA 1.506 2.36 0 N-CA-C 118.023 2.601 . . . . 0.0 118.023 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.66 HD22 HD12 ' A' ' 13' ' ' LEU . 43.6 t-20 -150.21 61.95 0.97 Allowed 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.41 -50.97 3.62 Favored Glycine 0 N--CA 1.481 1.637 0 N-CA-C 104.966 -3.254 . . . . 0.0 104.966 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.3 pt -125.09 146.4 53.61 Favored Pre-proline 0 C--N 1.308 -1.228 0 N-CA-C 103.853 -2.647 . . . . 0.0 103.853 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -67.25 177.74 3.57 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 122.372 2.048 . . . . 0.0 110.646 -177.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.491 ' SG ' HD11 ' A' ' 13' ' ' LEU . 2.9 m -144.78 25.53 1.45 Allowed 'General case' 0 N--CA 1.501 2.082 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.226 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 65.97 171.78 0.23 Allowed 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.93 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.5 2.067 0 O-C-N 124.426 1.079 . . . . 0.0 110.937 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 77.4 p . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 121.235 0.541 . . . . 0.0 110.829 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.473 ' SG ' ' C ' ' A' ' 20' ' ' ARG . 0.5 OUTLIER -104.8 36.37 2.46 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 114.138 -1.392 . . . . 0.0 111.355 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.443 ' HA ' ' NE ' ' A' ' 20' ' ' ARG . 54.2 t -22.55 -61.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.567 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -120.63 -25.94 5.41 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 113.41 -1.723 . . . . 0.0 107.654 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.457 ' CG1' ' HA ' ' A' ' 2' ' ' CYS . 2.2 pt -80.83 -175.86 0.68 Allowed Pre-proline 0 CA--C 1.562 1.442 0 CA-C-N 113.144 -1.844 . . . . 0.0 110.542 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.414 ' CD ' ' HB ' ' A' ' 5' ' ' ILE . 35.3 Cg_endo -87.24 -53.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.322 0 C-N-CA 124.985 3.79 . . . . 0.0 110.981 173.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.52 ' SG ' ' OG1' ' A' ' 10' ' ' THR . 45.5 t 179.34 -49.59 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 124.535 1.147 . . . . 0.0 109.689 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.5 t 36.27 26.68 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 119.621 3.193 . . . . 0.0 119.621 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.0 t -145.38 -55.15 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.635 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.52 ' OG1' ' SG ' ' A' ' 7' ' ' CYS . 41.7 p -95.82 -1.04 50.4 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 124.045 0.84 . . . . 0.0 110.241 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.25 -14.96 43.94 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.482 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.9 mt -54.8 -42.95 72.44 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 114.908 -1.042 . . . . 0.0 112.092 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.697 HD12 HD22 ' A' ' 24' ' ' ASN . 0.6 OUTLIER -89.38 -2.86 58.57 Favored 'General case' 0 C--N 1.31 -1.13 0 O-C-N 124.108 0.88 . . . . 0.0 111.381 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.3 36.8 6.12 Favored Glycine 0 N--CA 1.494 2.534 0 O-C-N 124.332 1.02 . . . . 0.0 110.808 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.3 t -83.3 90.69 7.17 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.847 1.308 . . . . 0.0 111.843 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.44 ' N ' ' O ' ' A' ' 23' ' ' TYR . 67.7 m -62.39 119.22 8.69 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 112.112 -2.313 . . . . 0.0 112.91 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.528 ' SG ' ' HA ' ' A' ' 20' ' ' ARG . 54.0 t -66.05 132.65 49.03 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 114.888 -1.051 . . . . 0.0 112.629 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.6 m -138.6 130.56 28.15 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 103.524 -2.769 . . . . 0.0 103.524 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.3 p30 46.49 43.12 11.81 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-O 122.816 1.293 . . . . 0.0 110.197 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.528 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 7.7 mtp180 55.87 37.66 29.11 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 112.223 -2.262 . . . . 0.0 112.645 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 63.0 t -135.97 111.76 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 CA-C-N 113.512 -1.676 . . . . 0.0 106.879 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.66 ' HB2' ' SG ' ' A' ' 28' ' ' CYS . 58.0 m -52.64 129.69 30.1 Favored 'General case' 0 N--CA 1.506 2.351 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.44 ' O ' ' N ' ' A' ' 16' ' ' SER . 0.2 OUTLIER -136.08 140.36 43.7 Favored 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 116.106 1.891 . . . . 0.0 116.106 -179.087 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.697 HD22 HD12 ' A' ' 13' ' ' LEU . 11.4 t-20 -145.12 57.13 1.26 Allowed 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.48 -48.82 3.39 Favored Glycine 0 N--CA 1.48 1.608 0 N-CA-C 104.377 -3.489 . . . . 0.0 104.377 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.414 ' H ' ' C ' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -126.3 145.33 52.26 Favored Pre-proline 0 C--N 1.308 -1.221 0 N-CA-C 102.82 -3.03 . . . . 0.0 102.82 179.492 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -64.87 177.45 2.34 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.243 1.962 . . . . 0.0 111.02 -175.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.66 ' SG ' ' HB2' ' A' ' 22' ' ' CYS . 2.2 p -142.1 9.17 1.89 Allowed 'General case' 0 N--CA 1.502 2.141 0 CA-C-N 114.693 -1.14 . . . . 0.0 108.486 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 28' ' ' CYS . . . 73.52 -176.04 0.16 Allowed 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 . . . . . 0 N--CA 1.502 2.166 0 O-C-N 124.047 0.842 . . . . 0.0 110.042 -179.869 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 31.6 p . . . . . 0 N--CA 1.495 1.822 0 CA-C-O 121.14 0.495 . . . . 0.0 111.055 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.43 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 1.7 m -104.75 36.34 2.46 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 114.275 -1.329 . . . . 0.0 109.726 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.416 ' H ' HG23 ' A' ' 3' ' ' VAL . 20.2 t -23.09 -57.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.616 0 O-C-N 125.106 1.504 . . . . 0.0 114.761 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -125.72 -56.97 1.47 Allowed 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 102.985 -2.969 . . . . 0.0 102.985 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.5 pt -70.02 151.79 96.02 Favored Pre-proline 0 C--N 1.306 -1.324 0 CA-C-N 112.371 -2.195 . . . . 0.0 108.798 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -59.39 -176.8 0.11 Allowed 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 123.066 2.511 . . . . 0.0 111.565 167.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.582 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 34.6 t -78.63 -53.39 7.22 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.0 p 39.05 37.29 0.21 Allowed 'General case' 0 N--CA 1.504 2.236 0 O-C-N 125.006 1.441 . . . . 0.0 114.887 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 51.1 t -141.57 -63.12 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 CA-C-N 112.77 -2.014 . . . . 0.0 106.788 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.434 ' OG1' ' SG ' ' A' ' 7' ' ' CYS . 35.6 p -92.31 -10.02 39.87 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.59 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.8 -19.13 15.54 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.912 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -52.35 -38.8 59.67 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 114.72 -1.127 . . . . 0.0 112.684 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.784 HD12 HD22 ' A' ' 24' ' ' ASN . 0.8 OUTLIER -89.53 -13.7 36.78 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 123.989 0.806 . . . . 0.0 111.374 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.36 27.75 3.26 Favored Glycine 0 N--CA 1.495 2.567 0 O-C-N 124.449 1.093 . . . . 0.0 111.178 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.459 ' SG ' ' C ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER -80.9 81.72 7.07 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 123.001 1.382 . . . . 0.0 111.819 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 38.7 m -58.02 125.03 21.39 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 112.407 -2.179 . . . . 0.0 113.397 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.582 ' SG ' ' HB2' ' A' ' 7' ' ' CYS . 35.0 m -65.66 82.77 0.06 Allowed 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.3 t -91.11 123.09 34.3 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.3 p30 45.98 47.01 12.66 Favored 'General case' 0 N--CA 1.504 2.269 0 CA-C-O 122.984 1.373 . . . . 0.0 110.409 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 2' ' ' CYS . 1.9 mtm180 56.53 36.83 28.2 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 111.907 -2.406 . . . . 0.0 112.686 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 69.2 t -136.11 118.79 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.459 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 4.3 m -58.38 123.05 14.82 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.87 133.84 38.17 Favored 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 117.064 2.246 . . . . 0.0 117.064 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.784 HD22 HD12 ' A' ' 13' ' ' LEU . 22.1 t-20 -144.17 60.71 1.35 Allowed 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.77 -32.1 4.09 Favored Glycine 0 N--CA 1.483 1.813 0 N-CA-C 107.977 -2.049 . . . . 0.0 107.977 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.449 ' H ' ' C ' ' A' ' 24' ' ' ASN . 4.3 tt -149.92 145.42 18.86 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 103.264 -2.865 . . . . 0.0 103.264 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -67.85 177.73 3.98 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.103 1.869 . . . . 0.0 111.108 -171.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.4 m -142.19 19.15 2.09 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.156 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 69.06 172.94 0.3 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 124.377 1.048 . . . . 0.0 110.335 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.501 2.114 0 O-C-N 124.444 1.09 . . . . 0.0 109.55 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 35.8 p . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.181 0.515 . . . . 0.0 111.299 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.425 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 1.6 m -104.67 36.98 2.24 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 114.162 -1.381 . . . . 0.0 109.727 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 19.6 t -25.48 -56.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.681 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -125.07 -57.31 1.52 Allowed 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 103.54 -2.763 . . . . 0.0 103.54 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.2 pt -69.53 152.96 96.14 Favored Pre-proline 0 C--N 1.306 -1.326 0 CA-C-N 112.311 -2.222 . . . . 0.0 108.675 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -59.74 -177.4 0.14 Allowed 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 123.005 2.47 . . . . 0.0 111.661 164.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.553 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 42.1 t -79.34 -50.94 10.09 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.319 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.9 p 37.21 40.99 0.2 Allowed 'General case' 0 N--CA 1.504 2.259 0 O-C-N 125.121 1.513 . . . . 0.0 115.055 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 43.6 t -145.23 -67.87 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-N 112.633 -2.076 . . . . 0.0 106.698 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.435 HG21 ' O ' ' A' ' 28' ' ' CYS . 29.3 p -85.05 -10.37 57.0 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.453 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.49 -17.8 9.45 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.32 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 33.1 mt -54.38 -38.64 66.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 124.332 1.02 . . . . 0.0 112.391 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.776 HD12 HD22 ' A' ' 24' ' ' ASN . 0.9 OUTLIER -89.44 -8.01 53.9 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 123.91 0.756 . . . . 0.0 111.283 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.22 30.21 4.24 Favored Glycine 0 N--CA 1.494 2.518 0 O-C-N 124.436 1.085 . . . . 0.0 111.33 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.469 ' SG ' ' C ' ' A' ' 22' ' ' CYS . 0.9 OUTLIER -80.98 82.33 6.99 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 122.842 1.306 . . . . 0.0 112.408 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.1 m -60.54 123.68 18.09 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 112.568 -2.106 . . . . 0.0 111.89 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.553 ' SG ' ' HB2' ' A' ' 7' ' ' CYS . 46.7 m -63.04 85.61 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.4 m -92.31 125.8 37.12 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 105.315 -2.106 . . . . 0.0 105.315 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.5 p30 46.6 45.17 14.14 Favored 'General case' 0 N--CA 1.505 2.318 0 CA-C-O 122.785 1.279 . . . . 0.0 110.743 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.425 ' HG2' ' O ' ' A' ' 2' ' ' CYS . 4.4 mtm180 56.24 37.09 28.5 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 112.244 -2.253 . . . . 0.0 112.18 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 55.7 t -136.32 121.05 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.469 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 7.2 m -56.17 122.65 12.21 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.61 136.09 40.75 Favored 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 117.485 2.402 . . . . 0.0 117.485 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.776 HD22 HD12 ' A' ' 13' ' ' LEU . 19.9 t-20 -145.95 61.15 1.25 Allowed 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 105.477 -2.045 . . . . 0.0 105.477 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.88 -32.8 3.66 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 108.052 -2.019 . . . . 0.0 108.052 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.464 ' H ' ' C ' ' A' ' 24' ' ' ASN . 3.6 tt -149.93 144.79 18.01 Favored Pre-proline 0 N--CA 1.488 1.457 0 N-CA-C 103.015 -2.957 . . . . 0.0 103.015 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -66.83 177.03 3.79 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.239 1.959 . . . . 0.0 111.646 -170.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.435 ' O ' HG21 ' A' ' 10' ' ' THR . 2.3 m -143.04 23.21 1.88 Allowed 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 114.715 -1.13 . . . . 0.0 108.863 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 69.75 174.65 0.29 Allowed 'General case' 0 N--CA 1.501 2.1 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.461 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 . . . . . 0 N--CA 1.502 2.141 0 O-C-N 124.726 1.266 . . . . 0.0 111.276 -179.923 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.8 p . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.346 0.593 . . . . 0.0 110.06 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.449 ' SG ' ' C ' ' A' ' 20' ' ' ARG . 19.4 p -104.61 57.07 0.7 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 114.013 -1.448 . . . . 0.0 107.844 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.411 HG23 ' H ' ' A' ' 3' ' ' VAL . 4.7 t -42.75 -51.57 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.403 0 N-CA-C 116.952 2.204 . . . . 0.0 116.952 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.412 ' H ' HD13 ' A' ' 5' ' ' ILE . 13.2 m-85 -122.14 -58.25 1.73 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 102.727 -3.064 . . . . 0.0 102.727 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.837 ' H ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -71.5 148.21 92.99 Favored Pre-proline 0 C--N 1.302 -1.485 0 CA-C-N 111.49 -2.595 . . . . 0.0 106.897 179.512 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -58.92 -178.81 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.899 2.399 . . . . 0.0 111.001 168.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.507 ' HB3' ' HB2' ' A' ' 11' ' ' ALA . 42.7 t -73.25 -54.43 8.42 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 114.605 -1.18 . . . . 0.0 111.704 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 68.0 p 41.78 34.45 0.42 Allowed 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 51.6 t -142.92 -65.22 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 113.468 -1.696 . . . . 0.0 106.974 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.442 ' OG1' ' SG ' ' A' ' 7' ' ' CYS . 22.7 p -86.61 -19.13 29.8 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.507 ' HB2' ' HB3' ' A' ' 7' ' ' CYS . . . -59.44 -21.26 59.76 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.357 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 92.6 mt -57.92 -34.24 69.64 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 124.444 1.09 . . . . 0.0 111.175 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.443 ' CD1' HD22 ' A' ' 24' ' ' ASN . 0.5 OUTLIER -89.51 -6.87 56.01 Favored 'General case' 0 N--CA 1.48 1.066 0 O-C-N 123.964 0.79 . . . . 0.0 111.153 179.809 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.15 12.11 6.53 Favored Glycine 0 N--CA 1.497 2.765 0 O-C-N 124.277 0.985 . . . . 0.0 113.893 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -80.74 85.12 6.14 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 123.254 1.502 . . . . 0.0 113.137 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.1 m -63.03 124.85 22.16 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 112.08 -2.327 . . . . 0.0 110.909 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 29.6 t -64.4 92.48 0.09 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 124.158 0.911 . . . . 0.0 113.142 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 27.8 p -109.66 140.22 43.77 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.3 p30 48.79 37.85 10.65 Favored 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 122.638 1.209 . . . . 0.0 111.028 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.449 ' C ' ' SG ' ' A' ' 2' ' ' CYS . 31.4 mtt180 56.48 31.92 19.78 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-N 112.8 -2.0 . . . . 0.0 112.894 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.2 t -136.2 138.34 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 CA-C-N 112.775 -2.011 . . . . 0.0 107.725 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 29.3 m -63.88 125.89 25.85 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -135.89 120.55 18.33 Favored 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 117.104 2.261 . . . . 0.0 117.104 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.443 HD22 ' CD1' ' A' ' 13' ' ' LEU . 27.7 t-20 -123.03 53.6 1.29 Allowed 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 104.056 -2.572 . . . . 0.0 104.056 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.56 -44.27 2.59 Favored Glycine 0 N--CA 1.479 1.564 0 N-CA-C 104.0 -3.64 . . . . 0.0 104.0 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.516 ' O ' HD12 ' A' ' 26' ' ' ILE . 1.1 pp -133.65 148.29 67.98 Favored Pre-proline 0 N--CA 1.482 1.161 0 N-CA-C 103.726 -2.694 . . . . 0.0 103.726 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -64.33 175.19 3.52 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.061 1.841 . . . . 0.0 112.073 -171.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.0 m -146.28 27.9 1.12 Allowed 'General case' 0 N--CA 1.5 2.045 0 CA-C-N 114.327 -1.306 . . . . 0.0 108.277 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 67.08 175.86 0.25 Allowed 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.759 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 . . . . . 0 N--CA 1.501 2.093 0 O-C-N 124.461 1.101 . . . . 0.0 111.389 -179.979 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.494 1.764 0 CA-C-O 121.576 0.703 . . . . 0.0 111.345 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.437 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 1.4 m -104.8 38.54 1.89 Allowed 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 113.442 -1.708 . . . . 0.0 109.674 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.6 t -26.21 -55.2 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.72 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -125.31 -58.14 1.45 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 103.266 -2.865 . . . . 0.0 103.266 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.2 pt -68.63 154.94 93.95 Favored Pre-proline 0 C--N 1.305 -1.331 0 CA-C-N 112.209 -2.269 . . . . 0.0 108.631 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -57.88 -174.92 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 123.075 2.517 . . . . 0.0 111.339 162.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.524 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 33.8 t -78.98 -51.09 10.1 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.47 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 68.8 p 41.24 34.8 0.35 Allowed 'General case' 0 N--CA 1.505 2.313 0 O-C-N 125.18 1.55 . . . . 0.0 114.787 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.3 t -145.58 -37.02 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-N 113.369 -1.741 . . . . 0.0 109.748 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.9 p -120.18 -15.14 8.73 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 124.493 1.121 . . . . 0.0 109.668 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.34 -19.09 7.82 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.079 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.1 pp -56.71 -34.51 67.54 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 124.05 0.844 . . . . 0.0 113.229 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.756 HD12 HD22 ' A' ' 24' ' ' ASN . 1.1 pp -89.4 -5.66 57.25 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 123.808 0.693 . . . . 0.0 111.085 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.39 28.02 4.78 Favored Glycine 0 N--CA 1.495 2.62 0 O-C-N 124.46 1.1 . . . . 0.0 111.465 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.483 ' SG ' ' C ' ' A' ' 22' ' ' CYS . 0.6 OUTLIER -83.35 81.06 8.88 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.736 1.255 . . . . 0.0 112.279 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.9 m -59.96 123.72 17.96 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 112.582 -2.099 . . . . 0.0 111.419 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.524 ' SG ' ' HB2' ' A' ' 7' ' ' CYS . 31.1 m -66.7 85.1 0.11 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 114.109 1.152 . . . . 0.0 114.109 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 96.1 p -96.15 132.86 41.13 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.6 p30 46.0 42.18 9.09 Favored 'General case' 0 N--CA 1.503 2.218 0 CA-C-O 122.663 1.221 . . . . 0.0 110.716 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' A' ' 2' ' ' CYS . 3.0 mtm-85 56.0 38.0 29.47 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-N 112.461 -2.154 . . . . 0.0 112.372 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.3 t -136.29 124.77 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.483 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 4.0 m -60.05 122.19 13.73 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.62 133.48 38.29 Favored 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 117.358 2.355 . . . . 0.0 117.358 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.756 HD22 HD12 ' A' ' 13' ' ' LEU . 32.3 t-20 -142.47 60.35 1.44 Allowed 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.73 -33.62 3.69 Favored Glycine 0 N--CA 1.484 1.844 0 N-CA-C 107.891 -2.084 . . . . 0.0 107.891 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.455 ' H ' ' C ' ' A' ' 24' ' ' ASN . 3.3 tt -149.6 144.56 17.94 Favored Pre-proline 0 N--CA 1.488 1.439 0 N-CA-C 103.168 -2.901 . . . . 0.0 103.168 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -65.99 177.45 3.0 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.266 1.978 . . . . 0.0 112.137 -169.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.7 m -141.82 25.81 1.94 Allowed 'General case' 0 N--CA 1.501 2.108 0 CA-C-N 114.821 -1.082 . . . . 0.0 109.03 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 68.96 166.97 0.27 Allowed 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 114.611 -1.177 . . . . 0.0 111.088 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 N--CA 1.501 2.111 0 O-C-N 124.464 1.102 . . . . 0.0 111.606 -179.956 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 62.1 p . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.635 0.731 . . . . 0.0 109.093 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.474 ' SG ' ' C ' ' A' ' 20' ' ' ARG . 14.6 p -104.37 60.4 0.71 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 113.559 -1.655 . . . . 0.0 107.425 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.479 ' H ' HG23 ' A' ' 3' ' ' VAL . 9.6 t -48.91 -49.0 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 CA-C-N 113.015 -1.902 . . . . 0.0 115.508 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -116.29 -51.11 2.63 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 104.841 -2.281 . . . . 0.0 104.841 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.9 pt -64.9 164.45 21.46 Favored Pre-proline 0 C--N 1.303 -1.433 0 CA-C-N 112.297 -2.229 . . . . 0.0 108.954 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -68.22 -179.96 2.55 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 123.309 2.672 . . . . 0.0 109.716 153.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.415 ' SG ' ' OG1' ' A' ' 10' ' ' THR . 43.0 t -71.89 -63.67 1.09 Allowed 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.76 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.8 p 43.2 42.85 3.67 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 115.281 1.586 . . . . 0.0 115.281 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 79.0 t -144.99 -70.43 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 105.08 -2.193 . . . . 0.0 105.08 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.663 HG21 ' O ' ' A' ' 28' ' ' CYS . 40.5 p -88.76 -7.84 55.51 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.32 -19.18 32.89 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.498 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 39.2 mt -53.82 -39.02 65.16 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 114.758 -1.11 . . . . 0.0 112.411 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.717 HD12 HD22 ' A' ' 24' ' ' ASN . 0.6 OUTLIER -89.4 -11.42 43.25 Favored 'General case' 0 N--CA 1.483 1.202 0 O-C-N 123.974 0.796 . . . . 0.0 110.944 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 124.82 15.57 3.18 Favored Glycine 0 N--CA 1.497 2.708 0 O-C-N 124.294 0.997 . . . . 0.0 113.167 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.88 90.52 5.31 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 123.276 1.513 . . . . 0.0 112.726 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 65.9 m -71.95 126.5 29.9 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 111.8 -2.454 . . . . 0.0 110.057 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.6 t -62.76 90.24 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 124.049 0.843 . . . . 0.0 112.728 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 12.2 m -104.51 137.79 41.84 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 11.1 p30 48.23 39.62 12.42 Favored 'General case' 0 N--CA 1.502 2.138 0 CA-C-O 122.696 1.236 . . . . 0.0 110.7 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.474 ' C ' ' SG ' ' A' ' 2' ' ' CYS . 30.4 mtt180 56.19 31.93 19.27 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-N 112.63 -2.077 . . . . 0.0 113.306 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 50.1 t -136.38 138.71 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-N 112.944 -1.934 . . . . 0.0 107.855 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 71.8 m -61.52 125.0 22.22 Favored 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -135.87 113.81 11.22 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 117.789 2.514 . . . . 0.0 117.789 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.717 HD22 HD12 ' A' ' 13' ' ' LEU . 38.3 t-20 -116.67 54.77 0.84 Allowed 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 104.497 -2.409 . . . . 0.0 104.497 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.62 -37.28 3.31 Favored Glycine 0 N--CA 1.482 1.711 0 N-CA-C 106.706 -2.558 . . . . 0.0 106.706 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.457 ' H ' ' C ' ' A' ' 24' ' ' ASN . 4.0 tt -144.08 143.13 21.53 Favored Pre-proline 0 N--CA 1.488 1.451 0 N-CA-C 102.412 -3.181 . . . . 0.0 102.412 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -65.11 175.63 3.76 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 122.071 1.848 . . . . 0.0 112.661 -166.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.663 ' O ' HG21 ' A' ' 10' ' ' THR . 3.1 m -144.77 30.16 1.2 Allowed 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 114.149 -1.387 . . . . 0.0 108.117 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 64.32 -177.4 0.17 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.461 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 N--CA 1.5 2.04 0 O-C-N 124.372 1.045 . . . . 0.0 110.427 179.974 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.2 p . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.271 0.557 . . . . 0.0 111.255 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.423 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 1.4 m -104.79 37.98 2.02 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 114.057 -1.429 . . . . 0.0 109.504 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.41 HG23 ' H ' ' A' ' 3' ' ' VAL . 18.1 t -25.4 -56.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.623 0 N-CA-C 115.027 1.492 . . . . 0.0 115.027 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -125.04 -56.74 1.54 Allowed 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 103.526 -2.768 . . . . 0.0 103.526 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.6 pt -70.14 153.57 95.2 Favored Pre-proline 0 C--N 1.305 -1.349 0 CA-C-N 112.284 -2.234 . . . . 0.0 108.819 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -59.41 -175.78 0.1 OUTLIER 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.892 2.395 . . . . 0.0 111.211 163.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.532 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 13.8 t -79.47 -52.19 8.37 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.125 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.0 p 40.89 36.37 0.41 Allowed 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 37.2 t -144.46 -41.01 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-N 112.845 -1.98 . . . . 0.0 107.983 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.433 ' OG1' ' SG ' ' A' ' 7' ' ' CYS . 16.0 p -116.38 -0.15 12.63 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 124.415 1.072 . . . . 0.0 108.784 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.11 -25.86 68.29 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.455 ' H ' HD23 ' A' ' 12' ' ' LEU . 1.6 pt? -56.59 -31.75 64.56 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.871 HD12 HD22 ' A' ' 24' ' ' ASN . 0.4 OUTLIER -89.55 -9.95 47.94 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 123.451 0.469 . . . . 0.0 110.569 179.843 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.89 25.32 5.7 Favored Glycine 0 N--CA 1.494 2.537 0 O-C-N 124.266 0.979 . . . . 0.0 112.236 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.448 ' SG ' ' C ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER -80.34 86.53 5.69 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.721 1.248 . . . . 0.0 111.348 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 24.0 m -64.69 122.6 17.24 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 112.679 -2.055 . . . . 0.0 111.249 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.532 ' SG ' ' HB2' ' A' ' 7' ' ' CYS . 32.8 m -63.65 84.84 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 124.506 1.129 . . . . 0.0 113.992 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.6 t -92.58 128.33 38.4 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.7 p30 46.64 44.21 13.4 Favored 'General case' 0 N--CA 1.504 2.226 0 CA-C-O 122.678 1.227 . . . . 0.0 110.811 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.423 ' HG2' ' O ' ' A' ' 2' ' ' CYS . 2.5 mtm-85 56.04 37.39 28.79 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 112.308 -2.224 . . . . 0.0 112.173 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.1 t -136.21 121.08 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.448 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 4.0 m -56.94 123.25 14.45 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.48 111.6 9.63 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 116.682 2.105 . . . . 0.0 116.682 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.871 HD22 HD12 ' A' ' 13' ' ' LEU . 45.5 t30 -110.2 53.28 0.7 Allowed 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.5 -38.67 3.19 Favored Glycine 0 N--CA 1.483 1.769 0 N-CA-C 106.282 -2.727 . . . . 0.0 106.282 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.45 ' H ' ' C ' ' A' ' 24' ' ' ASN . 3.5 tt -138.53 144.64 43.23 Favored Pre-proline 0 N--CA 1.489 1.479 0 N-CA-C 102.225 -3.25 . . . . 0.0 102.225 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -65.56 176.37 3.52 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 122.157 1.905 . . . . 0.0 111.888 -167.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.521 ' SG ' HD11 ' A' ' 13' ' ' LEU . 3.2 m -145.76 25.36 1.31 Allowed 'General case' 0 N--CA 1.501 2.122 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.116 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 66.46 173.38 0.24 Allowed 'General case' 0 N--CA 1.5 2.04 0 CA-C-N 114.746 -1.115 . . . . 0.0 110.962 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 . . . . . 0 N--CA 1.501 2.092 0 O-C-N 124.421 1.076 . . . . 0.0 111.664 -179.897 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 12.3 t . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 122.366 1.079 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.535 ' SG ' ' N ' ' A' ' 21' ' ' VAL . 0.7 OUTLIER -106.07 41.3 1.43 Allowed 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 111.975 -2.375 . . . . 0.0 110.607 -179.9 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.415 HG23 ' H ' ' A' ' 3' ' ' VAL . 20.9 t -30.92 -53.71 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.571 0 CA-C-N 113.525 -1.671 . . . . 0.0 113.196 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -124.43 -55.44 1.65 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 104.488 -2.412 . . . . 0.0 104.488 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -61.92 131.06 93.03 Favored Pre-proline 0 C--N 1.307 -1.246 0 CA-C-N 112.968 -1.924 . . . . 0.0 109.368 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -37.55 -48.01 1.88 Allowed 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 123.987 3.125 . . . . 0.0 112.752 172.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.62 ' HB3' ' HB2' ' A' ' 11' ' ' ALA . 45.5 t 179.08 -45.04 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 O-C-N 124.145 0.903 . . . . 0.0 110.023 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.9 t 36.97 24.68 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 118.56 2.8 . . . . 0.0 118.56 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.7 t -146.89 -54.1 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.589 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.495 ' OG1' ' SG ' ' A' ' 7' ' ' CYS . 16.4 p -101.72 -5.24 25.21 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 124.002 0.814 . . . . 0.0 110.956 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.62 ' HB2' ' HB3' ' A' ' 7' ' ' CYS . . . -61.59 -14.2 28.35 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.574 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -55.77 -41.79 74.55 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 114.946 -1.024 . . . . 0.0 111.816 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.62 HD12 HD22 ' A' ' 24' ' ' ASN . 0.8 OUTLIER -89.44 4.18 49.92 Favored 'General case' 0 N--CA 1.482 1.169 0 O-C-N 124.097 0.873 . . . . 0.0 111.118 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.41 34.5 7.44 Favored Glycine 0 N--CA 1.492 2.426 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.987 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.401 ' SG ' ' HB3' ' A' ' 22' ' ' CYS . 3.2 t -81.33 89.22 6.07 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 122.801 1.286 . . . . 0.0 111.8 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 23' ' ' TYR . 57.8 m -66.8 120.05 12.88 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 112.308 -2.224 . . . . 0.0 111.246 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.57 ' SG ' ' HA ' ' A' ' 20' ' ' ARG . 21.4 t -58.96 146.45 37.92 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.4 m -150.09 124.45 9.57 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 103.6 -2.741 . . . . 0.0 103.6 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.8 p30 45.64 45.25 10.88 Favored 'General case' 0 N--CA 1.505 2.305 0 CA-C-O 122.99 1.376 . . . . 0.0 110.134 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.57 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 4.4 mtm-85 55.34 38.86 30.94 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 112.052 -2.34 . . . . 0.0 112.94 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.535 ' N ' ' SG ' ' A' ' 2' ' ' CYS . 42.5 t -136.18 116.98 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.401 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 34.1 m -53.35 131.52 37.84 Favored 'General case' 0 N--CA 1.511 2.583 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.439 ' O ' ' N ' ' A' ' 16' ' ' SER . 0.2 OUTLIER -135.84 140.45 44.2 Favored 'General case' 0 N--CA 1.504 2.274 0 N-CA-C 116.423 2.009 . . . . 0.0 116.423 -179.336 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.62 HD22 HD12 ' A' ' 13' ' ' LEU . 11.8 t-20 -148.8 59.97 1.06 Allowed 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.52 -50.36 3.53 Favored Glycine 0 N--CA 1.482 1.752 0 N-CA-C 104.733 -3.347 . . . . 0.0 104.733 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.2 pt -127.59 148.72 67.86 Favored Pre-proline 0 C--N 1.306 -1.311 0 N-CA-C 102.48 -3.156 . . . . 0.0 102.48 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -65.08 175.76 3.64 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 121.978 1.785 . . . . 0.0 110.34 -176.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.409 ' O ' HG21 ' A' ' 10' ' ' THR . 2.0 m -140.69 20.67 2.34 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-N 114.854 -1.067 . . . . 0.0 108.887 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 69.31 179.1 0.25 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 124.328 1.017 . . . . 0.0 109.278 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 . . . . . 0 N--CA 1.5 2.026 0 O-C-N 124.353 1.033 . . . . 0.0 111.165 -179.941 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 17.0 m . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.564 0.697 . . . . 0.0 111.689 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.522 ' SG ' ' HB2' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -104.67 34.53 3.1 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 113.769 -1.559 . . . . 0.0 110.143 -179.936 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.467 ' H ' HG23 ' A' ' 3' ' ' VAL . 42.1 t -27.54 -53.69 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.754 0 O-C-N 125.023 1.452 . . . . 0.0 113.089 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -125.7 -55.57 1.51 Allowed 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 104.387 -2.449 . . . . 0.0 104.387 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.5 pt -67.68 165.68 28.72 Favored Pre-proline 0 C--N 1.306 -1.302 0 CA-C-N 113.247 -1.797 . . . . 0.0 108.9 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -58.4 -178.37 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 123.043 2.495 . . . . 0.0 111.42 154.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.522 ' HB2' ' SG ' ' A' ' 2' ' ' CYS . 0.6 OUTLIER -88.96 -52.24 5.19 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 114.371 -1.286 . . . . 0.0 108.469 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 34.05 54.48 0.57 Allowed 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.5 HG12 HG23 ' A' ' 10' ' ' THR . 26.0 t -150.03 -41.26 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-N 112.849 -1.978 . . . . 0.0 107.287 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.682 HG21 ' O ' ' A' ' 28' ' ' CYS . 33.3 p -123.74 -19.4 5.77 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 114.59 -1.186 . . . . 0.0 109.033 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.45 -27.1 5.88 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.8 pp -54.86 -36.63 65.3 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.678 HD12 HD22 ' A' ' 24' ' ' ASN . 0.7 OUTLIER -89.59 -5.07 57.52 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -179.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.62 14.76 5.16 Favored Glycine 0 N--CA 1.5 2.923 0 O-C-N 124.066 0.853 . . . . 0.0 112.6 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.495 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 74.1 m -80.59 87.43 5.76 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 123.95 1.833 . . . . 0.0 109.606 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.0 m -67.19 125.51 26.26 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 111.566 -2.561 . . . . 0.0 112.106 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.4 m -66.41 82.4 0.09 Allowed 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 122.187 0.994 . . . . 0.0 111.796 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.3 m -93.6 123.82 37.18 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.3 p30 47.06 42.37 12.65 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 124.548 1.155 . . . . 0.0 110.402 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 2' ' ' CYS . 0.0 OUTLIER 58.3 36.81 25.86 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 112.475 -2.148 . . . . 0.0 111.815 -179.852 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 74.3 t -136.61 119.99 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 179.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.558 ' SG ' ' OG1' ' A' ' 10' ' ' THR . 0.1 OUTLIER -61.4 124.41 20.53 Favored 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 179.843 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -135.5 125.73 26.34 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -179.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.678 HD22 HD12 ' A' ' 13' ' ' LEU . 45.7 t-20 -130.63 61.36 1.61 Allowed 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.3 -50.93 3.65 Favored Glycine 0 N--CA 1.48 1.569 0 N-CA-C 104.373 -3.491 . . . . 0.0 104.373 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.68 150.15 60.93 Favored Pre-proline 0 C--N 1.308 -1.217 0 N-CA-C 103.769 -2.678 . . . . 0.0 103.769 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -64.49 175.29 3.56 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.215 1.943 . . . . 0.0 110.503 -173.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.682 ' O ' HG21 ' A' ' 10' ' ' THR . 2.8 m -149.35 19.9 0.95 Allowed 'General case' 0 N--CA 1.497 1.875 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.914 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 62.68 -172.49 0.16 Allowed 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.061 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 . . . . . 0 N--CA 1.498 1.959 0 O-C-N 124.325 1.015 . . . . 0.0 110.561 179.999 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 73.7 p . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.493 0.663 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.482 ' SG ' ' C ' ' A' ' 20' ' ' ARG . 6.2 p -104.77 51.96 0.75 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 113.747 -1.569 . . . . 0.0 109.577 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.443 ' H ' HG23 ' A' ' 3' ' ' VAL . 9.7 t -40.67 -51.41 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.451 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -120.56 -60.18 1.69 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 103.638 -2.727 . . . . 0.0 103.638 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.2 pt -66.74 147.64 98.98 Favored Pre-proline 0 C--N 1.305 -1.345 0 CA-C-N 112.414 -2.175 . . . . 0.0 106.807 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -60.21 -179.75 0.26 Allowed 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.858 2.372 . . . . 0.0 111.104 169.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 40.8 t -65.38 -61.62 2.01 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.933 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.1 p 37.73 38.51 0.17 Allowed 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.47 ' O ' HD23 ' A' ' 12' ' ' LEU . 27.5 t -139.71 -67.44 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-N 112.945 -1.934 . . . . 0.0 106.513 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.661 HG21 ' O ' ' A' ' 28' ' ' CYS . 25.6 p -94.36 -5.1 47.27 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 124.222 0.951 . . . . 0.0 109.087 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.34 -18.8 30.2 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.812 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.47 HD23 ' O ' ' A' ' 9' ' ' VAL . 3.0 pp -54.91 -36.4 65.16 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.762 HD12 HD22 ' A' ' 24' ' ' ASN . 0.7 OUTLIER -89.44 -11.79 42.08 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 123.831 0.707 . . . . 0.0 110.934 179.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.85 21.46 3.21 Favored Glycine 0 N--CA 1.496 2.641 0 O-C-N 124.417 1.073 . . . . 0.0 112.443 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -83.36 84.92 7.33 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 123.194 1.474 . . . . 0.0 112.348 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.8 m -65.46 127.37 31.53 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 111.777 -2.465 . . . . 0.0 111.339 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 39.6 t -63.32 87.37 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 124.113 0.883 . . . . 0.0 113.162 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.9 m -99.59 131.02 45.86 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.3 p30 47.22 43.55 14.82 Favored 'General case' 0 N--CA 1.504 2.248 0 CA-C-O 122.861 1.315 . . . . 0.0 110.624 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.482 ' C ' ' SG ' ' A' ' 2' ' ' CYS . 5.7 mtm-85 55.29 33.23 20.26 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 112.248 -2.251 . . . . 0.0 113.155 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.1 t -136.35 130.4 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 CA-C-N 113.059 -1.882 . . . . 0.0 107.244 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 74.2 m -59.5 125.15 22.47 Favored 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -135.88 125.39 25.12 Favored 'General case' 0 N--CA 1.503 2.205 0 N-CA-C 117.632 2.456 . . . . 0.0 117.632 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.762 HD22 HD12 ' A' ' 13' ' ' LEU . 37.8 t-20 -132.9 55.96 1.87 Allowed 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.13 -48.38 3.19 Favored Glycine 0 N--CA 1.482 1.75 0 N-CA-C 104.522 -3.431 . . . . 0.0 104.522 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.41 ' H ' ' C ' ' A' ' 24' ' ' ASN . 1.5 pt -127.41 144.42 50.76 Favored Pre-proline 0 C--N 1.308 -1.233 0 N-CA-C 103.365 -2.828 . . . . 0.0 103.365 179.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -65.28 176.3 3.38 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.196 1.931 . . . . 0.0 111.732 -174.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.661 ' O ' HG21 ' A' ' 10' ' ' THR . 2.9 m -146.13 27.04 1.18 Allowed 'General case' 0 N--CA 1.5 2.052 0 CA-C-N 114.671 -1.15 . . . . 0.0 108.185 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 63.35 -176.36 0.15 Allowed 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.539 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 . . . . . 0 N--CA 1.5 2.036 0 O-C-N 124.081 0.863 . . . . 0.0 110.106 -179.992 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 21.0 m . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.952 0.882 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.49 ' SG ' ' N ' ' A' ' 21' ' ' VAL . 0.2 OUTLIER -104.55 42.9 1.15 Allowed 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 112.986 -1.916 . . . . 0.0 110.388 179.983 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.424 HG23 ' H ' ' A' ' 3' ' ' VAL . 15.4 t -33.46 -50.41 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.429 0 CA-C-N 113.256 -1.793 . . . . 0.0 113.555 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -123.41 -58.19 1.62 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 104.756 -2.313 . . . . 0.0 104.756 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -61.2 133.41 92.81 Favored Pre-proline 0 C--N 1.306 -1.311 0 CA-C-N 112.587 -2.097 . . . . 0.0 109.009 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -41.48 -46.24 5.99 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 123.472 2.781 . . . . 0.0 112.427 173.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.424 ' SG ' ' OG1' ' A' ' 10' ' ' THR . 52.9 t 179.11 -57.08 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 O-C-N 124.409 1.068 . . . . 0.0 108.542 179.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 71.4 p 38.16 34.63 0.07 Allowed 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 115.961 1.837 . . . . 0.0 115.961 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 50.3 t -144.56 -62.52 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-N 113.621 -1.627 . . . . 0.0 108.707 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.677 HG21 ' O ' ' A' ' 28' ' ' CYS . 15.8 p -98.29 0.56 45.84 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 124.22 0.95 . . . . 0.0 110.514 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.13 -17.37 39.79 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.928 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 48.1 mt -54.92 -44.24 74.05 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 114.448 -1.251 . . . . 0.0 111.52 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.579 HD12 HD22 ' A' ' 24' ' ' ASN . 0.6 OUTLIER -89.45 2.55 54.36 Favored 'General case' 0 C--N 1.31 -1.139 0 O-C-N 124.174 0.922 . . . . 0.0 111.886 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.34 33.76 7.45 Favored Glycine 0 N--CA 1.494 2.558 0 CA-C-N 115.023 -0.989 . . . . 0.0 112.736 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 2.1 t -80.65 93.31 6.12 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 122.392 1.092 . . . . 0.0 111.449 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 23' ' ' TYR . 67.7 m -73.24 118.07 15.75 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 113.128 -1.851 . . . . 0.0 109.261 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.458 ' SG ' ' HA ' ' A' ' 20' ' ' ARG . 49.3 t -66.45 148.41 51.92 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 60.9 p -150.2 136.62 18.91 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 104.123 -2.547 . . . . 0.0 104.123 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.9 p30 46.53 39.76 7.26 Favored 'General case' 0 N--CA 1.504 2.266 0 CA-C-O 122.652 1.215 . . . . 0.0 110.933 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.458 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 5.0 mtm-85 55.46 39.04 31.05 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 112.624 -2.08 . . . . 0.0 112.501 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.49 ' N ' ' SG ' ' A' ' 2' ' ' CYS . 55.0 t -136.2 116.79 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 59.2 m -51.86 133.45 31.97 Favored 'General case' 0 N--CA 1.512 2.63 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.402 ' O ' ' N ' ' A' ' 16' ' ' SER . 0.2 OUTLIER -135.75 131.56 35.7 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 117.038 2.236 . . . . 0.0 117.038 -179.291 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.579 HD22 HD12 ' A' ' 13' ' ' LEU . 11.4 t-20 -138.13 62.06 1.58 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 105.553 -2.018 . . . . 0.0 105.553 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.73 -39.45 3.11 Favored Glycine 0 N--CA 1.485 1.907 0 N-CA-C 107.322 -2.311 . . . . 0.0 107.322 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.446 ' H ' ' C ' ' A' ' 24' ' ' ASN . 2.5 tt -147.44 147.44 28.13 Favored Pre-proline 0 N--CA 1.487 1.408 0 N-CA-C 101.942 -3.355 . . . . 0.0 101.942 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -63.84 176.26 2.49 Favored 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 121.792 1.661 . . . . 0.0 111.63 -168.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.677 ' O ' HG21 ' A' ' 10' ' ' THR . 3.4 m -136.54 21.3 3.13 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 114.436 -1.256 . . . . 0.0 109.045 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 28' ' ' CYS . . . 69.33 174.08 0.29 Allowed 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.254 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 . . . . . 0 N--CA 1.501 2.078 0 O-C-N 124.405 1.066 . . . . 0.0 110.176 -179.854 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 10.7 m . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.9 p -104.68 57.29 0.7 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 114.242 -1.345 . . . . 0.0 109.853 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.404 HG13 ' NH2' ' A' ' 20' ' ' ARG . 54.4 t -34.45 -66.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.387 0 CA-C-N 113.4 -1.727 . . . . 0.0 115.093 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -116.86 -52.95 2.52 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 103.065 -2.939 . . . . 0.0 103.065 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.2 pt -72.23 133.97 83.06 Favored Pre-proline 0 C--N 1.304 -1.395 0 CA-C-N 112.24 -2.255 . . . . 0.0 106.675 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -56.17 179.91 0.09 OUTLIER 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.884 2.389 . . . . 0.0 111.479 173.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.48 ' SG ' ' OG1' ' A' ' 10' ' ' THR . 42.1 t -68.53 -58.08 4.84 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 114.521 -1.218 . . . . 0.0 111.037 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.4 p 36.19 41.29 0.13 Allowed 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 115.759 1.762 . . . . 0.0 115.759 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.5 t -146.97 -67.0 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-N 113.076 -1.875 . . . . 0.0 106.644 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.48 ' OG1' ' SG ' ' A' ' 7' ' ' CYS . 36.6 p -84.49 -11.19 56.61 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.1 -18.6 36.94 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.231 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 88.2 mt -55.0 -37.7 66.92 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.108 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.761 HD12 HD22 ' A' ' 24' ' ' ASN . 0.7 OUTLIER -89.37 -11.48 43.12 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 123.909 0.755 . . . . 0.0 110.931 179.911 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 123.06 17.72 3.29 Favored Glycine 0 N--CA 1.497 2.743 0 O-C-N 124.27 0.981 . . . . 0.0 113.138 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.75 88.99 6.73 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 122.993 1.378 . . . . 0.0 113.071 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.6 m -70.61 126.92 30.97 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 112.409 -2.178 . . . . 0.0 110.301 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.7 t -62.28 89.89 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 124.133 0.895 . . . . 0.0 112.689 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.7 t -105.69 134.57 48.59 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.7 p30 47.78 42.72 16.17 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 124.762 1.289 . . . . 0.0 111.251 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.404 ' NH2' HG13 ' A' ' 3' ' ' VAL . 10.7 mtp180 56.86 30.91 18.69 Favored 'General case' 0 N--CA 1.502 2.169 0 CA-C-N 112.58 -2.1 . . . . 0.0 112.948 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 53.7 t -136.29 136.31 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 CA-C-N 113.159 -1.837 . . . . 0.0 108.166 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 84.4 m -62.78 126.98 29.15 Favored 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 105.785 -1.932 . . . . 0.0 105.785 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.82 117.25 14.72 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 118.414 2.746 . . . . 0.0 118.414 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.761 HD22 HD12 ' A' ' 13' ' ' LEU . 41.5 t-20 -121.96 55.97 1.1 Allowed 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.0 -37.24 3.28 Favored Glycine 0 N--CA 1.484 1.842 0 N-CA-C 107.16 -2.376 . . . . 0.0 107.16 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.455 ' H ' ' C ' ' A' ' 24' ' ' ASN . 4.5 tt -146.06 142.21 17.46 Favored Pre-proline 0 N--CA 1.487 1.408 0 N-CA-C 102.294 -3.225 . . . . 0.0 102.294 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -65.67 174.98 4.79 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.084 1.856 . . . . 0.0 112.749 -166.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.2 m -140.26 28.12 2.08 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 113.899 -1.5 . . . . 0.0 107.723 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 66.26 -178.49 0.2 Allowed 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.319 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 . . . . . 0 N--CA 1.501 2.096 0 O-C-N 124.439 1.087 . . . . 0.0 112.189 -179.988 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 52.2 p . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 121.553 0.692 . . . . 0.0 110.5 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.471 ' HB3' ' O ' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -104.79 38.6 1.87 Allowed 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 113.764 -1.562 . . . . 0.0 111.046 -179.954 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.464 ' H ' HG23 ' A' ' 3' ' ' VAL . 12.1 t -23.87 -53.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.527 0 CA-C-N 113.146 -1.843 . . . . 0.0 115.571 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -122.74 -37.48 2.75 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.442 ' CG1' ' HA ' ' A' ' 2' ' ' CYS . 14.9 pt -72.0 178.47 1.31 Allowed Pre-proline 0 CA--C 1.561 1.379 0 CA-C-N 112.789 -2.005 . . . . 0.0 111.188 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.471 ' O ' ' HB3' ' A' ' 2' ' ' CYS . 13.2 Cg_endo -82.03 -52.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 124.106 3.204 . . . . 0.0 110.766 168.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.558 ' HB3' ' HB2' ' A' ' 11' ' ' ALA . 51.9 t 179.04 -59.4 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 124.188 0.93 . . . . 0.0 109.334 179.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.2 p 40.38 38.12 0.52 Allowed 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 115.008 1.485 . . . . 0.0 115.008 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.467 HG12 HG23 ' A' ' 10' ' ' THR . 42.1 t -144.29 -63.68 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-N 113.27 -1.786 . . . . 0.0 108.362 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.638 HG21 ' O ' ' A' ' 28' ' ' CYS . 26.1 p -100.42 -14.25 18.39 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 124.102 0.876 . . . . 0.0 110.797 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.558 ' HB2' ' HB3' ' A' ' 7' ' ' CYS . . . -50.81 -20.08 1.17 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 123.743 0.652 . . . . 0.0 112.37 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 35.2 mt -54.19 -45.07 72.08 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 124.297 0.998 . . . . 0.0 112.271 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.719 HD12 HD22 ' A' ' 24' ' ' ASN . 0.7 OUTLIER -89.58 13.86 12.98 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 124.182 0.926 . . . . 0.0 112.361 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.68 29.44 16.09 Favored Glycine 0 N--CA 1.495 2.6 0 CA-C-N 115.046 -0.979 . . . . 0.0 113.267 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.623 ' SG ' HD11 ' A' ' 13' ' ' LEU . 78.6 m -81.3 80.11 7.78 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.67 1.224 . . . . 0.0 110.013 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.8 m -66.52 117.48 8.78 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 112.392 -2.185 . . . . 0.0 110.407 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.629 ' SG ' ' HA ' ' A' ' 20' ' ' ARG . 48.6 t -63.23 144.43 56.94 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 114.567 -1.197 . . . . 0.0 113.993 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.5 m -147.3 130.15 16.18 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 103.443 -2.799 . . . . 0.0 103.443 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.2 p30 45.6 41.59 7.22 Favored 'General case' 0 N--CA 1.506 2.335 0 CA-C-O 122.769 1.271 . . . . 0.0 110.154 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.629 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 0.2 OUTLIER 56.3 41.33 29.28 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 112.346 -2.206 . . . . 0.0 112.741 -179.878 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 78.9 t -136.07 111.84 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 105.685 -1.968 . . . . 0.0 105.685 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 59.5 m -52.44 127.46 22.52 Favored 'General case' 0 N--CA 1.507 2.389 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -135.58 113.67 11.29 Favored 'General case' 0 N--CA 1.509 2.487 0 N-CA-C 117.293 2.331 . . . . 0.0 117.293 -179.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.719 HD22 HD12 ' A' ' 13' ' ' LEU . 52.8 t30 -106.26 54.47 0.69 Allowed 'General case' 0 N--CA 1.506 2.348 0 N-CA-C 103.948 -2.612 . . . . 0.0 103.948 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.84 -43.07 2.96 Favored Glycine 0 N--CA 1.482 1.741 0 N-CA-C 104.77 -3.332 . . . . 0.0 104.77 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.474 ' H ' ' C ' ' A' ' 24' ' ' ASN . 2.6 pt -125.08 150.53 67.0 Favored Pre-proline 0 C--N 1.308 -1.204 0 N-CA-C 102.917 -2.994 . . . . 0.0 102.917 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -64.12 174.87 3.62 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 121.827 1.685 . . . . 0.0 110.632 -171.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.638 ' O ' HG21 ' A' ' 10' ' ' THR . 5.3 m -148.53 20.4 1.05 Allowed 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 114.614 -1.175 . . . . 0.0 108.701 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 62.46 -172.53 0.16 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.052 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 . . . . . 0 N--CA 1.5 2.046 0 O-C-N 124.277 0.986 . . . . 0.0 110.958 -179.919 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 73.3 m . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.74 0.781 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.518 ' SG ' ' C ' ' A' ' 20' ' ' ARG . 1.4 p -103.98 47.17 0.89 Allowed 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 113.266 -1.788 . . . . 0.0 109.382 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.41 ' HA ' ' HG2' ' A' ' 20' ' ' ARG . 24.0 t -47.55 -46.3 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 CA-C-N 113.937 -1.483 . . . . 0.0 113.059 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -118.52 -55.66 2.19 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 104.789 -2.3 . . . . 0.0 104.789 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.4 ' O ' ' HB2' ' A' ' 2' ' ' CYS . 0.4 OUTLIER -61.86 150.81 81.57 Favored Pre-proline 0 C--N 1.307 -1.255 0 CA-C-N 113.192 -1.822 . . . . 0.0 108.424 179.635 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -58.94 -48.43 14.48 Favored 'Trans proline' 0 N--CA 1.492 1.441 0 C-N-CA 123.343 2.695 . . . . 0.0 112.891 169.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.419 ' SG ' ' N ' ' A' ' 11' ' ' ALA . 42.0 t 179.49 -62.63 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 60.3 p 40.32 32.52 0.13 Allowed 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 55.3 t -148.06 -44.79 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-N 113.766 -1.561 . . . . 0.0 110.614 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.704 HG21 ' O ' ' A' ' 28' ' ' CYS . 2.6 p -118.01 -3.1 11.16 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 124.316 1.01 . . . . 0.0 112.83 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.419 ' N ' ' SG ' ' A' ' 7' ' ' CYS . . . -63.22 -20.14 65.16 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.115 0.483 . . . . 0.0 110.259 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.446 ' H ' HD12 ' A' ' 12' ' ' LEU . 3.4 mp -55.74 -38.17 69.45 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-N 114.4 -1.273 . . . . 0.0 113.624 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.827 HD12 HD22 ' A' ' 24' ' ' ASN . 0.6 OUTLIER -89.32 -4.24 58.18 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 123.903 0.752 . . . . 0.0 112.217 -179.958 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.65 18.46 10.12 Favored Glycine 0 N--CA 1.497 2.706 0 O-C-N 124.221 0.95 . . . . 0.0 112.556 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.715 ' HB3' ' SG ' ' A' ' 22' ' ' CYS . 2.0 t -75.56 119.87 20.2 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 122.063 0.935 . . . . 0.0 110.088 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.5 m -95.38 118.18 31.67 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 112.914 -1.948 . . . . 0.0 112.419 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.612 ' SG ' ' HA ' ' A' ' 20' ' ' ARG . 42.7 t -62.03 106.01 0.66 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 115.273 1.583 . . . . 0.0 115.273 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.9 m -113.58 133.48 55.25 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 103.934 -2.617 . . . . 0.0 103.934 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.0 p30 46.37 42.12 10.13 Favored 'General case' 0 N--CA 1.506 2.372 0 CA-C-O 122.741 1.258 . . . . 0.0 110.73 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.612 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 0.2 OUTLIER 54.75 38.0 29.37 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 112.341 -2.208 . . . . 0.0 113.354 -179.893 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.478 ' N ' ' SG ' ' A' ' 2' ' ' CYS . 54.4 t -136.4 117.7 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.715 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 0.5 OUTLIER -55.79 129.94 41.4 Favored 'General case' 0 N--CA 1.509 2.493 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 179.893 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.74 105.98 6.36 Favored 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 116.938 2.199 . . . . 0.0 116.938 -178.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.827 HD22 HD12 ' A' ' 13' ' ' LEU . 25.5 t-20 -96.94 56.11 1.39 Allowed 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.93 -43.44 3.07 Favored Glycine 0 N--CA 1.484 1.867 0 N-CA-C 106.088 -2.805 . . . . 0.0 106.088 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.436 ' H ' ' C ' ' A' ' 24' ' ' ASN . 3.9 tt -131.37 147.07 64.69 Favored Pre-proline 0 N--CA 1.488 1.474 0 N-CA-C 101.442 -3.54 . . . . 0.0 101.442 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -64.84 174.46 4.62 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 C-N-CA 121.936 1.757 . . . . 0.0 111.429 -166.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.704 ' O ' HG21 ' A' ' 10' ' ' THR . 1.9 m -145.66 21.0 1.49 Allowed 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 114.286 -1.325 . . . . 0.0 108.952 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 66.94 -176.95 0.2 Allowed 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.731 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 . . . . . 0 N--CA 1.499 2.015 0 O-C-N 124.423 1.077 . . . . 0.0 110.98 -179.924 . . . . . . . . 0 0 . 1 stop_ save_